EXPLORING BRAIN FUNCTIONAL ANATOMY WITH POSITRON TOMOGRAPHY
The Ciba Foundation is an international scientific and ed...
75 downloads
1153 Views
18MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
EXPLORING BRAIN FUNCTIONAL ANATOMY WITH POSITRON TOMOGRAPHY
The Ciba Foundation is an international scientific and educational charity. It was established in 1947 by the Swiss chemical and pharmaceutical company of ClBA Limited- now CIBA-GEIGY Limited. The Foundation operates independently in London under English trust law. The Ciba Foundation exists to promote international cooperation in biological, medical and chemical research. It organizes about eight international multidisciplinary symposia each year on topics that seem ready for discussion by a small group of research workers. The papers and discussions are published in the Ciba Foundation symposium series. The Foundation also holds many shorter meetings (not published), organized by the Foundation itself or by outside scientific organizations. The staff always welcome suggestions for future meetings. The Foundation’s house at 41 Portland Place, London W1 N 4BN, provides facilities for meetings of all kinds. Its Media Resource Service supplies Information to journalists on all scientific and technological topics. The library, open five days a week to any graduate in science or medicine, also provides information on scientific meetings throughout the world and answers general enquiries on biomedical and chemical subjects. Scientists from any part of the world may stay in the house during working visits to London.
Ciba Foundation Symposium 163
EXPLORING BRAIN FUNCTIONAL ANATOMY WITH POSITRON TOMOGRAPHY A Wiley-Interscience Publication
1991
JOHN WlLEY & SONS Chichester
. New York
. Brisbane
. Toronto . Singapore
OCiba Foundation 1991 Published in 1991 by John Wiley & Sons Ltd. Baffins Lane, Chichester West Sussex PO19 IUD,England All rights reserved. No part of this book may be reproduced by any means, or transmitted, or translated into a machine language without the written permission of the publisher.
Olher Wiley Edilorial Offices John Wiley & Sons, Inc., 605 Third Avenue, New York, NY 10158-0012, USA Jacaranda Wiley Ltd, G.P.O.Box 859, Brisbane, Queensland 4001, Australia John Wiley & Sons (Canada) Ltd, 22 Worcester Road, Rexdale, Ontario M9W 1L1, Canada John Wiley & Sons (SEA) Pte Ltd, 37 Jalan Pemimpin 05-04, Block B. Union Industrial Building, Singapore 2057 Suggested series entry for library catalogues: Ciba Foundation Symposia Ciha Foundation Symposium 163 x + 287 pages, 42 figures, 14 tables
Library of Congress Cataloging-in-PublicationData Exploring brain functional anatomy with positron tomography. p. cm.-(Ciba Foundation symposium; 163) Editors: Derek J. Chadwick (organizer) and Julie Whelan. “Symposium on Exploring Brain Functional Anatomy with Positron Tomography, held at the Ciba Foundation, London, 12-14 March 1991”Contents p. “A Wiley-Interscience Publication.” Includes bibliographical references and indexes. ISBN 0 471 92970 0 1. Brain-Tomography-Congresses. 2. Brain-MetabolismCongresses. 3. Cerebral circulation-Congresses. 1. Chadwick, Derek. 11. Whelan, Julie. 111. Symposium on Exploring Brain Functional Anatomy with Positron Tomography (1991: Ciba Foundation) IV. Series. 1DNLM: 1. Brain-metabolism-congresses. 2. Brain-radionuclide imaging-congresses. 3. Tomography, Emission-Computed-congresses. W3 C161F v. 163/WL 141 E96] QP376.E93 1991 612.8 ’ 2-dc20 DNLM/DLC 91-40214 for Library of Congress ClP British Library Cataloguing in Publication Duta A catalogue record for this book is available from the British Library ISBN 0 471 92970 0 Phototypeset by Dobbie Typesetting Limited, Tavistock, Devon. Printed and bound in Great Britain by Biddles Ltd., Guildford.
Contents Symposium on Exploring Brain Functional Anatomy with Positron Tomography, held at the Ciba Foundation, London 12-14 March 1991 The topic of the symposium was proposed by Professor Richard Frackowiak Editors: Derek J. Chadwick (Organizer) and Julie Whelan R. Porter Introduction
1
R. C. Collins* Basic aspects of functional brain metabolism Discussion 16
6
H. Iida, I. Kanno and S. Miura Rapid measurement of cerebral blood flow with positron emission tomography 23 Discussion 37 General discussion Brain energy metabolism: cell body or synapse? Oxidative metabolism in brain 5 1
43
D. W. Townsend Optimization of signal in positron emission tomography scans: present and future developments 57 Discussion 69 K. J. Friston, P. M. Grasby, C. D. Frith, C. J. Bench, R. J. Dolan, P. J. Cowen, P. F. Liddle and R. S. J. Frackowiak The neurotransmitter basis of cognition: psychopharmacological activation studies 76 Discussion 87 J. C. Mazziotta, D. Valentino, S. Grafton, F. Bookktein, C. Pelizzari, G. Chen and A. W. Toga Relating structure to function in vivo with tomographic imaging 93 Discussion 101 *In Professor Collins’ unavoidable absence his paper was presented by Professor John Mazziotta. V
vi
Contents
P. E. Roland and R. J. Seitz Positron emission tomography studies of the somatosensory system in man 113 Discussion 120 P. T. Fox and J. V. Pardo Does inter-subject variability in cortical functional organization increase with neural ‘distance’ from the periphery? 125 Discussion 140
S. Zeki A thought experiment with positron emission tomography 145 Discussion 154 M. Corbetta, F. M. Miezin, G. L. Shulman and S. E. Petersen Selective attention modulates extrastriate visual regions in humans during visual feature discrimination and recognition 165 Discussion 175 C. D. Frith Positron emission tomography studies of frontal lobe function: relevance to psychiatric disease 181 Discussion 191 M. E. Raichle Memory mechanisms in the processing of words and wordlike symbols 198 Discussion 204
R. J. Wise, U. Hadar, D. Howard and K. Patterson Language activation studies with positron emission tomography 218 Discussion 228
R. S. J. Frackowiak, C. Weiller and F. Chollet The functional anatomy of recovery from brain injury 235 Discussion 244
J. C. Baron Testing cerebral function: will it help the understanding or diagnosis of central nervous system disease? 250 Discussion 26 1
Final general discussion 265
R. Porter Summing-up 275 Index of contributors 278 Subject index 280
Participants J. C. Baron Centre Cyceron, INSERM U. 320, BP 5027, Bd Henri Becquerel, F-14021 Caen Cedex, France S. F. Cappa Clinica Neurologica, Universita di Brescia, Neurologia I1 Spedali Civili, Piazzale Ospedale 1, 1-25125 Brescia, Italy
F. Chollet Department of Neurology, HBpital Purpan, F-31059 Toulouse, France R. C. Collins* UCLA Department of Neurology, Reed Neurological Research Center, 710 Westwood Plaza, Los Angeles, CA 90024-1769, USA M. Corbetta Department o f Neurology & Neurological Surgery, Washington University School of Medicine, Box 81 11, 660 South Euclid Avenue, St Louis, MO 63110, USA
A. C. Evans Positron Imaging Laboratories, McConnell Brain Imaging Centre, Montreal Neurological Hospital & Institute, 3801 University Street, Montreal, Quebec, Canada H3A 2B4
P. T. Fox Research Imaging Center, The University of Texas Health
Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284-7800, USA
R. S. J. Frackowiak MRC Cyclotron Unit, Hammersmith Hospital, Ducane Road, London W12 OHS, UK K. J. Friston** MRC Cyclotron Unit, Hammersmith Hospital, Ducane Road, London W12 OHS, UK *Professor Collins was unable to attend the symposium. His paper was presented by Professor Mazziotta. **Present address: Neurosciences Institute, 1230 York Avenue, New York, NY 100021, USA. vii
viii
Participants
C. D. Frith Division of Psychiatry, Clinical Research Centre, Watford Road, Harrow, Middlesex, HA1 3UJ, UK B. Gulyas Department of Clinical Neurophysiology, Karolinska Hospital, Box 60500, S-104 01 Stockholm 60, Sweden
H. Iida Research Institute of Brain & Blood Vessels, Senshu-KubotaMachi, Akita City 010, Japan M. Jeannerod Vision et Motricitt, INSERM U. 94, 16 Avenue du Doyen LCpine, F-69500 Bron, France
T. Jones PET Methods Section, MRC Cyclotron Unit, Hammersmith Hospital, Ducane Road, London W12 OHS, UK N. A. Lassen Department of Clinical PhysiologicaVNuclear Medicine, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark E. T. MacKenzie Centre Cyceron. INSERM U. 320, BP 5027, Bd Henri Becquerel, F- 14021 Caen Cedex, France
J. C. Mazziotta Department of Neurology, UCLA School of Medicine, University of California, Los Angeles, CA 90024-1769, USA R. E. Passingham Department of Experimental Psychology, University of Oxford, South Parks Road, Oxford OX1 3UD, UK F. Plum Department of Neurology, The New York Hospital-Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA R. Porter (Chairman) Faculty of Medicine, Monash University, Clayton, Melbourne, Victoria 3168, Australia
M. E. Raichle Division of Radiation Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA P. E. Roland Department of Clinical Neurophysiology, Karolinska Hospital, Box 60500, S-104 01 Stockholm 60, Sweden L. Sokoloff Laboratory for Cerebral Metabolism, National Institute of Mental Health, Building 36, Room lAO5, National Institutes of Health, Bethesda, MD 20892, USA
Participants
ix
D. W. Townsend Division of Nuclear Medicine, HBpital Cantonal, University of Geneva, CH-1211 Geneva 4, Switzerland E. K. Warrington Department of Clinical Neuropsychology, The National Hospital, Queen Square, London WClN 3BG, UK R. J. Wise PET Clinical Group, Westminster & Charing Cross Hospital, Reynolds Building, St Dunstan’s Road, London W6 8RP, UK S. Zeki Department of Anatomy and Developmental Biology, University College London, Gower Street, London WClE 6BT, UK
Introduction Robert Porter Faculty of Medicine, Monash University, Clayton, Melbourne, Victoria 3 168, Australia
Historically, the exploration of brain functional anatomy has used the methods of clinicopathological correlation. Enormous difficulties and great uncertainty surround the interpretation of the signs and symptoms which seem t o be associated with damage or disease of localized brain regions. Broca’s contribution established the fact of anatomical localization of function within the cerebral cortex in 1861, even though, as Marie later demonstrated, his description of the extent of the lesion in his aphasic patient was incomplete. Hughlings Jackson’s studies of patients with partial epileptic seizures led him to draw conclusions about the structural organization of motor functions within the cerebral cortex which were soon shown to exist in the living, normal brain, when electrical stimulation of the cerebral cortex revealed the ordered nature of the functional representation of movement. Foerster, already a respected clinical neurologist, began to perform neurosurgical operations in the early 1920s. In the process of providing treatment for his patients, he seems to have regarded each operation as a n opportunity to conduct a physiological experiment and to study functional anatomy. Many of his observations on the interpretation of these experiments and his conclusions about the functions of different regions of the cerebral cortex in movement performance, deduced from both stimulation and ablation experiments, are summarized in his Hughlings Jackson lecture in 1935. From this work and from the observations of Penfield and his co-workers, who utilized the opportunity provided by operative excision of cerebral tumours, vascular malformations, or epileptic foci, to stimulate the exposed surface of the cerebral cortex electrically in conscious patients and to record the resulting effects in elaborate detail, have come most of our general views of human brain functional anatomy (Fig. 1). Almost all of this information relates to surface topography: the surface of the brain has been the only part accessible both to the surgeon’s scalpel and to his stimulating electrode. Moreover, and creating a problem for those developing theories of functional anatomy, some influence of the fact that the subjects were all suffering disorders which required surgical intervention could have distorted the findings towards those created by pathology rather than to observations about normal physiology. Even the earlier methods of study of regional cerebral blood flow, which could be applied to normal human subjects, 1
2
Porter
FIG. 1. Schematic diagram of the functional anatomy of the human brain, as depicted in summarizing the observations of Penfield & Boldrey (1937). (Reproduced with permission of Macmillan Publishing Company from The cerebral cortex of man by Penfield & Rasmussen. Copyright 1950 Macmillan Publishing Company; copyright renewed 01978 Theodore Rasmussen.)
allowed information about the flow through only the most superficial structures to be used as a gauge of increased or decreased local metabolism, resulting from more, or less, functional neuronal and synaptic activity in the region. Positron emission tomography (PET), whether used to study regional cerebral blood flow or to examine directly the regional metabolism or transmitter turnover of the brain, can, by its very nature, allow deep as well as superficial regions of the brain to be examined. Methods of illustrating blood flow or metabolism in these deep structures have been developed which allow tomographic sections to be constructed by computer and to reveal functional activities in deep, previously hidden regions. Yet we shall still need to validate the precise relationships between oxygen consumption, glucose metabolism, blood flow changes and neuronal interactions which describe these phenomena quantitatively (Fig. 2).
3
Introduction
NERVE SIGNAL TRANSMISSION
FIG. 2. This schematic diagram illustrates the deductive steps that are involved in interpreting changes in glucose metabolism or blood flow as modifications of neuronal activity which must have occurred in regions of the brain. Although oxygen consumption and blood flow are linked, the temporal relationships between changes in these following alterations in nerve signal transmission are poorly understood, and the precise neurophysiologicalcauses of the energy debt, and such things as the quantitative metabolic costs of excitation and inhibition at synapses, are still debated.
How has the evidence obtained with these new techniques, in normal human subjects and in those with disordered brain function, advanced our knowledge of the functional anatomy of the human brain? Which aspects of any global neuronal function, that can be separately described, are in fact localized, where are these localized, and what are the biochemical mechanisms used for that localization? That is what we are here to discuss. However, we shall also have to attempt to evaluate the techniques themselves, to examine the influence of the methods used on the functional anatomical information that they make available to us. Have we significantly advanced our knowledge beyond that
4
Porter
available from the results of electrical stimulation or other studies? What are the limitations of the techniques? What is the spatial resolution of the method of measurement and does this vary with the different positron emitters that are used to probe different metabolic events? How could spatial resolution be improved? A major problem for the study of analysable function has been the temporal resolution of all our methods of studying the human brain, apart from the realtime measures of electrical or magnetic changes produced by the nervous tissue itself during the performance of that function. Can the real-time evaluation of function be analysed, using modifications of PET, and what are the approaches that could be adopted to relate changing metabolic events directly, and temporally, to functional states, even while these are occurring? A part of the programme of this symposium must deal with the technique itself and with the sophisticated computer manipulation of measures of the coincidence of events. But the several brain functions, to the study of which the method is applied, also need our consideration. Some of those functions are ones in which there is an opportunity to control the stimulus and to analyse the details of the response. Human vision is a case in point. Already we know a great deal about the functional anatomy and the psychophysics of vision. In relation to other aspects of human brain function we have less ability to control the physiological events whose underlying regional metabolic changes we wish to analyse. Learning and memory and language are cases in point. It is surely to address these more complex questions that we need to apply new research tools, and we should not be daunted by the difficulties of interpreting the results of our studies. Finally, is there a clinical role for these investigations in the understanding of disorder in the human brain, and what is the role of PET in diagnosis? Are there examples, other than the localization of a difficult-to-detect epileptic focus, of the application of PET in patient management? We shall hear about the role of PET in following recovery from brain injury and in assessing frontal lobe function with relevance to psychiatric illness. Is this an indication that the routine monitoring of brain status in some clinical conditions may employ these methods in the future? As a neurophysiologist, I shall be interested to learn whether we have evidence of changes in regional function during development, as learned patterns of behaviour are established; or as the nervous system ages and the functional capacities of the human brain decline. Where do these changes during development or during ageing manifest themselves, and what is their biochemical basis? At this exciting stage of the development of this technique and its applications, the questions that can be raised outnumber the answers that have yet been provided. At this symposium, however, we have the opportunity to exchange views on the latest evidence that is available, to speculate on its meaning, and to project our thinking into the future and into the unknown.
Introduction
5
References Penfield W, Boldrey E 1937 Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain 60:389-443 Penfield W, Rasmussen AT 1950 The cerebral cortex of man. A clinical study of localisation of function. Macmillan, New York
Basic aspects of functional brain metabolism Robert C. Collins
Department of Neurologyp Reed Neurological Research Center, UCLA School of Medicine, Los Angeles, CA 90024, USA
Abstract. Brain energy metabolism and blood flow are greatest in neuropil where there is a high density of oxidative enzymes and capillaries. Here fluctuations in synaptic potentials cause the greatest demand on metabolism through the continuous need to pump ions to maintain membrane charge. A transient increase in functional activity within a pathway causes an increase in energy metabolism followed by an increase in blood flow. The vascular response is biphasic, with an initial increase followed by a plateau phase. The site and magnitude of the response reflect the quality and intensity of the stimulus. Prolonged changes in functional activity within a pathway cause a reorganization of energy metabolizing
enzymes and vascular architecture.
1991 Exploring brain functional anatomy with positron tomography. Wiley, Chichester (Ciba Foundation Symposium 163) p 6-22
The last several years have witnessed important advances in the use of positron emission tomography for the study of functional anatomy in humans. New techniques and experimental strategies can now provide partial localization of simple and complex sensory processing (Fox et a1 1987a,b, Lueck et a1 1989), aspects of language (Petersen et a1 1988, 1990) and selected cognitive functions (Posner et a1 1988, Pardo et a1 1991). This progress has largely come from improvement in temporal resolution, which means that it is now possible to study blood flow changes in brain functional activity in time windows of 40 seconds (Raichle et a1 1983). In addition, improvements in tomographic design now permit studies of glucose utilization in small zones and structures in brain, such as the superior colliculus and the cerebellar dentate nucleus (Spinks et a1 1988). Finally, advances in image analysis have allowed subtraction of one image from another-permitting the subtraction of different behavioural states from each other (Fox et a1 1988). This has allowed the separation of experimental states from control conditions, as well as the localization of more complex brain functions either ‘parallel’ to simple functions, or in a hierarchical relation to them. The studies underlying these advances are the subject of this symposium. 6
Functional brain metabolism
7
TABLE 1 Experimental approaches to functional anatomy ~
Technique
Species
Lesion analysis
Humans and Loss of behaviour after damage to a site animals indicates its contribution to the missing
The epileptic focus
The stimulating electrode The recording electrode
Metabolic mapping
Function
behaviour Focal seizures crudely evoke the functional properties of a site and its circuits Animals The evoked behaviour reveals the functional properties of the stimulated site and its circuits (primarily motor system) Changes in neuronal firing, linked to Animals receptive field stimuli or movement, localize sites and patterns of functional organization Humans and Regional changes in blood flow and energy metabolism localize sites of animals physiological activation Humans
Definitions of functional anatomy are highly dependent on the method of analysis (Table 1). Ultimately there must be some congruence between the various approaches to determining the brain sites and systems activated during selected behaviours. Congruence is high for simple behaviours; for example, all methods agree on the localization of primary visual cortex. The identification of distributed systems underlying complex behaviours will require comparison of results obtained using many different procedures. It is important to define how each method is limited by the sensitivity and capacity of its measurements, if we are to identify false negatives and positives. In order to understand these issues for metabolic mapping it is necessary to appreciate basic aspects of the anatomy, physiology and biochemistry that underlie functional brain changes.
Functional architecture of brain The distribution of blood vessels throughout the brain follows a few common principles of design (Bar 1980). For laminated structures like cerebral cortex, hippocampus and the olfactory bulb, surface arteries break up into arterioles that penetrate at right-angles into the brain. The distribution of penetrating arterioles is non-random on cerebral cortex and reflects functional organization, such as the whisker fields in the rodent’s somatosensory cortex (Pate1 1983). Feeding capillaries branch off from the penetrating arterioles to supply capillary networks within horizontal laminae. The penetrating arterioles lie in register with the vertical orientation of ascending cortical dendrites, whereas capillary
8
Collins
networks become differentially distributed to supply functional subspecializations along or within horizontal laminae. The variation in capillary density throughout brain shows a high correlation ( r = 0.88, P
Functional brain metabolism
9
The functional architecture of the brain thus reflects a highly heterogeneous pattern of metabolic and vascular structures distributed t o serve different intensities of function. Zones with high densities of cytochrome oxidase activity and capillaries have the highest rates of glucose utilization and blood flow in the resting or control state. These zones would have a higher steady state of synaptic activity-ion pumping-energy utilization than other areas, regardless of the behavioural function subserved. Some zones that are relatively poor in oxidative metabolism and capillary supply are relatively rich in glycolytic enzymes. The separation of these zones is best appreciated in archaecortex and palaeocortex (Fig. 1). Activation of functional zones Simple sensory stimulation has proved to be the best experimental paradigm for studying basic aspects of functional activation of brain. Using the visual system of rat, Miyaoka et a1 (1979) found a quantitative relationship between the intensity of light and the magnitude of glucose utilization in visual centres. We (Toga & Collins 1981) found a linear relationship between the frequency of photoflash stimulation and increasing glucose utilization in rat superior colliculus. The lateral geniculate nucleus and visual cortex did not show a robust response to this type of stimulus, however, reflecting the fact that on-off receptive field signals project primarily to the superior colliculus. This indicates the importance of stimulus quality in activating functional zones. Moving bars and gratings are very poor activating visual stimuli for rodents, but very potent stimuli for cats and primates. Similarly, electrical stimulation of a peripheral nerve is not as potent a stimulus as the natural use of a nerve’s function, such as the tactile-kinaesthetic exploration of an object. Stimulation of the median nerve (R. C. Collins & M. E. Raichle, unpublished observations) does not produce as great an increase in focal somatosensory blood flow and metabolism as either passive vibration (Fox et a1 1987b) or active object manipulation (Ginsberg et a1 1988). Stimulus frequency is also an important variable when activating brain. Stimulation of rat forelimb motor cortex (500 Hz, 20 ms train stimuli) produced a linear increase in glucose utilization in first-order projections (e.g. caudate) with rates up t o 60 stimuli/minute, but no further increase up to 180/minute (Collins et a1 1986). By contrast, metabolism continued to increase linearly in second-order projections in globus pallidus and substantia nigra. This indicates that functional zones have different capacities for responding t o high frequency electrical stimulation. There can also be a dissociation between blood flow and metabolism at high rates of stimulation. Whereas glucose utilization increases linearly in rat superior colliculus with photoflash up to 32/s, blood flow only increases up to 8/s (Sundermann et a1 1985). Photoflash stimulation in man likewise causes an increase in visual cortex blood flow up to 8 stimuli/s, with
Collins
10
a
FIG. I. Segregation of energy metabolizing enzymes and capillaries in laminated brain structures. (a) Olfactory bulb. The anatomical inputs into the histological fields are diagrammed at the top of the figure. (A) shows histological staining using thionin. There is a high density of capillaries (B), cytochrome oxidase activity (C), and lactate dehydrogenase activity (D) in the glomerular zone (GL). Cytochrome oxidase and capillaries are also high in the external plexiform layer (EPL) where lactate dehydrogenase is low. Histological layers: olfactory nerve layer (ONL), glomerular layer (GL), external plexiform layer (EPL), mitral body layer (MBL), inner plexiform layer (IPL) and granule layer (GRL). Other abbreviations: C, centrifugal fibres; AON, fibres from anterior olfactory nucleus; AC, fibres from anterior commissure.
Functional brain metabolism
11
b
FIG. 1. Segregation of energy metabolizing enzymes and capillaries in laminated brain structures, (b) Olfactory cortex. (A) shows histological staining using thionin. Compare the density of capillaries (B), cytochrome oxidase activity (C) and lactate dehydrogenase activity (D) among the histological fields. All three are relatively high in zone IA, which receives input from the lateral olfactory tract (LOT). Cytochrome oxidase activity and capillary density fall in zone IB, which receives association fibres (ASSOC.) from the prepiriform cortex. (Fig. 1 from Borowski & Collins 1989a by permission of Alan R. Liss, Inc.)
12
Collins
a falling off in response beyond that (Fox & Raichle 1984). These results indicate the capacity of a system to follow repetitive stimuli. The dissociation of flow and metabolism and the decremental blood flow response at high stimulus rates (and in pathological conditions) probably reflect the unnatural properties of the stimulus condition. Simply put, the functional architecture of the nervous system was not designed to process stimuli at unnaturally high frequencies or intensities. The site and magnitude of response reflect the quality and intensity of stimuli in the real world. The sequence of responses in functional zones upon activation has become better clarified with the introduction of new techniques and experimental strategies. High resolution optical imaging techniques allow the visualization of sequential changes in cortical blood flow and metabolism in vivo in response to afferent stimulation (Grinvald et a1 1988). Charge-capture devices are used to measure changes in the reflectance of light from cortex at different wave lengths of stimulation. Extremely small signals can be detected at high spatial resolution, using signal averaging and image analysis techniques. The method has allowed the study of changes within the functional zones tuned to ocular dominance, orientation and colour (Ts’o et al 1990, Frostig et a1 1990). The arrival of a sensory volley into a cortical zone causes an activity-dependent change in light absorbance when illumination at 600-639nm is used. This is thought to reflect shifts in oxygen delivery at capillaries or changes in the state of cytochromes and/or NADH. This event is followed quickly by changes in absorbance with illumination at 570 nm, which reflects an increase in haemoglobin or blood volume. Studies using high resolution optical imaging thus confirm that physiological activation of brain activates metabolism first, then blood flow. Using a different approach, Ngai et a1 (1988) have also found a delay in the blood flow response to afferent stimulation. These investigators stimulated rat sciatic nerve and measured changes in the diameter of pial arterioles. Of interest, they found a frequency-dependent response, with maximal arteriolar dilatation at 5 Hz (0.15 V, 0.5 ms) with a decrement at higher rates. The vascular response was both delayed, beginning a few seconds after the onset of stimulation, and biphasic, with a rapid 2-3 second maximal 150% dilatation followed by a prolonged plateau (1 16%). Vasodilatation usually outlasted the stimulus by several seconds. The origin of the vascular response remains unclear. Although neurotransmitter receptors have been found on arterioles and capillaries, their precise physiological role remains uncertain (see review, Collins 1987). The delay and biphasic nature of the response suggests the release of a metabolic substance that causes an immediate maximal response, followed by a wash-out of the stimulus. Adenosine (Morii et a1 1987) and nitrous oxide (Moncada et a1 1988) are two possible chemical substances that could play a role in the vascular response. Because afferent sensory stimuli first activate middle layers of cortex, it is unclear how metabolic signals here are communicated to surface arterioles.
Functional brain metabolism
13
Various hypotheses are being tested that include intercellular electrotonic coupling within a vascular tree (Segal & Duling 1986) and delivery-diffusion of metabolites from veins leaving an activated zone to dilate incoming arterioles (Hester 1990). Plasticity of functional architecture The quantity of energy-related enzymes in sensory pathways is dependent upon the quantity of stimulation. Sensory deprivation causes a decrease in the mitochondria1 oxidative enzyme cytochrome oxidase in sensory pathways in animals and man (Dietrich et al 1981, Horton & Hedley-Whyte 1984; for review, Wong-Riley 1989). Lesions or impulse blockade of central pathways will also cause changes in energy-related enzymes in terminal fields. When lesions (Borowski & Collins 1989b) or reversible impulse blockade (Collins & Borowski 1991) are induced in the perforant pathway into the hippocampus, a decrease occurs in cytochrome oxidase activity in the outer two-thirds of the dentate gyrus. At the same time there is an increase and expansion of the lactate dehydrogenaserich zone of the inner third of the dentate gyrus. This occurs as the commissural pathway sprouts and expands. These studies indicate that the location and density of energy metabolism enzymes are determined by the distribution and activity of specific pathways. Sensory stimulation can cause an increase in components of functional metabolism. An increase in whisker activity in rodents causes changes in energyrelated enzymes in cortical barrels (Dietrich et a1 1982). Extensive physical treadmill exercise in rats causes an increase in capillary density in forelimb zones in the cerebellum (Black et a1 1990). By contrast, motor learning in rats causes an increase in synaptogenesis in these same zones, but no increase in capillary density. These studies indicate that prolonged intense repetitive use of synapses result in the production of more enzyme and capillaries to serve energy needs, while learning entirely new behaviours results in new synapses with an expansion of the existing functional architecture. There are several implications from these experiments in animals for positron emission tomography (PET) studies in man. First, the pattern and intensity of resting metabolism and blood flow depend upon the exact behaviour of the subject ‘at rest’. This must be defined and controlled carefully. Considerable variance will occur between control subjects unless sensory, motor and internal stimuli are precisely matched. Second, considering the plasticity of functional architecture, there will always be an irreducible variance that will reflect the different histories of individuals. Learning and training are experiential factors that sculpt the functional architecture of brain. For these reasons, each subject will be his best control for comparing subtle differences in functional states. In addition, knowing the comparative differences in functional metabolic maps among individuals of different functional skills would be instructive. ,
14
Collins
Finally, functional maps can be changed. Learning new skills should a d d new features, while intense training should increase the magnitude of responses. PET studies could provide a n opportunity to localize, define and study unique attributes of the human brain.
References Auker CR, Mesler RM, Carpenter DO 1983 Apparent discrepancy between single unit activity and [ I4C]deoxyglucose labeling in optic tectum of the rattlesnake. J Neurophysiol 49: 1504- 1516 Bar T 1980 The vascular system of the cerebral cortex. Adv Anat Embryo1 Cell Biol 59: 1-65 Black JE, Isaacs KR, Anderson BJ, Alcantara AA, Greenough WT 1990 Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. Proc Natl Acad Sci USA 875568-5572 Borowski IW, Collins RC 1989a Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities. J Comp Neurol 288~401-413 Borowski IW, Collins RC 1989b Histochemical changes in enzymes of energy metabolism in the dentate gyrus accompany deafferentation and synaptic reorganization. Neuroscience 33:253-262 Collins RC 1987 Physiology-metabolism-bloodflow couples in brain. In: Raichle ME, Powers WJ (eds) Cerebrovascular diseases. Raven Press, New York, p 149-163 Collins RC, Borowski IW 1991 Metabolic architecture of brain, oxidative and glycolytic systems. In: Ingvar DH, Lassen NA, Raichle ME, Friberg L (eds) Brain work 11. Munksgaard, Copenhagen (Alfred Benzon Symposium 3 l), in press Collins RC, Santori EM, Der T, Toga AW Lothman EW 1986 Functional metabolic mapping during forelimb movement in rat. I. Stimulation of motor cortex. J Neurosci 6~448 -462 Dietrich WD, Durham D, Lowry OH, Woolsey TA 1981 Quantitative histochemical effects of whisker damage on single identified cortical barrels in the adult mouse. J Neurosci 1:929-935 Dietrich WD, Durham D, Lowry OH, Woolsey TA 1982 ‘Increased’ sensory stimulation leads to changes in energy-related enzymes in the brain. J Neurosci 2:1608-1613 Fox PT, Raichle ME 1984 Stimulus rate dependence of regional cerebral flow in human striate cortex, demonstrated by positron emission tomography. J Neurophysiol 51:1109-1121 Fox PT, Miezin FM, Allman JM, Van Essen DC, Raichle ME 1987a Retinotopic organization of human visual cortex mapped with positron-emission tomography. J Neurosci 7:913-922 Fox PT, Burton H, Raichle ME 1987b Mapping human somatosensory cortex with positron emission tomography. J Neurosurg 67:34-43 Fox PT, Mintun ME, Reiman EM, Raichle ME 1988 Enhanced detection of focal brain responses using intersubject brain averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab 8:642-653 Frostig RD, Lieke EE, Ts’o DY, Grinvald A 1990 Cortical functional architecture and local coupling between neuronal activity and the microcirculation revealed by in vivo high-resolution optical imaging of intrinsic signals. Proc Natl Acad Sci USA 87:6082-6086
Functional brain metabolism
15
Ginsberg MD, Chang JY, Kelley RE et all988 Increase in both cerebral glucose utilization and blood flow during execution of a somatosensory task. Ann Neurol 23: 152- 160 Grinvald A, Frostig RD, Lieke E, Hildesheim R 1988 Optical imaging of neuronal activity. Physiol Rev 68:1285-1366 Hester RL 1990 Venular-arteriolar diffusion of adenosine in hamster cremaster microcirculation. Am J Physiol 258:H1918-1924 Horton JC, Hedley-Whyte ET 1984 Mapping of cytochrome oxidase patches and ocular dominance columns in human visual cortex. Philos Trans R SOCLond B Biol Sci 304:255-272 Livingstone M, Hubel D 1988 Segregation of form, color, movement, and depth: anatomy, physiology, and perception. Science (Wash DC) 240:740-749 Lueck CJ, Zeki S, Friston KJ et all989 The colour centre in the cerebral cortex of man. Nature (Lond) 340:386-389 Mata M, Fink DJ, Gainer H et al 1980 Activity dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem 34:213-215 Miyaoka M, Shinohara M, Batipps M, Pettigrew KD, Kennedy C, Sokoloff L 1979 The relationship between the intensity of the stimulus and the metabolic response in the visual system of the rat. SOCNeurosci Abstr 5:411 Moncada S, Radomsk MW, Palmer MJ 1988 Endothelium-derived relaxing factor. Biochem Pharmacol 37:2495-2501 Morii S, Ngai AC, KO KR, Winn HR 1987 Role of adenosine in regulation of cerebral blood flow: effects of theophylline during normoxia and hypoxia. Am J Physiol 253 :H165-H175 Ngai AC, KO KR, Morii S, Winn HR 1988 Effect of sciatic nerve stimulation on pial arterioles in rats. Am J Physiol 254:H133-H139 Pardo JV, Fox PT, Raichle ME 1991 Localization of a human system for sustained attention by positron emission tomography. Nature (Lond) 34951 -64 Patel U 1983 Non-random distribution of blood vessels in the posterior region of the rat somatosensory cortex. Brain Res 289:65-70 Petersen SE, Fox PT, Posner MI, Mintun M, Raichle ME 1988 Positron emission tomographic studies of cortical anatomy of single-word processing. Nature (Lond) 331:585-589 Petersen SE, Fox PT, Snyder AZ, Raichle ME 1990 Activation of extrastriate and frontal cortical areas by visual words and word-like stimuli. Science (Wash DC) 249:1041-1044 Posner MI, Petersen SE, Fox PT, Raichle ME 1988 Localization of cognitive operations in the human brain. Science (Wash DC) 240:1627-1631 Raichle ME, Martin WRW, Herscovitch P, Mintun MA, Markham J 1983 Blood flow measured with intravenous H2150. J Nucl Med 24:790-798 Segal SS, Duling BR 1986 Flow control among microvessels coordinated by intercellular conduction. Science (Wash DC) 2342368-870 Spinks TJ, Jones T, Dilardi MC, Heather JD 1988 Physical performance of the latest generations of commercial positron scanners. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 35:721-725 Sundermann R, Gitelman D, Toga AW, Collins RC 1985 There is a loose relationship between cerebral blood flow and metabolism during visual stimulation. SOCNeurosci Abstr 11:1125 Toga AW, Collins RC 1981 Metabolic response of optic centers to visual stimuli in albino rat: anatomical and physiological considerations. J Comp Neurol 199:443-464 Tootell RBH, Silverman MS, Hamilton SL, De Valois RL, Switkes E 1988a Functional anatomy of macaque striate cortex. 111. Color. J Neurosci 8:1569-1593 Tootell RBH, Silverman MS, Hamilton SL, Switkes E, De Valois RL 1988b Functional anatomy of macaque striate cortex. V. spatial frequency. J Neurosci 8:1610- 1624
16
Collins
Ts’o DY, Frostig RD, Lieke EE, Grinvold A 1990 Functional organization of primate visual cortex revealed by high resolution optical imaging. Science (Wash DC) 249~417-420 Wong-Riley MTT 1989 Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94- 101 Zeki S 1991 A century of cerebral achromatopsia. Brain 113:1721-1778
DISCUSSION
Porter: Let me invite discussion on any of the issues raised in Dr Collins’ paper, and perhaps particularly on the nature of the changes that have been described in relation to plasticity of function. Zeki: I am interested in a problem with respect to colour vision. Two apparently contradictory results have been obtained. One is a temporary loss of colour vision in cases of arterial insufficiency, coupled to falling attacks. The general view is that this loss is due to some deficiency in the arterial system which supplies the occipital lobe. It is transient, and the subjects recover their colour vision quickly (within hours). One could account for this recovery by saying that the blobs of the striate cortex, which are metabolically very active and have a good blood supply, are much more susceptible to an arterial insufficiency than are the metabolically less active interblobs. Against that is the well-documented fact that subjects with carbon monoxide poisoning commonly have a selective sparing of colour vision. Several studies have described this independently. Yet one would expect that the blobs, which are much more susceptible to hypoxia than the interblobs, would be much more impaired than the latter in carbon monoxide poisoning. Mazziotta [replying f o r Dr CollinsJ: This is certainly a paradox. One possibility is a non-uniform effect of injury across the brain. We know that sublethal carbon monoxide poisoning produces selective neuroanatomical damage to different parts of the brain; globus pallidus is damaged more than cortex. Similarly, regions of hypoperfusion will have a distribution of susceptibility to ischaemia which seems t o be more related to vascular supply and watershed zones. However, from the point of view of colour vision centres which might be neuroanatomically distinct, as opposed to the initial colour system in the visual (calcarine) cortex, which is distributed uniformly, although in a non-random fashion, according to the blobs, it is difficult t o explain those two facts that you describe. One might have to consider the secondary areas where colour vision is organized as neuroanatomically distinct operations. Zeki: Is it established that areas of high metabolic activity in the cerebral cortex, such as the stripes of V2 or the blobs of V1, are richer in blood supply than metabolically less active subregions? Is the capillary bed richer? Porter: Surely Dr Collins’ presentation would suggest that this is so, but there is currently no published work that addresses these questions directly.
Functional brain metabolism
17
Mazziotta: In the example of the hippocampal dendritic organization that Dr Collins gave (p 8), the implication is of an increased capillary density. Raichle: I wonder if the data are not simply lacking. Tom Woolsey, in exciting preliminary work on the mouse whisker barrel (Woolsey et a1 1990), has begun to look at the capillary architecture and the different layers of the cortex, and has shown glomeruli of capillaries in certain layers. This is some of the first detailed work related to this kind of organization of the cortex. I am not aware that it has been done with the blobs and interblobs. If it hasn’t, it would be extremely interesting to know if similar types of vascular organization accompany functionally organized areas. Zeki: What happens in the barrel fields? Raichle: The mouse whisker barrels are not only more vascular, but if you look at them in a cross-section of the cortex, the vascular pattern changes as you go through the layers; there is almost a glomerulus-like structure of the capillaries in layer four. It is highly specialized. One would guess that the blobs have something similar. Porter: Professor Zeki, do you have a comment yourself about the paradox that you raised? Zeki: No; I am very puzzled by it. I think the facts are correct, but I have not been able to reach a conclusion. Plum: The clinical circumstances of carbon monoxide poisoning are tricky, because the process produces an impure mixture of hypoxia and oligaemia. We are accustomed to attributing to carbon monoxide a pure effect of anoxaemia on the brain, but in fact there is also a profound effect on cardiovascular output. In all probability, for example, the striatal ischaemia that so often occurs is due to hypotension and focal underperfusion, rather than an even-handed hypoxia distributed equally across all brain areas. Whether the double vascular supply from middle and posterior cerebral artery origins to the occipital pole provides relative sparing to certain groups of neurons, I do not know. Nevertheless, I would have thought that the striate cortex, being supplied by the terminal branches of both arteries, might very well share with the basal ganglia a selective vulnerability to hypoperfusion in the face of systemic hypotension. In this respect, then, human carbon monoxide poisoning may not represent a satisfactory model by which to judge the effects of pure hypoxaemia on the occipital cortex. Raichle: I have often wondered whether there is a differential susceptibility to hypoxia in the area of the blobs. Where one is dealing with more reversible levels of hypoxia, one might wonder whether there is a differential diminution in the ability to perceive colour. I am not aware of such studies, but they must have been done. Zeki: I haven’t seen such a case myself, but from the literature, although colour vision is not unaffected after carbon monoxide poisoning, it is much less affected than other visual attributes. Such patients often have to use colour to identify objects, which they therefore identify wrongly.
18
Discussion
Plum: Dr Mazziotta, is the lactate dehydrogenase concentration proportionally elevated in relation to other cortical areas, or is it simply that cytochrome oxidase is relatively deficient, in the areas of high LDH concentration? Mazziotta: I am uncertain about the absolute values. It is simply a map of the relative difference between the two enzymes. Plum: The implication of my question was an attempt to find out what is the biological advantage of the increased LDH concentrations. Mazziotta: If the particular area of brain is primarily operating on glycolysis, rather than oxidative metabolism, this could be important. Plum: I’m sorry, I still don’t understand the advantage. Sokoloff: The biological advantage would be under conditions of special stress. The glycolytic enzymes that are usually present in brain tissue are in considerable excess of their normal physiological use. It is estimated that the use of hexokinase is about 2-5% of its total capacity in the brain in normal conditions. The brain, however, more than any other organ, has the capacity to increase its rate of glycolysis. In complete anoxia, for example, there is about a 10-fold increase in glycolytic rate, and lactate accumulates because of conversion of pyruvate to lactate by lactate dehydrogenase. This great capacity for increasing its glycolytic rate could be an advantage under conditions in which there is a deficiency of oxygen. In normal conditions, LDH may not have much to do, but its biological value is in the protection it offers against special periods of stress due to the lack of oxygen, when it serves as a reservoir for oxidative substrates when the oxygen is restored. Also, glycolysis itself provides some ATP generation, though less then oxidative metabolism. Raichle: Could you speculate why LDH is differentially distributed, as Bob Collins has shown? Are the areas where it seems to be proportionately greater also those areas that would be more phasically active? SokolofJ I could only speculate teleologically. LDH may be highest in regions that may have the greatest danger of becoming deficient in oxygen, under certain circumstances, and also in regions with normally high rates of energy metabolism. Porter: Do we know whether the enzyme measurements relate to synaptic organizations, or to glial structures? There is a considerable difference in the distribution of synaptic complexes and glial arrangements within the brain regions shown to have high concentrations of the different enzymes. Do we understand the significance of those differences in terms of neuronal or synaptic function? Sokoloff: This is not known. In general, the enzymes of energy metabolism correlate well with blood flow rates of the brain regions and also with energy metabolism rates (Friede 1966, Turek et a1 1986). We also found a good rankorder correlation between the density of capillary surfaces that Craigie (1920) had described and the local rates of blood flow in the brain (Sokoloff 1961). At about that time, Friede (1966), working on a histochemical assay of succinate
Functional brain metabolism
19
dehydrogenase, found a good correlation between the distribution of this Krebs cycle enzyme and rates of blood flow, and also with capillary density. So there seems to be a correlation. Whether it has to do with glial or neuronal elements is still unresolved. Frackowiak: It is of special interest to those who are studying the brain using positron tomography to have clear the evidence that the majority of the energy is consumed at the synaptic terminals, particularly in relation to some of the features discussed in Dr Collins’ paper relevant to the plasticity of the brain; because that implies synaptic change of a rather more permanent nature, and opens up the possibility that one can measure those plastic changes. Such changes need not be initiated only as a result of development, or injury, but also as a result of learning, or changes of a pharmacological nature. I therefore wonder how strong the evidence is, and if we know what proportion of the energy metabolism is due to synaptic activity. Sokoloff: I can’t give you a quantitative estimate of how much is due to synaptic activity and how much t o the metabolic activity going on in neuronal and glial cell bodies, but the evidence that the function-related changes in energy metabolism are primarily in synaptic regions of the brain is strong, and I have some data on this (see General discussion, p43). Porter: Another, related matter concerns the time scale of the plastic changes in synaptic density and in enzymic distribution that were illustrated in the experimental study on rats. Do we know the time scale of the increases in activity of different enzymes with plastic changes in brain function? Mazziotta: In the study of Black et a1 (1990) it was in the order of weeks. There are also interesting human data, from changes in children, where the ‘plasticity clock’ may be running at a higher rate. These children were having a portion of the brain removed, because of epilepsy. We were able to observe reorganization of the remaining structures- cerebellar changes and ipsilateral and contralateral hemispheric changes-at various time intervals, where the structure is still present but its activity falls. On Dr Plum’s earlier question about the value of having high activity of glycolytic enzymes in certain brain areas, I can think of another possibility. In a neuronal system like the hippocampus, the distal neuropil zone is high in capillaries, glucose utilization and cytochrome oxidase, and the proximal perikaryon zone has elevated LDH activity. If one were suddenly to lower the substrate supply to that whole system, what would survive is the proximal zone, high in LDH. If you wanted to protect the system with any chance of regeneration, it seems reasonable that you would want to protect the cell body and proximal axon and dendritic tree. Those elements might then allow for a subsequent sprouting or reorganization, following the extreme conditions. Plum: Why protect it with the least efficient enzyme? Mazziotta: If the system is going to be most susceptible to losses in oxygen, that would provide the reason. If you are saying that the only chance of survival is via carbohydrates, then anaerobic enzyme systems should predominate.
20
Discussion
Sokoloff: One possibility is that the neuron can lose its terminals, and the terminals will regenerate, but if the cell body is destroyed, then the terminals and functional usefulness of the cell body can’t be regenerated. Plum: Barbiturate anaesthesia reduces by about 63% the overall oxidative uptake of the cerebral cortex. Using PET technology, Blacklock et al (1987) measured 2-deoxyglucose uptake in patients with brain tumours. The resulting values showed a 67% reduction in cortical grey matter uptake-a reduction similar to that found in the human chronic vegetative state by Levy et a1 (1987). Given the pharmacology of barbiturates and the profound reduction in energy metabolism, one could infer that synaptic blockade was largely responsible for the decline in glucose consumption. Wise: I am interested in the question, raised in Dr Collins’ paper, of the tendency of blood flow to increase when you give an intermittent stimulus up to a certain rate, and then to fall off rapidly as the stimulus rate increases (Fox & Raichle 1984). Does the organism still appreciate that the stimulus is in fact intermittent, beyond the range when blood flow starts to fall, or does it then appreciate the stimulus (photoflash) as a continuous stimulus? Fox: The falling-off of blood flow occurs well before flicker fusion; all the subjects in that experiment can appreciate the stimulus as flickering above 50 Hz, whereas the blood flow begins to decline by 32Hz (Fox & Raichle 1984). Frackowiak: Can we consider the question of blood flow, and the metabolism of oxygen and of glucose and their relationship? When we think about the synaptic terminals, where cytochrome oxidase concentration is highest, and where the majority of the energy consumption that is associated with brain function is expended, we are led to believe, through the results of Dr Raichle’s laboratory, that glucose and oxygen consumption are profoundly uncoupled. How is that explained, in evolutionary or functional or biochemical terms? Raichle: The observations in our laboratory, on both the visual and the somatosensory systems (Fox & Raichle 1986, Fox et a1 1988), and now the corroborative evidence in humans from magnetic resonance spectroscopy (personal communication, J. W. Prichard & R. G. Shulman, Yale University), all suggest that under the stimulus conditions that we use, there is an uncoupling of glucose and oxygen consumption, but there’s no obvious explanation for this. One could of course generalize and say that this is a general principle and at whatever level the system is going to perform this way, but we don’t have direct evidence for that. Another possibility is that with the kind of stimuli being used, or the rate at which they are presented, one pushes the system to a point where it resorts to this ‘uncoupled’ behaviour; if one stimulated at a lower rate, and produced blood flow changes that are more commonly seen with the kind of activation studies that will be discussed here, and instead of changes in flow of 40-50% in the local area, we produced flow changes of 5-lo%, the same uncoupling might not occur. We don’t have an answer to that.
Functional brain metabolism
21
Frackowiak: If I may speculate further, to try to resolve this puzzling phenomenon, might it be that the changes in blood flow and glucose metabolism that you see are not due to what is happening within the synapse itself, but rather due to cellular elements that lie around the synapse and help maintain its functional integrity? We may be seeing an in vivo ‘amplification system’ which is convenient for us working with PET, but which in itself is an indirect marker of synaptic firing, to which it is coupled through mechanisms which are not understood. Raichle: Yes. It seems to me that some very interesting experiments could be done here. The blob-interblob system might be ideally suited to that, because you have systems or areas that segregate according to their enzymic ‘anatomy’, and we have means through stimuli to turn various components of this on differentially (for example, see Livingstone & Hubel 1987). It might lend itself to looking at this coupling in different elements within an area. One might expect to find that, depending upon which parts of the system are differentially stimulated, you get more, or less, oxidative metabolism. This is also speculation, but it’s certainly an experiment that can be designed and probably executed. Roland: There is one piece of evidence missing when we discuss whether high frequency stimulation of the sensory system would involve a greater increase in blood flow throughout the frequency range, as you imply. This evidence concerns the postsynaptic potentials, which we don’t know about. We do not know about the excitatory and inhibitory postsynaptic potentials after such stimulation. I am not aware of any data which tell us to what extent the integrated EPSPs in the dendritic tree of neurons in such a stimulated area do increase at high frequency stimulation. This is the evidence that we have to consider in order to interpret why the blood flow decreases at a higher stimulus frequency and why the glucose consumption seems to increase when measured with 2-deoxyglucose. Collins [author’s note added in proof]: A recent study of the vascularization of primate visual cortex is of interest (Zheng et a1 1991). There is an increased density of radial vessels (20-50 pm) and capillaries in cytochrome oxidase-rich blobs compared to interblobs in area 17, and in cytochrome oxidase-rich stripes compared to interstripes in area 18. Within cortex the capillary density is greatest in lamina IVc. These findings support the observation that capillaries and oxidative enzymes are distributed in support of high resting functional activity. References Black JE, Isaacs KR, Anderson BJ, Alcantara AA, Greenough WT 1990 Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. Proc Natl Acad Sci USA 875568-5572 Blacklock JB,Oldfield EH, DiChiro G et a1 1987 Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies. J Neurosurg 67:11-75
22
Discussion
Craigie EH 1920 On the relative vascularity of various parts of the central nervous system of the albino rat. J Comp Neurol 31:429-464 Fox PT, Raichle ME 1984 Stimulus rate dependence of reigonal cerebral flow in human striate cortex, demonstrated by positron emission tomography. J Neurophysiol 5 1:1 109- 1 121
Fox PT, Raichle ME 1986 Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 83:1140-1144 Fox PT, Raichle ME, Mintun MA, Dence C 1988 Nonoxidative glucose consumption during focal physiologic neural activity. Science (Wash DC) 241:462-464 Friede RL 1966 Topographic brain chemistry. Academic Press, New York Levy DE, Sidtis JJ, Rottenberg DA et a1 1987 Differences in cerebral blood flow and glucose utilization in vegetative versus locked-in patients. Ann Neurol 22:673-682 Livingstone MS, Hubel DH 1987 Psychophysical evidence for separate channels for the perception of form, color, movement and depth. J Neurosci 7:3416-3468 Sokoloff L 1961 Local cerebral circulation at rest and during altered cerebral activity induced by anesthesia or visual stimulation. In: Kety SS, Elkes J (eds) The regional chemistry, physiology and pharmacology of the nervous system. Pergamon Press, Oxford, p 107-117 Turek TJ, Hawkins RA, Wilson JE 1986 Correlation of hexokinase and basal energy metabolism in discrete regions of brain. J Neurochem 46:983-985 Woolsey TA, Rovainen CM, Robinson 0 1990 Videomicroscopy of flow in single blood vessels in mouse barrel cortex in vivo. SOCNeurosci Abstr 16:25 Zheng D, LaMantia A-S, Purves D 1991 Specialized vascularization of the primate visual cortex. J Neurosci 11 :2622-2629
Rapid measurement of cerebral blood flow with positron emission tomography Hidehiro lida, lwao Kanno and Shuichi Miura Research Institute for Brain & Blood Vessels-Akita,6- 10 Senshu Kubota-Machi, Akita City, 010 Japan
Abstract. The intravenous administration of H2150 makes possible the quantitative evaluation of regional changes in cerebral blood flow (CBF) during various neuronal activations in man. Many variations on this technique have been proposed. We have compared bolus and slow administration procedures and short and long scan lengths. For a short scan period this study suggests that the bolus injection procedure (with a scan length of 60-120 seconds) provides better CBF count statistics and less sensitivity to errors in the input function than the slow infusion procedure. For a long scan length ( > 3 min) the slow infusion procedure is recommended. Continuation of H2I5Oinfusion allows prolongation of the scan length, which enables us to obtain sufficient CBF statistics (the statistical error may be negligibly small if a sufficient amount of H2150 is infused). Another advantage of the slow infusion method may be related to the fluctuation of CBF during the scan period. If CBF fluctuates during this period the slow infusion procedure is expected to provide an average estimate of CBF, whereas the bolus injection procedure provides an estimate (an average over 10 seconds) of CBF which is more sensitive to short-term variations. The feasibility of using I5O, inhalation t o measure regional CBF has also been investigated. By means of a dynamic H,I5O scan which measures the regional distribution volume of water and a static C150 emission scan which measures blood volume prior to the 150,scan, both CBF and cerebral metabolic rate for oxygen (CMRO,) have been accurately measured by the I5O, scan for various physiological conditions. The application of this technique in a human study confirmed the uncoupling of CBF and CMRO, during motor and visual activation.
1991 Exploring brain functional anatomy with positron tomography. Wiley, Chichester (Ciba Foundation Symposium 163) p 23-42
The use of the 150isotope of oxygen and positron emission tomography (PET) enables us to measure regional changes in physiological function in living humans because of its short half-life (approximately 2 min). A number of studies have used HzI5Oto detect regional changes in cerebral blood flow (CBF) (Fox et a1 1984, Lammertsma et a1 1990, Friston et a1 1990) and have used the short-period inhalation of gaseous 1502 to make rapid measurements of the regional cerebral 23
lida et a1
24
metabolic rate for oxygen (CMR02) (Mintun et a1 1984, Meyer et a1 1987, Holden et a1 1988). There have been some variations in these techniques, with different rates of administration of tracer and different scanning periods. This article describes studies of the effects of changing the rate of administration and the scan length on the measurement of CBF by H2lS0autoradiography (see below). We have compared bolus or slow administrations and short or long scan lengths. An optimal procedure will then be discussed which has the following aims: (1) to maximize the available counts within a limited short scan period, (2) to minimize effects of non-linearity between CBF and PET-integration counts due to clearance of H2150 from the brain, (3) to minimize effects of errors in the input function (delay and dispersion in the peripherally sampled arterial radioactivity curve), and (4) t o minimize the effects of fluctuating CBF during the scan. Secondly, we have investigated the feasibility of using a short period inhalation of 1502 to measure regional CBF and CMROl simultaneously. This technique has been used in a study of neuronal activation in man. Methods H2lS0 autoradiography
Theory. On the basis of the single-compartment model (Kety 1951), integration of the tissue radioactivity for the scan period [0, TI is given by:
(fp + A ) “ d t ioTCi(t)dt= ~orf.C‘o(t)*e~ where the asterisk denotes the convolution integral, C&) is the arterial input function, Ci(t) the tissue concentration curve, f,regional CBF, p , the partition coefficient, and A the decay constant of 150.Thus, using the measured arterial input function, tissue concentration, and a fixed value of p of 0.80 (mllml), equation (I) can be solved for CBF (f)(Raichle et al 1983, Howard et al 1983, Kanno et al 1984, 1987, Iida et a1 1986, Lammertsma et al 1990). This holds for any H2150 administration speed or scan length. Scan length providing minimum statistical noise. A simulation study has investigated the optimum scan length which minimized statistical uncertainty (i.e. maximized signal-to-noise ratio) in the CBF values calculated for given tracer administration procedures. This simulation addressed both the limited counts in the original PET image and the non-linearity of the relationship between CBF value and the H2ISO accumulation. The simulation was performed for two input functions described in Fig. 1, which were obtained from typical studies in humans with a bolus injection and a continuous (slow) infusion over 3.5 min of H2”O. The statistical error in CBF (ACBF) was estimated according to equation (2),
25
Rapid cerebral blood flow measurement
(AI/$)/f
--
CBF
where Z is the integration of the head curve (I=S,Tci(t) dt), and Waf is the slope of the table of the integration versus CBF. The statistical noise of the integration (AZ) was estimated using equation (1) according to the known statistical relationship, AIocfl. This calculation was done for various scanning periods with CBF values of 0.2, 0.5 and 0.8 ml/min per g. A study was also performed in a volunteer listening to white noise at rest. H2150was given t o the subject eight times at 10-min intervals (four times as a bolus injection and a further four times by slow infusion over a 2-min time period). After each of the H2150administrations a dynamic scan was performed and autoradiographic CBF images were calculated for various scan lengths. A standard deviation of the CBF values (ACBF) and the ratio (ACBF/CBF) were then calculated for each pixel of the CBF images. Effects of delay a n d dispersion in the input function on CBF. The effects of delay and dispersion on the calculated CBF values were evaluated for both the bolus and slow administration procedures. First, integration of the tissue radioactivity curve was calculated according to equation (1) (values of f= 0.5 ml/min per g and p = 0.8 ml/ml were assumed) for various integration
150000
-E
-
'
Bolus
-
injection
100000 -
. v)
n 0
50000
0
-
I . '
'
.
I
..
"'
".
(a1
'
I
.
.
.
'
(b)
FIG. 1. Typical input functions for a bolus injection of H2150(a) and slow infusion of H,I5O over 3.5 min (b) obtained from typical human studies. These curves were used for all simulations. Curves are not corrected for the radioactivity decay.
lida et al
26
periods using both typical bolus and slow input functions. By shifting (delaying) the assumed input function, CBF values were calculated, and errors due to delay were evaluated for various scanning periods. Secondly, the assumed input function was dispersed with a dispersion function assumed to 6e a single exponential function (Iida et a1 1986). CBF values were calculated, and errors due to dispersion were evaluated for various scanning periods. Contribution of transient CBF to total integration. The integrated PET counts are a result of a summation of all the contributions of transient CBF over a short period of time during the scan. In order to estimate this contribution to the total integration when the scanning length and the administration speed are given, the left side of equation (1) has been expanded into a transient domain as a product of a contribution weight, w(t), and transient CBF (equation 3). ioTCi(t)dt= joTw(t)*CBF(t)dt
(3)
The contribution weight is estimated as follows. In conditions of constant CBF, the amount of H2150 extracted into the brain tissue at a certain time, t , is proportional to the temporary arterial concentration, Ca(t), and this radioactivity stays in the tissue, with physical decay and clearance by CBF. The contribution weight (contribution of extracted H2150 at time t to the total integration) is, then, expressed as in equation (4):
This has been estimated for both bolus and slow administration procedures with various scanning periods for f = 0.5 ml/min per g and p = 0.8 ml/ml. CBF and CMROzdetermination by lSO2inhalation Description of the technique. A method has been developed for measuring CBF and CMR02 simultaneously by a single PET scan with a short-period, and its applicability to repeat cerebral activation continuous inhalation of 1502, studies has been investigated. This technique was based on fitting CBF and CMR02, which are defined by Mintun's model (Mintun et a1 1984), to a tissue curve. To complement this technique, the determination measured 1502 of two additional quantities is required before the 1 5 0 2 scans, namely the regional distribution volume of water ( Vd) by a dynamic H2150scan and the regional blood volume (V,) by a static C150 scan. Therefore, dynamic 1502 scans can be repeated to measure CBF and C M R 0 2 for a number of physiological conditions (e.g. at rest and during behavioural activation). The scan is estimated using the arterial H2I50concentration curve during the 1502
Rapid cerebral blood flow measurement
27
whole-blood radioactivity curve by approximating the production of the arterial H2150 by a single rate constant model.
Validation of the technique. In order to validate this technique against our reference method, we performed dynamic H2I5O and dynamic 1 5 0 2 scans together with a static C150scan for two conditions, namely at rest and during motor activation (finger opposition). CBF was calculated by fitting to the dynamic H2150 data, and CMR02 was obtained according to the combined fitting technique (i.e. simultaneous fitting of three parameters of CBF, CMR02 and V, to the dynamic H2150and l S 0 2 curves). These values of CBF and CMR02 were then compared with results from the present technique (i.e. determination of CBF and CMR02 from the I5O2data alone, in which values of Vd and VB were measured at rest by the dynamic H2150 and static C150 scans, respectively). Data obtained from the primary motor cortex region from four healthy volunteers were analysed. The scanner used was a CTI PET scanner (Model 931 09/12 Knoxville, TN, USA) at Hammersmith Hospital, London (Spinks et a1 1988). Application of the technique. The applicability of this technique to a neuronal activation study was tested. The protocol employed was visual stimulation by the use of a flickering visual display (8 Hz). The study was performed on four healthy volunteers, and data were collected from the primary visual cortex region. A set of paired scans of dynamic H2150,dynamic I5O2 and static C150 was made under a resting eyes-closed condition; thereafter, single dynamic 1502 scans were performed twice during the flicker activation, to measure both CBF and CMR02. The inhalation period of 1502 was approximately 1.5 min and the length of the dynamic scan was 4.5 min. The first scan was started 1 min after the start of flickering; the second scan began 20 min after the flickering began. The scanner used was Headtome-IV installed in Akita-Noken, Japan (Iida et a1 1989b). Results Figure 2 shows global H2150 head time-activity curves of a typical slice obtained from a bolus injection and a slow infusion study. The radioactivity concentration increases rapidly after the bolus injection of H2150,and then is maintained at almost the same level during a slow tracer clearance. In the slow infusion study, the tracer level increases slowly according to a ramp function. Figure 3 shows the results of the simulation, showing errors in the calculated CBF values (ACBF/CBF) due to statistical noise in the original PET image. The errors were plotted as a function of the scan length. For the bolus administration (a), there was an optimum scan length which gave minimum statistical error. Minimum error was obtained when the scan length was between
lida et al
28
E
\
Is( u
FIG. 2. Global H,150 head time-activity curves (true coincidence counting rates of a typical brain slice) obtained from a typical bolus injection and 3.5-min slow infusion study. After the bolus injection the head time-activity curve reaches the maximum level rapidly and maintains almost the same level. On the other hand, after the slow infusion, the head time-activity curve increases monotonically.
60 and 120 s for a CBF range of 50-80 ml/min per 100 g, and longer than 120 s for a CBF of 20ml/min per 1OOg. On the other hand, for the slow administration (b), the error decreased monotonically as scan length increased (as long as the infusion continued). When this simulation was done for the same integration counts of the input function (integrating over 0-600 s), the bolus injection and the slow infusion gave the same minimum value of the error. The statistical error (standard deviation divided by the average CBF [ACBF/CBF] ) is summarized in Table 1. The values were calculated as an average of the grey and white matter regions for various scan lengths. As can be seen, the data were consistent with results from the simulation study. Errors in the calculated CBF values due to delay and dispersion of the arterial curve are shown in Tables 2 and 3 respectively. Results are presented for both the bolus injection and the slow infusion procedures. As can be seen, larger errors are caused by the delay and dispersion for the shorter scan length. Smaller errors were seen in the bolus injection procedure than in the slow infusion procedure, with the exception of a scan length of less than 20 seconds. These errors were not dependent on the CBF values assumed in the simulation. Figure 4 shows the results of the simulation, which represent the weights of the contribution of transient CBF to the total integration of the tissue curve.
29
Rapid cerebral blood flow measurement 0.04
.
0.04
- .. I5
:
O'03;
0.02
0.02
-
0.01
0.01
-
L
: m m
.
-
*
, . - .
Vd = 0.80 m h l
t . . . . , . . . . , . . . . l 200 300
0
0.00
100
0
.
---
I
0.00
r
.
0
a
.
\; I
0.03
I
. . . . ' . .
'
100
Time (sec)
.
I
200
.
.
Time (sec)
. .
300
cb)
(a1
FIG. 3. Results of the simulation which represents effects of choosing different scan lengths on the statistical error in the H,I5O autoradiographic CBF values. The errors (ACBF/CBF Yo) were presented for bolus (a) and slow (b) administration procedures. In these simulations, the two input functions were normalized to give the same integration counts (integrating over 0-600 s), corresponding to the same total administration dose. TABLE 1 Results from a volunteer PET study, representing the statistical error in CBF (standard deviation divided by average of CBF: ACBFKBF, 070) in the HZi5O autoradiographic method for various scan lengths
Scan length (s) Bolus injection Slow infusion
Structure
40
60
90
120
I80
Grey matter White matter Grey matter White matter
12.0 27.9
11.0 22.4 14.2 27.9
11.1 17.9 11.1 21.6
12.8 17.3 10.3 14.7
13.8 14.2
-
1.0
@lo 070
10.8
In the bolus injection study (a), these weights have a sharp peak, corresponding
t o the peak of the arterial input function, and independent of the scan length. By
contrast, in the slow infusion study (b), the weights are broad, covering almost the whole scanning period chosen. Figure 5 compares CBF and CMR02 values obtained by the present technique with the reference method (separate determination) for the motor
30
lida et al
TABLE 2 Results of simulation: Vo errors in the H,'50 autoradiographic CBF due to the delay of the arterial time-activity curve Scan length (s)
DeIay
20
(S)
Bolus injection Slow infusion
+3 -3 +3 -3
74.0 -45.0 44.9 -39.0
40
19.0
- 15.0
22.9 -21.2
60
90
7.6 -7.8 16.9
5.1 -5.7 10.0 -10.2
-15.2
120
180
4.0 -3.7 8.2 -8.1
2.9 -2.6 5.8 -5.8
Vo Vo
Notes: Delay of the arterial time-activity curve induced overestimation in the calculated CBF, and vice versa. The errors caused by the ambiguous delay adjustment were symmetrical concerning the direction of the shift of the arterial curve. The effects of CBF on this error were negligible at a CBF range between 20 and 80 ml/min per 100 g.
TABLE 3 Results of simulation: errors in the H,'50 autoradiographic CBF due to the dispersion in the arterial input function
___
Bolus injection
Slow
infusion
Dispersion Scan length (s) time constant (S) 20 40 3
43.0 71.2 34.0 56.7
5
3 5
20.0 26.3 24.2 38.5
~
60
90
120
180
11.8 15.8 16.3 21.0
6.4 9.5 10.8 15.4
4.5 8.0 8.1 11.1
3.2 % 5.3 5.9 070 7.4
~.
.__
Notes: Dispersion of the arterial curve induced overestimation in the calculated CBF, and this error was increased rapidly as the scan length was shortened. The effects of CBF on this error were negligible at a CBF range between 20 and 80 ml/min per 100 g.
activation study. When the measured Vd values were used, consistent values of both CBF and CMR02 were obtained when compared with the reference method: CBF values of 0.56 f0.16 compared to 0.53 f0.11 ml/min per ml for the resting condition, and 0.64 f0.12 compared to 0.63 f0.13 ml/min per ml for the activated condition, and CMR02 values of 0.0399 f0.0043 compared to 0.0387 f0.0048 at rest, and 0.0414 k 0.0059 compared to 0.0407 k 0.0054 ml/ min per ml during the activation. On the other hand, when the assumed value of vd was used, CBF values were dependent on the v d value (see Fig. 5a): the resting (activated) CBF values were 0.95 k 0.42 (1.09 +_ 0.39), 0.60 f 0.20 (0.67 k 0.17) and 0.36 0.09 (0.40 k 0.07) ml/min per ml for assumed vd values of 0.98, 0.80 and 0.60ml/ml, respectively. In contrast, the value of CMR02 was not sensitive to the assumed value of Vd used, as shown in Fig. 5(b): the resting (activated) CMR02 values were 0.0412 f0.0045 (0.433 k 0.0050), 0.0392k 0.0041 (0.0405f0.0056) and 0.0377 k 0.0043 (0.0386 f 0.0059) ml/min per ml for assumed v d values of 0.98, 0.80 and 0.60ml/ml, respectively.
+
Rapid cerebral blood flow measurement
... ,
010
U J
008
r
- !,
E
.-m s
;;
L 006-,
5
. . . , . . . . .. . .I
3
P .c
0015
Scan length (sec)
-------
-
C
0 .c
31
40
60
120
0010
. .
Scanlength(sec) .
I
- ; !\ \ -i t'
.I'
-
-------
\
120 240 300
004-
L
Time (sec)
(a)
Time (sec)
0.4
FIG. 4. Results of the simulation representing the contribution weights of transient CBF values in the total integration. Data are shown for a bolus injection procedure (a) and for a 3.5-min slow infusion procedure (b). Weights are normalized so that the total integration of each curve is unity.
Results from the visual activation study are shown in Table 4 as the percentage increase in CBF and CMR02 caused by flicker activation for 1 min and 20 min after the start of the stimulation. Discussion
Advantages of a bolus injection Because most PET scanners have limiting characteristics at high count rates (due to the deadtime and the non-negligible random coincidence events), the square function (rather than a ramp function) tissue response curve would give the maximum total counts within a limited short period. This curve is nearly achieved by the bolus administration, as can be seen from Fig. 2. The total head time-activity curve is almost flat after the bolus injection during the first short period, while it increases continuously in the slow infusion procedure. Thus, when a short scan period (e.g. c 1-2 min) is required to measure the CBF over short time scales, the bolus injection technique provides better statistics than the slow infusion technique. Another advantage of using a bolus injection is related to the error sensitivity of the delay and dispersion in the input function. As shown in Tables 2 and 3,
lida et al
32
N
0 U
FIG. 5 . (a) Comparison of CBF values at rest and during activation (finger opposition) obtained by fitting to the dynamic HzL50 curve (reference) with those from the I5O, inhalation study. Values were consistent when measured values of v d were used in the I5O, (Vd=meas.), though 1502 CBF was sensitive to the v d used in the calculation, as shown in the right three columns. (b) Comparison of CMROz values at rest and during activation obtained by paired fitting to the dynamic lSOzand dynamic H,150 data (reference) with those obtained by the present technique. In contrast to the CBF determination, the present technique was not sensitive to the v d values used, and yielded results consistent with the reference methods, both at rest and during activation.
Rapid cerebral blood flow measurement
33
TABLE 4 Results from the simultaneous determination
of CBF and CMRO, by an flicker activation
Subject
150,
inhalation during the
% increase in CBF
Yo increase in CMROz
One min after the start of flickering 1 2 3
48.3 21.3 24.0 4 9.5 Average and SD 25.82 16.3
20.3 3.6 4.3 3.7 8.0k8.2
20min after the start of flickering 26.5 30.8 21.3 4 15.7 Average and SD 23.6k6.6
1 2 3
18.0 0.3 1.2 3.4 7.2 2 7.7
both delay and dispersion induced smaller errors in the bolus injection procedure than in the slow infusion technique. In addition, adjustment for the delay would be more accurate for the bolus injection than for the slow infusion, because of the sharp rise in the input and the tissue curves (Iida et a1 1988). Thus, the need to minimize the effects due to delay and dispersion also favours the bolus injection procedure. In deciding the scan length for obtaining maximum statistical accuracy in CBF estimation for the bolus injection procedure, it is important to consider two factors: (1) the non-linearity between CBF and PET counts when scanning for long periods (due to the effects of equilibration between areas of high and low CBF; Volkow et a1 1991), and (2) the statistical errors in the original raw image when scanning for short periods. In the present study, scan length has, therefore, been optimized so as to minimize the statistical error in CBF, but not in the integration counts. This process included correcting for the nonlinearity between CBF and the PET counts. The present study also included effects of tissue heterogeneity, because the Vd value of 0.80ml/ml was used, which empirically corrected for the tissue heterogeneity and provided constant CBF values independent of scan length (Iida et a1 1989a). This study suggested choosing a scan length of approximately 60-120 seconds in order to obtain the minimum statistical error in CBF estimation for a CBF range of 50-80 ml/min per 100 g. For smaller CBF rates (20 ml/min per 100 g), the optimum scan length was longer than this.
34
lida et al
Advantages of slo w infusion As discussed above, the bolus injection procedure is recommended in order to obtain maximum counts when a short scan length is chosen (e.g. < 1-2 min). However, when a long scan period is appropriate (e.g. > 3 min), the bolus injection technique is limited in value because of the equilibration between the high and low CBF regions, and the consequent reduction in statistical accuracy occurs (see Fig. 3a and Table 1). In this situation, the slow infusion procedure provides better count statistics. Continuation of Hz”O infusion allows prolongation of the scan length. By infusing sufficient amounts of H2150and scanning for a long period, the statistical error in CBF may be negligibly small (i.e. ACBF/CBF z 0). However, the following two points should be mentioned. (1) When the bolus and slow administration procedures were compared under the condition of the same administration dose (i.e. the same integration counts of the input functions), the minimum value of ACBF/CBF was found to be about the same as shown in Fig. 3, indicating that the prolongation of the infusion period with a prolonged scan length is not an essential solution for improving the statistics in CBF estimates, when the total dose administered is limited. (2) The choice of a long scan period is not suitable for repeating measurements in a variable number of stimulated conditions. Recently, a number of cerebral activation studies have been done based on normalizing the whole-brain CBF to a certain value (e.g. 50 ml/min per 100 g) and using subtraction techniques to detect the location of the changes (Fox et a1 1984, 1988, Friston et a1 1990). In applying this technique especially to cerebral activation studies involving cognitive tasks, it might be important to average the cerebral activity over the period of the scan to remove phasic changes in CBF due to repeated task performance or habituation. As shown from the comparison in Fig. 4, the total integration is almost determined by the first 20 seconds in the bolus injection procedure (the full-width of the half-maximum of the contribution weights is approximately 10 s). Hence, the calculated CBF is likely to vary depending o n the timing of the peak of the H2I5Oinput. On the other hand, in the slow infusion procedure, the contribution weights cover the whole scan period. Therefore, if this hypothesis (CBF fluctuation during the scan) is true, a slow infusion is expected to provide a more stable response for cognitive activation paradigms by averaging a fluctuating CBF. Further study of the range and frequency of CBF fluctuation is needed in order to evaluate this effect.
Feasibility of using ”0, The use of 1502 inhalation was found to be feasible for the determination of CBF. This technique provided both CBF and CMROz values which were consistent with the reference methods, and was applicable to the human neuronal
Rapid cerebral blood flow measurement
35
activation study. The results suggest an uncoupling between CBF and CMR02 during the visual activation (1 min and 20 min of continuous flicker stimulation), However, the determination of CBF by this technique depends on choosing an adequate value of Vd. Assuming a different value of v d resulted in very different values for CBF, as shown in Fig. 5 . Since the v d value is underestimated compared with the expected true partition coefficient of water, and this is caused by the tissues heterogeneity (Huang et al 1987, Iida et al 1989b), the v d value is dependent on the selected region-of-interest. Therefore, the Vd value had to be measured by the H2150 dynamic scan for each regionof-interest. In contrast, CMR02 was not sensitive to the vd values used, indicating that Vd measurement is not necessary for CMR02 determination alone.
Conclusion In the calculation of CBF by using H p O , the present study suggests the following conclusions. (1) Given repeated rapid measurements of CBF in various activated conditions using a short scan length, the bolus injection procedure provides better count statistics than the slow infusion procedure. (2) Choosing a scan length of between 60 and 120 seconds provides minimum statistical error in CBF estimation using the bolus injection procedure. (3) If a long scan length is chosen (e.g. > 3 rnin), the slow infusion procedure gives better count statistics in CBF than the bolus injection procedure. (4) When the H21S0is infused continuously, prolongation of the scan length improves the statistical accuracy of the CBF estimate. ( 5 ) Errors due to delay’ and dispersion are smaller in the bolus injection procedure than in the slow administration procedure. (6) The slow infusion procedure provides a CBF value which is averaged over the scan period, while the bolus injection procedure provides a momentary CBF value (average for approximately 10 seconds), which may be dependent on the timing of the H p O injection and the CBF fluctuation. The feasibility of measuring CBF by 1 5 0 2 inhalation has also been confirmed, but measurement of v d is required for each region-of-interest using a dynamic H2150scan before the 1502 scan. By measuring the blood volume and the regional v d , both CBF and CMR02 can be measured by a single 1502 scan for various activated conditions. A ckno wledgemenIs We thank Dr Karl J. Friston from Hammersmith Hospital, London, for invaluable discussions and advice in the preparation of this manuscript. This work was in part supported by the Japan Heart Foundation, grant for 1990.
36
lida et al
References Fox PT, Mintun MA, Raichle ME, Herscovitch P 1984 A noninvasive approach to quantitative functional brain mapping with H2I5Oand positron emission tomography. J Cereb Blood Flow Metab 4:329-333 Fox PT, Mintun MA, Reiman EM, Raichle ME 1988 Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab 8:642-653 Friston KJ, Frith CD, Liddle P F , Dolan RJ, Lammertsma AA, Frackowiak RSJ 1990 The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 10:458-466 Holden JE, Eriksson L, Roland PE, Stone-Elander S, Widen L, Kesselberg M 1988 Direct comparison of single-scan autoradiographic with multiple-scan least-squares fitting approaches t o PET CMRO, estimation. J Cereb Blood Flow Metab 8:671-680 Howard BE, Ginsberg MD, Hassel WR, Lockwood AH, Freed P 1983 On the uniqueness of cerebral blood flow measured by the in vivo autoradiographic strategy and positron emission tomography. J Cereb Blood Flow Metab 3:432-441 Huang SC, Mahoney DK, Phelps ME 1987 Quantitation in positron emission tomography. 8. Effect of nonlinear parameter estimation on functional images. J Comput Assisted Tomogr 1 1 :3 14-325 Iida H , Kanno I, Miura S, Murakami M, Takahashi K, Uemura K 1986 Error analysis of a quantitative cerebral blood flow measurement using H2I5Oautoradiography and positron emission tomography. Wth respect to the dispersion of the input function. J Cereb Blood Flow Metab 6:536-545 Iida H , Higano S, Tomura N et a1 1988 Evaluation of regional differences of tracer appearance time in cerebral tissues using I50-water and dynamic positron emission tomography. J Cereb Blood Flow Metab 8:285-288 Iida H, Kanno I, Miura S, Murakami M, Takahashi K, Uemura K 1989a A determination of the regional braidblood partition coefficient of water using dynamic positron emission tomography. J Cereb Blood Flow Metab 9:874-885 Iida H , Miura S, Kanno 1 et al 1989b Design and evaluation of Headtome-IV, a wholebody positron emission tomograph. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 36~1006-1010 Kanno I, Lammertsma AA, Heather J D et a1 1984 Measurement of cerebral blood flow using bolus inhalation of C'502 and positron emission tomography. J Cereb Blood Flow Metab 4:224-234 Kanno I, Iida H , Miura S et al 1987 A system for cerebral blood flow measurement using H2150autoradiographic method and positron emission tomography. J Cereb Blood Flow Metab 7:143-153 Kety SS 1951 The theory and applications of exchange of inert gas at the lungs and tissues. Pharmacol Res 3: 1-41 Lammertsma AA, Cunningham VJ, Deiber M-P et a1 1990 Combination of dynamic and integral methods for generating reproducible functional CBF images. J Cereb Blood Flow Metab 10:675-686 Meyer E, Tyler JL, Thompson CJ, Redies C, Diksik M, Hakim AM 1987 Estimation of cerebral oxygen utilization rate by single bolus 150z inhalation and dynamic positron emission tomography. J Cereb Blood Flow Metab 7:403-414 Mintun MA, Raichle ME, Martin WRW, Herscovitch P 1984 Brain oxygen utilization measured with 0-15 radiotracers and positron emission tomography. J Nucl Med 25~177-187 Raichle ME, Martin WRW, Herscovitch P et a1 1983 Brain blood flow measured with intravenous H,I5O. 11. Implementation and validation. J Nucl Med 24:790-798
Rapid cerebral blood flow measurement
37
Spinks TJ, Jones T, Gilardi MC et a1 1988 Physical performance of the latest generation of commercial positron scanner. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 35:721-725 Volkow ND, Mullani N, Gould LK, Adler SS, Gatley SJ 1991 Sensitivity of measurements of regional brain activation with oxygen-15-water and PET to time of stimulation and period of image reconstruction. J Nucl Med 3258-61
DISCUSSION
Jones: Dr Iida, in your simulations of optimum scanning times, did you take into account mixtures of grey and white matter? Zida: Yes, in our simulations we used a value for the distribution volume of water, 0.8, which we obtained empirically by fitting the dynamic H2I5Odata for several human studies, and not the theoretical prediction (a ratio of the water content of tissue t o blood). We expected this empirical value to be corrected for the tissue mixture, because, in a kinetic H2I5Oanalysis, the tissue mixture causes systematic underestimation in the distribution volume. If we used a theoretical value for the distribution volume, the tissue mixture caused a timedependent and falling CBF value in the autoradiographic method (see Fig. 1 on p 38). Using a fitted value, we get constant and time-independent CBF values for the cortical grey regions, even when we accumulate the data over 4.5 minutes after the bolus injection of H2150.Also for the 1502 study, we observe a timeindependent CMR02 value (which has been reported by Holden et a1 1988). On the basis of these values we presumed that tissue mixture has been taken into account in our simulations. Frackowiak: I am particularly interested in the issue of the bolus injection and the slow ramp infusion, and the distinctions you drew between them. Most people think of the alterations in brain state or the responses to the physiological stimuli that we apply, which alter flow to the brain, as very dynamic and rapid changes which rapidly habituate. That would suggest that we need to take a quick snapshot of blood flow, and perhaps use a bolus technique. Alternatively, it may be more important to average brain activity over the scanning period, to integrate all the primary local and resulting secondary blood flow changes which may themselves modulate the primary responses and arise in areas constituting a functional network that is widely distributed in the brain. Such a view might lead one to favour a smoother ramp-like administration of tracer. I think you are suggesting that there is room for both these experimental approaches at the technical level and that the choice essentially depends on the physiologist’s prediction of the response? Iida: Yes, I think that both the bolus and slow ramp infusion techniques have their own advantages, depending on the paradigm employed, but I am not sure how CBF changes during the simulation. It must be very important to know how much CBF fluctuates following and during a stimulation with cognitive tasks. Can anybody give us any information?
38
Discussion
r
0.6
0.5
-
0.4
-
0.3 0.2
O.’ 0.0
=
1
0.8 rnllrnl
1
C@pJ@ ! $U 0 0
-
0
Vd
Activated
- Resting
t‘
,
1
Vd
1.0 mllml
I
I
100
200
1 I 300
Scan length (sec)
FIG. 1 ( M a ) . Autoradiographic CBF values as a function of scan length for a visual cortex region. Values were calculated for activated and resting conditions with different values of the distribution volume ( V d ) . A Vd value of 0.8 rnl/rnl provided tirneindependent CBF values for both activated and resting conditions, while a V, value of 1.0 ml/ml provided a fall in CBF values. The statistical uncertainty is expected to be large for a short scan period because of the statistical noise, and also large for a long scan length due to the wash-out effect (i.e., a large correction for the non-linearity between the CBF and the original accumulated counts).
Raichle: Dr Winn has shown with sciatic nerve stimulation in the rat that there is an abrupt rise in blood flow and then it changes over time (Ngai et a1 1988). The time course was 10-20 seconds, so it seemed like a relatively slow response, which is another issue. When one thinks of what is called an ‘intrinsic signal’ that has been observed in work with optical techniques (Grinvald et a1 1986), which some would attribute to vascular phenomena, the onset of this ‘intrinsic signal’ is more like 200 ms after the start of the stimulus. But beyond that it has a complex wave form; it isn’t something that goes up and stays there; it sometimes comes down, and occasionally if the stimulus stops it goes below baseline and comes back up (personal communication, A. Grinvald, Rockefeller University, New York). So it’s a moving target, probably within time frames below the temporal resolution of PET scanners. We shall therefore always be faced with averaging across temporally complex vascular responses t o neural activity. Porter: Part of the difficulty is that you can’t interrogate the brain of the rat, as to what is going on during that period of time. Fox: On another issue related to your simulations of measurements comparing bolus to ramp techniques, Dr Iida, you showed us every measure except the
Rapid cerebral blood flow measurement
39
one I wanted! What happens when you have a local signal? For example, during a visual stimulus, there is an active area of very high blood flow. The tracer will wash into that area; and it will then wash out. So it will leave more quickly than in other areas, as well as enter more quickly. We have approached this by looking at signal-to-noise ratios and asking whether this area of high neural activity is high relative to the background noise. It’s clear that as you scan for longer, image quality gets better and you have a less ‘noisy’ image, but you are also losing signal, by 90 seconds. Zida: That is right. We therefore took the effect of the wash-out into account, which we called the non-linearity effect, and also the statistical noise problem. If you really want to see a maximum difference in the original accumulated image for a certain amount of CBF change, you have to choose an extremely short scanning period, but you will see a poor quality image, because only short scan lengths provide the ideal and linear relation between CBF and PET counts. In our analysis, by taking into account these two factors, we approached the optimal scan length of around 90 seconds for the bolus injection technique. For low flow, the optimal time was longer, we found, and for high flow, it was slightly shorter, though longer than 60 seconds for a physiological flow range. Jones: Dr Fox is really talking about the heterogeneity problem. If you have a piece of grey matter, and you know the correct value for the tracer’s volume of distribution ( Vd),the longer you scan, the better, statistically, until the time when equilibrium is reached for the concentration of tracer between the tissue and arterial blood. A time of 90 seconds should be about right. But with the heterogeneity question, you are recording average values, the contributions to which change because of the slower wash-out from white matter. This is really the issue Dr Fox is raising. Raichle: There’s another issue here, namely that we have been discussing measurements of blood flow, but what is often done is that people simply record radioactive counts in a particular area of interest and do not compute blood flow. The question of the time of the data collection becomes very important, because the tracer will wash out faster from the area of higher flow, as Peter Fox says. Our experience has been that the signal-to-noise properties of such a scan deteriorate as a function of time (Mintun et a1 1989). This seems surprising, because one would expect that one could integrate over this time and obtain more and more counts, and be statistically better off. But count rates are changing differently in different areas and most rapidly in areas of greatest interest. Porter: That is also a spatial-averaging issue. It’s not simply the temporal average, but also the spatial zone over which the average is computed that must be understood. Roland: I tend to agree with Peter Fox in his analysis. It is certainly true that if you use a model that is very strict, like the 133Xe-intracarotidmodel,
40
Discussion
you observe a decrease in blood flow (in m1/100g per min) measured in a dynamic way, not as integration of counts, with time. This is due, I think, to two factors. There is the high clearance seen in an active brain region, but also a low clearance from the non-active grey matter, if you are looking at exactly the same spot. The weight of the non-active grey matter for the rCBF calculation will increase as you prolong the scanning time. Zida: I agree that we have a higher clearance in activated areas than nonactivated areas, and we lose a little bit of the signal, but, on the other hand, we should not forget the noise problem. Our model provides a constant and time-independent flow value. In this condition, we looked for a scan length which minimizes the statistical fluctuation of the CBF expected value, even for an activated flow range. As for the other issue, the optimal scan length should be the same if you are looking at the original accumulated counts and count ratios, although, in the paper, we discussed only CBF values. We minimized the percentage error of CBF (ACBF/CBF) by optimizing the scan length. This is equivalent to the minimization of the percentage error of accumulated counts ( A \ ,TCi(t)dt/j ,%i(t)dt). Fox: Consider the following. I put a region-of-interest over an area of stimulus-induced activation and then compare that to the background noise levels. The background noise falls over time but the signal falls faster. Thus for detecting functional activation (but not for blood flow measurement accuracy per se), the optimal scan time is shorter than two minutes. It is more in the range of 60 seconds. Zida: No! I think you are neglecting the statistical noise problem, and you are talking about a comparison of the amplitude of signals in activated and non-activated areas. Clearly, the brain tissue gets more radioactivity, as long as the radioactivity concentration is higher in the blood than in the tissue, which happened during the first period. After this, wash-out is greater than wash-in. The wash-out, as you say, causes a reduction in the activated-to-non-activated ratio; I agree with this. However, fortunately, the rate of wash-out is slower than the rate of wash-in. Therefore, there is an advantage in extending the scan length after the cross-over point in the blood and tissue curves. By taking into account both wash-out and statistical problems, we estimated the optimal scan time, and obtained our result. What we have to think about is the fluctuation (or error!) in the expected value of the activated-to-non-activated CBF ratio, and not simply the magnitude of the ratio. Fox: That is contrary to what we found, although it seems a reasonable prediction. Mazziotta: As has been mentioned, there’s a difference between measuring blood flow and detecting a change in flow, and the statistical and modelling approaches to each are different. To find an increment in a small volume of tissue will require a distinct strategy, in terms of signal-to-noise ratio and also in terms of sampling. We know now that lower spatial resolution will enhance
Rapid cerebral blood flow measurement
41
certain aspects of detectability while at the same time producing a poorer image of the distribution of cerebral blood flow, and that some combination of approaches, where you find the site of change in one analysis of the data, can then allow you to take those coordinates and identify, in the high resolution image, the site where that response came from. I think there’s a difference between the measurement of the absolute variable, and the detection of the change in the brain. Jones: Could you comment, Dr Iida, on the optimum way of giving I5O2t o measure CMR02-as a bolus, a short inhalation period, or a prolonged inhalation period? M a : The same argument as discussed for the H p O study can be applied, apart from one point. In the I5O2inhalation study, we need to estimate the recirculating H2I5Oconcentration in the blood as a function of time. This may not be an essential problem, if we can measure this recirculating water curve precisely, maybe by centrifuging the arterial blood very quickly to get a number of plasma samples. This is boring and hard work! Therefore, in our institute at the moment, we are employing a modelling approach to simulate this curve. I think the accuracy would be reasonable, but it is preferable to minimize the absolute amount of recirculating water in the blood. From this point of view, I think a slow administration would have some advantages. Roland: Dr Iida, how do you measure the distribution volume of water, and do you think it will change over a short time period-say, a couple of minutes? I assume that you might measure the distribution volume after some time, since it takes several minutes for the Patlak plot to become horizontal. However, if the vo!ume of distribution changes during the initial time course, as the experiments of John Mazziotta and Bob Collins showed might occur, we are left with the wrong distribution volume. Zida: We measured the distribution volume of water by fitting the dynamic H2150 data, for different fitting periods. We observed that the values were significantly smaller than the expected value and changed (fell) with increasing fitting periods, even after correcting the input function for delay and dispersion. This time dependency was found to be more in regions in which we expected a larger contamination of white matter spillover into the grey matter regions (Iida et a1 1989). One of the reasons for this time dependency is, therefore, most likely to be the heterogeneity of the grey and white matter. In our data analyses and simulations, for both H2I5O and lSO2studies, we used an empirical value of the distribution volume, which was an average of the fitted value (approximately 0.80). Fortunately, within the range of change of distribution volume, we got a time-independent value for either CBF or CMR02.
Evans: In the oxygen model you are measuring blood volume as a separate step. Have you looked at any simulations of incorporating the vascular component as a free parameter in the model?
42
Discussion
Zida: We have tried this, but the problem is the limitation of the statistical accuracy, and maybe systematic accuracy too, such as inaccurate correction for delay and dispersion. When we fitted four parameters, such as the vascular component ( VB), distribution volume (I‘d), CBF and CMR02, we got very strange results. We have tried to fix Vd, because fixing other parameters such as CBF and CMROl doesn’t make sense, but the results were still strange and fluctuated very much. The value for CBF in particular changed a lot, depending on the assumed V, value. So, I think that if the data quality is improved, fitting of the vascular component might be possible. But, for the moment, it may not be satisfactory for practical use. Evans: How does that behave differentially between the bolus and ramp input? Zida: I don’t think there is a big difference between the bolus and slow administration of the tracer because, for both administration procedures, the same amount of radioactive blood comes into the field of view. Evans: I think it helps to get the radioactivity into the brain quickly, because of the better statistics on the early frames. You can get a tighter determination of the influx constant and the vascular component, and distinguish between those more easily, if you have high activity in the early frames. With a ramp input they are difficult to separate out. So there is a case for a bolus input if you want to determine the vascular component in the uptake curve and try to avoid the need for a separate scan to measure blood volume. Zida: This may be true. And also it could be easier to adjust the delay of the input function in the bolus technique. But I am not sure how much we can improve the data quality. References Grinvald A, Lieke E, Frostig RD, Gilbert CD, Wiesel TN 1986 Functional architecture of cortex revealed by optical imaging of intrinsic signals. Nature (Lond) 324:361-364 Holden JE, Eriksson L, Roland PE, Stone-Elander S, Widen L, Kesselberg M 1988 Direct comparison of single-scan autoradiographic with multiple-scan least-squares fitting approaches to PET CMRO, estimation. J Cereb Blood Flow Metab 8:671-680 Iida H, Kanno I, Miura S, Murakami M,Takahashi K, Uemura K 1989 A determination of the regional braidblood partition coefficient of water using dynamic positron emission tomography. J Cereb Blood Flow Metab 9:874-885 Mintun MA, Raichle ME, Quarles RP 1989 Length of data acquisition inversely affects ability to detect focal areas of brain activation. J Cereb Blood Flow Metab 9 (suppl I):S349 Ngai AC, KO KR, Morii S, Winn HR 1988 Effect of sciatic nerve stimulation on pial arterioles in rats. Am J Physiol 254:H133-H139
Ge neral d iscussion Brain energy metabolism: cell body or synapse?
SokolofJ We have some information on the question of what proportions of the brain’s energy are being used by the cell bodies and by the synaptic regions. When the deoxyglucose method for measuring local cerebral glucose utilization was developed (Sokoloff et a1 1977), we expected to find metabolic activity primarily in cell bodies, where neurophysiologists had presumably been recording spikes. We were surprised to find the converse. For example, in the rat hippocampus, we found a dark band in the autoradiograms that turned out to be the molecular layer, which is a synapse-rich layer, not a cell body layer (Sokoloff et a1 1977). We also studied the effects in rhesus monkeys of eye-patching (Kennedy et a1 1976). In monkey with both eyes open, we found that the most labelled layer in the striate cortex was a sublayer of layer 4, a synapse-rich layer (Fig. 1). When both eyes were patched, glucose utilization was reduced throughout the striate cortex, but the most prominent effect by far was in this synaptic layer, which almost disappeared in the autoradiograms. The implication was that not only was the metabolic rate in the synapse-rich areas higher, but these seemed to be the areas most involved in changes in functional activity. William Schwartz was interested in stressing the hypothalamic-hypophysial system (Schwartz et al 1979). He salt-loaded rats by giving them 2% NaCl to drink for several days. In the autoradiograms of the deoxyglucose studies of control rats we did not see the paraventricular (PVN) and supraoptic (SON) nuclei clearly. In the salt-loaded rats, the labelling in the posterior pituitary was increased markedly, whereas the SON and PVN were not significantly changed from normal (Fig. 2). This was a surprise because electrophysiologsts have recorded from the hypothalamo-hypophysial tract and found increased spike activity in that pathway with salt-loading. The terminal projection zone of the pathway, the posterior pituitary, showed increased energy metabolism, but in the cell bodies of the PVN and SON, the sites of origin of the pathway, we couldn’t find any significant changes in metabolism. We thought that, perhaps, the cell bodies were too dispersed and that, therefore, they could not be distinguished from the surrounding tissue in the autoradiograms. When, however, Dr Savaki studied the effects of hypotension induced by phenoxybenzamine or by blood loss, she could also turn on the PVN and SON as well as the posterior pituitary (Fig. 2D). The difference between the salt-loaded rat and the hypotensive rat was that the increase in activity in 43
General discussion
44
the hypothalamo-hypophysial pathway of the hypotensive rat is due to reflex activity from the brainstem by pathways that project to the PVN and SON. In all these brain areas we are really looking at regions that are heterogeneous with respect to cell body and synaptic elements. In the dorsal root ganglion the cell bodies are clearly separated from their processes. Dr Kadekaro electrically stimulated the sciatic nerve of anaesthetized rats at different frequencies, took
t-------(
5.0mm
Cell body or synaptic metabolism?
45
out the dorsal root ganglia and lumbar cord, and autoradiographed them at the same spinal level (Kadekaro et a1 1985). There were no significant changes in glucose utilization in the cell body region of the dorsal root ganglia, but in the terminal zones of that pathway-for example, in the dorsal horn of the lumbar spinal cord-she found a quantitative relationship between frequency of stimulation and rate of glucose utilization (Fig. 3). In the resting state there is a significant amount of glucose utilization in the cell body; on stimulation at different frequencies there is no change in glucose utilization in the cell bodies, whereas in the terminal zone, where the nerve terminals of that pathway are, there is a practically linear relationship between glucose utilization and spike frequency (Fig. 4). This bothered us, and also neurophysiologists who record from cell bodies. We had other evidence indicating that the increase in energy metabolism associated with increased electrical activity is related to activation of the enzyme, Na+/K+ -ATPase, presumably to restore the ionic gradients across the neural membranes that were degraded as a result of the ion currents occurring during the spike activity (Mata et a1 1980). We wondered why cell bodies do not show increases in metabolism if they do indeed spike; if so, then the Na+K+-ATPase activity should be increased. Our neurophysiological colleagues said that they were sure that they record spikes from cell bodies. We asked if they were sure that they were not recording from the initial segments. Some have intracellular recordings, but hadn’t measured current and voltage changes at the same time. Membrane physiologists who use patch-clamp techniques told us that the perikaryonal membrane is not very excitable (Smith 1983). If so, we asked, how does the signal get across the cell body from the dendrites to the axonal side? They claimed that the transmission across the cell body was electrotonic, not true conduction by spikes, until it reaches the initial segment, where the voltage
FIG. 1 (Sokolofs). [ I4C]Deoxyglucose autoradiograms demonstrating effects of bilateral and monocular visual occlusion on local glucose utilization in striate cortex of the monkey. The greater the density (i.e., darkness) the greater is the rate of glucose utilization. A. Striate cortex from animal with both eyes open. Note heterogeneity in the laminae; the darkest lamina corresponds to layer IV. B. Striate cortex from monkey with both eyes patched. Note the general reduction in density and almost complete disappearance of the laminar heterogeneity. C. Striate cortex from animal with only right eye patched. The left half of the autoradiogram corresponds to the left hemisphere contralateral to the occluded eye. Note the alternating dark and light columns traversing the full thickness of the striate cortex; these are the ocular dominance columns. The dark bands represent the columns for the open eye; the light bands represent the columns for the patched eye and demonstrate the reduced glucose utilization resulting from the reduced visual input. The arrows point to regions of bilateral asymmetry; these are the loci of representation of the blind spots of the visual fields. (From Kennedy et al 1976.)
46
General discussion
Cell body or synaptic metabolism?
47
threshold is low. There are very few voltage-dependent sodium channels in the perikaryonal membrane. We, therefore, think that most of the functionally related changes in metabolic activity seen with altered functional activity are in the nerve terminals. The cell bodies d o have a significant level of energy metabolism, but it is mostly for vegetative functions, such as axonal transport and synthesis of proteins, and is not related directly to the transmission of the signal down the pathway. Porter: So you are suggesting that the metabolic cost is the cost of ion transport at the synaptic sites? This will have both pre- and postsynaptic contributions. Sokoloff: Yes, most of the cost can be attributed to ion transport at synaptic sites. Roland: There may be another implication of your beautiful studies. As far as I understand it, the GABAergic terminals end on the proximal dendrites of the hippocampal pyramidal cells, and that is a region where you don’t find much enhancement of glucose consumption after stimulation. Would you agree too that GABAergic activity does not really increase the regional metabolic rate for glucose in ordered structures like the hippocampus? SokolofJ Yes. This brings up another point. We had found, in studies with dopamine agonists, brain areas in which glucose utilization was increased. These regions were part of the nigro-striatal pathways. For example, in the caudate nucleus, apomorphine or amphetamine increased glucose metabolism. Neuropharmacologists claimed that dopamine acts as a n inhibitory neurotransmitter in the caudate nucleus. Then why this increase in glucose utilization? We couldn’t explain that then, but now that we realize that the spike frequency in the nerve terminals determines the rate of glucose utilization in a region-of-interest, we can. The effect of firing rates in the afferent terminals determines the rate of glucose utilization, whether an excitatory or an inhibitory neurotransmitter is released. In either case, it is the effect of the electrical activity in the afferent terminals that is observed. Both inhibitory and excitatory pathways, when activated, show increased rates of glucose utilization. FIG. 2 (Sokoloffi. Effects of activation of hypothalamo-neurohypophysial pathway by salt-loading or hypotension on local cerebral glucose utilization in the rat. A. Histological sections of brain stained with cresyl violet (Nissl) and pituitary stained with toluidine blue, demonstrating positions of supraoptic nucleus (SON), paraventricular nucleus (PVN), posterior pituitary (PP), and anterior pituitary (AP). B. [ 14C]Deoxyglucose autoradiograms of brain and pituitary from normal control rat drinking only water. C. [ I4C]Deoxyglucose autoradiograms from rat given 2% NaCl to drink for five days. Note selective marked increase in density in posterior hypophysis, indicating increased glucose utilization. D. [ I4C]Deoxyglucose autoradiograms from rat made hypotensive by administration of 20 mg/kg of phenoxybenzamine, 45-60 minutes before [ I4C]deoxyglucose was given. Note selective increases in labelling of supraoptic and paraventricular nuclei and posterior pituitary. (From Schwarz et a1 1979.)
48
sections of the lumbar cord and dorsal root ganglia. The arrows point to the side of stimulation. (From Kadekaro et a1 1985.)
FIG. 3 (Sokoloff). [ I4C]Deoxyglucose autoradiograms illustrating effects of electrical stimulation of sciatic nerve at different frequencies on glucose utilization in the dorsal root ganglion (right) and lumbar spinal cord (left). A and E are cresyl violet-stained
$
General discussion T
50
40
30
4 Means?
20
SEM
(n)=Number
of Animals
10
0
3
Dorsal
R o o t Ganglion
(4)
(4) -1 0
I
5
10
15
FREQUENCY OF STIMULATION (Hz)
FIG. 4 (Soko/off).Frequency-dependent effects of electrical stimulation of sciatic nerve on glucose utilization in dorsal root ganglion and dorsal horn of lumbar spinal cord. The error bars represent SEM. (From Kadekaro et al 1985.)
To distinguish between the two, one must look one synapse downstream; if an inhibitory neurotransmitter is released at the first synapse, one will observe reduced glucose utilization in the next synapse. If an excitatory neurotransmitter is released, then glucose utilization is increased at the next synapse. Wise: This is also the question of surface area. You say that the cell body doesn’t have many sodium channels in it, but just adjacent to the cell body (the initial segment) there is a variable amount of electrical activity. The surface area there is very small, whereas at the level of the dendrites there is a large total surface area with many ion channels. The net sum of the inhibitory and excitatory influences on the dendritic tree of an axon is transmitted through the axon hillock, but local metabolic rate will be influenced by the activity at
Oxidative metabolism in brain
51
dendritic level and not by the spike rate in the axon. In other words, local metabolic rate is governed by input, not output. Sokoloff: True! Porter: And there is a huge concentration of neuropil and synapses, both excitatory and inhibitory, with glial processes around them. Sokoloff: There is a large surface-to-volume ratio in the nerve terminals. Oxidative metabolism in brain
Fox: I would like your thoughts, Dr Sokoloff, on how we might perform, at autoradiographic resolution, the counterparts of the experiments performed at low resolution with PET (Fox & Raichle 1986, Fox et a1 1988) and proton spectroscopy (Prichard et a1 1987). These studies indicate that a large fraction of the increase in brain glucose metabolism induced by neural activity is nonoxidative and, therefore, yields very little energy. We have done our best at the macroscopic level (using PET and spectroscopy). You are the expert on measuring metabolism at microscopic resolution. How should we proceed to resolve this issue? Sokoloff: My interpretation of the alleged dissociation of blood flow and glucose utilization from oxygen consumption is that there is something wrong with the oxygen consumption model and method. Fox: It has been confirmed with proton spectroscopy. Sokoloff: What were seen with proton NMR spectroscopy were increases in lactate in the brain with functional activation, something that should be expected. Pyruvate is an intermediate in the pathway of energy metabolism in the brain, and it is a substrate for the Krebs cycle. Its formation is increased whenever glycolysis is increased. A large amount of lactate dehydrogenase exists in brain tissue, and there is rapid equilibration between pyruvate and lactate, with the equilibrium favouring lactate. When pyruvate formation is stimulated, the amount of lactate increases. In rat brain there is about 1 mM lactate. By NMR, on functional activation the lactate concentration increases only to 2-3 mM. This is small compared to the flux of carbon going through the glycolytic and oxidative pathways. Think of a number of bottles connected in series, with water from the top one running into the next bottle and then into the next, and so on. That’s analgous to a metabolic pathway with many steps. One will get an increase in water level in every bottle, once the flow from the first bottle is accelerated. The fact that lactate and pyruvate increase in the brain doesn’t mean that the energy is coming from anaerobic glycolysis only. From one mole of glucose the theoretical amount of ATP generated is about 36 moles. Allowing for a lack of efficiency, this estimate is reduced to 28-30 moles. From, say, 30 moles ATP formed, only two come from glycolysis. If one stimulated glycolysis by 50%, one would add only one mole of ATP, out of 30. That doesn’t make
52
General discussion
economic or biochemical sense. Moreover, the same biochemical changes that occur within a cell that turn on glycolysis will, under aerobic conditions, also turn on electron transport and oxygen consumption. Therefore, if you are telling me that you are not increasing oxygen consumption when you stimulate glucose utilization under aerobic conditions, I don’t understand it at all. Frackowiak: Have you done any autoradiography a t a cellular level, using 3H-labelled deoxyglucose, to see which cell population at the synapse is metabolically most active? Is it the synapse itself, or is it the surrounding glia? Sokoloff: No, we have not, and we don’t know, but would like to. It is possible that it is mainly glial but, if so, what are all those mitochondria doing in the nerve terminals? Jones: Going back to Peter Fox’s question, could autoradiographic methods be used to study the oxygen consumption of tissue? This would provide an independent measure of the activation of oxygen consumption and help us to understand whether there are errors in the PET methods, and where they come from. Sokoloff: I don’t know how. We do know that in vitro,in brain slices, oxygen consumption is increased by electrical stimulation or by raising the K concentration in the medium. Raichle: A group of investigators at Rutgers University suggested a means of detecting oxygenation of haemoglobin in tissue sections (Buckweitz et al 1980). One might propose looking at the variation in the A-V difference in oxygen concentration across the stimulated part of the cortex, to see if it changes, on stimulation. One would have to study something like the barrel fields in the rat or mouse cortex, to do that (Woolsey et a1 1990). Sokoloff: Lockwood’s group (Izumiyama et a1 1989) have proposed a method for measuring local oxygen consumption autoradiographically. Raichle: This method of Dr Buckweitz is autoradiographic in a sense, but using the signal that is within the tissue and fast-freezing it, using the optical properties of brain venules versus incoming arterial blood. Frackowiak: On this issue of the potential errors in the ‘autoradiographic’ oxygen method, the problem is compounded by the fact that the very few steadystate measurements of oxygen consumption and blood flow performed under conditions of activation suggest a correspondence between them. The method is exceedingly tiresome and uneconomical in terms of radiation exposure, when you are trying to do repeat measurements, and therefore is not done. We carried out one PET study some time ago, comparing an eyes-closed and eyes-open condition. The increases in blood flow posteriorly were 30% and of oxygen metabolism, 25%. That was a single observation, but it raised for us the problem of why there seemed to be a discrepancy between the rapid oxygen metabolism measurements with the bolus technique and the steady state. One explanation may be that there are a number of cellular populations in the volume of tissue that we are looking at with PET. These may differ in their capacity for oxidative +
Oxidative metabolism in brain
53
metabolism, which presumably has to do with neurotransmission, and for glycolysis, which may be more concerned with other local cellular functions. Sokoloff:There is the possibility of a temporal dissociation between glucose utilization and oxygen consumption. Before more oxygen can be consumed, there must be an increased supply of oxidizable carbon and hydrogen sources. It is necessary to produce more pyruvate to oxidize more. There may be an initial increase in the supply of substrates-for example, pyruvate and lactate-to the Krebs cycle, followed by increased oxygen consumption later, or, for example, an oxygen debt like that which occurs in muscle. Is this supported by the evidence? Raichle: This is certainly the most attractive possibility, but our data do not support it. This dissociation of oxygen consumption and glucose utilization was not what we were planning to find! We thought hard about the oxygen model (Mintun et a1 1984), but of the various models used to measure oxygen consumption, this one (Mintun et a1 1984) has most empirical validation. The model is basically looking at the arteriovenous oxygen difference. It is easy to say that this model does not work properly, and I would be happy to concede, if those who make such statements provided hard data to back them up. Sokoloff: A steady-state O2 consumption method would not have that problem of temporal dissociation. Raichle: It might not be viewed as a problem, if there are temporal changes to be uncovered. SokolofJ True. I have been doing some modelling of the effects of changes in glucose concentration in the arterial plasma on the free glucose concentration in brain tissue. I tried to take into account the fact that the brain doesn’t know anything about what’s in arterial blood; it only knows what is in the capillary. Therefore, we have to attempt to determine what the brain sees. To determine or model what is happening in the capillary we need to make a large number of worrisome assumptions. We have to worry about what the local A-V difference is for glucose. This is related to its rate of metabolism, the blood flow, and arterial glucose concentration. We have also to know the gradient down the capillary. Then we have to determine how much is capillary blood, venous blood, and arterial blood in the tissue. We have also to worry about the local haematocrit. All those things are assumed in our modelling, but I don’t have much confidence in the validity of these assumptions, because I haven’t been able to carry out independent verifications of any of them. I think you have the same problem in the oxygen consumption method, and the many implicit assumptions required by the method are the places to look for problems, especially under conditions where these relationships may change. You may make reasonable assumptions for a normal state, but when you perturb the system, they may not apply. Raichle: I agree that all these models depend on assumptions. However, assumptions, clearly stated, at least lay out the issues to be addressed. And at
54
General discussion
the theoretical level one can look at the error propagation of these various assumptions. The model is more sensitive to some than to others. But, having said this, I would return to my position that the model used to analyse our data (Mintun et a1 1984) has been empirically validated under normal conditions and I would consider the activation we performed to be normal function. Sokoloff: Before we revise our standard biochemical thinking, we ought to examine the possibility that there is a methodological problem, rather than a fundamental error in our biochemical thinking! Raichle: To evaluate a method such as ours (Mintun et a1 1984), one needs some standard, and in this instance most of us would accept the notion of measuring the A-V difference across the brain and multiplying by the blood flow to give us the metabolic rate for oxygen. We used this standard to validate our method (Mintun et a1 1984). Such a validation, rare among PET methods, is good empirical evidence that you are accurately measuring what you intend to measure, in this case oxygen consumption, despite whatever assumptions you are making in the model. Sokoloff: There are at least 50 years of experimental data, mostly not based on hypothetical models. Investigators just measured arterial-venous differences for oxygen and glucose by very good chemical methods. In almost all conditions, except hypoglycaemia and ketosis, the oxygen-to-glucose ratios were found to lie between 5 and 6mmol/mmol: that’s hard to argue with. Raichle: Yes, but our method provides exactly the same data, except that it permits regional measurements in normal humans with PET which could not be obtained otherwise. Lassen: May I add something on this point? In epilepsy, the venous blood gets more red, so evidently blood flow overshoots. Frackowiak: Everyone, I think, accepts that flow overshoots. And we should remember that using PET we are very lucky, in that by following blood flow, which is the most convenient thing we have to measure, we obtain the highest physiological signals which remain related in some way to neural activity. But in terms of this biochemical discussion at a fundamental level, it is not this overshoot of blood flow that is the important issue. Sokoloff: Dr Plum, you studied dogs with experimental seizures and found an outpouring of lactate from the brain, but when the dogs were given artificial respiration and the musculature was blockaded with neuromuscular blocking drugs, then the lactate output was essentially reduced to normal or negligible levels, in spite of the seizure activity. Plum: As you imply, we became interested some time ago in the uncoupling that occurs between blood flow and oxidative metabolism in the stimulated brain. Wilder Penfield had remarked in 1937 that he was able to identify a discharging seizure focus in the human brain by the reddened venous blood draining the area. Our laboratory looked at the mechanisms of this dramatic uncoupling between blood flow and oxidative metabolism in a series of experiments between
Oxidative metabolism in brain
55
1967 and 1975 (summarized in Plum & Duffy 1975). We used seizures of a variety of intensities as our stimulus and observed in all instances that during the seizures, blood flow increased sufficiently to exceed oxygen demand in the epileptic regions but venous C 0 2 remained constant. Calculated brain pH fell in the tissue, presumably intracellularly, but electrode-measured interstitial pH remained constant throughout the seizure. Direct tissue measurements showed modest (PcO.05)reductions in ATP but up to five-fold increases in lactate (P
References Buckweitz E, Sinha AK, Weiss HR 1980 Cerebral oxygen consumption and supply in anesthetized cat. Science (Wash DC) 209:499-501 Fox PT, Raichle ME 1986 Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 83: 1140- 1144 Fox PT, Raichle ME, Mintun MA, Dence C 1988 Nonoxidative glucose consumption during focal physiologic neural activity. Science (Wash DC) 241:462-464 Izumiyama M, Kogure K, Lockwood AH, Yap E, Tewson TJ 1989 Evidence of a microcirculatory and metabolic penumbra in postischemic rat brain: a I5O autoradiography. J Cereb Blood Flow Metab 9 (suppl 1):S382 Kadekaro M, Crane AM, Sokoloff L 1985 Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc Natl Acad Sci USA 82:6010-6013 Kennedy C, Des Rosiers MH, Sakurada 0 et a1 1976 Metabolic mapping of the primary visual system of the monkey by means of the autoradiographic [ 14C]deoxyglucose technique. Proc Natl Acad Sci USA 73:4230-4234 Mata M, Fink DJ, Gainer H et a1 1980 Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem 34:213-215 Mintun MA, Raichle ME, Martin WRW, Herscovitch P 1984 Brain oxygen utilization measured with 0-15 radiotracers and positron emission tomography. J Nucl Med 25: 177- 187
56
General discussion
Plum F, Duffy TE 1975 The couple between cerebral blood flow and metabolism during seizures. In: Lassen N (ed) Brain work. Alfred Benzon Symposium VIII. Munksgaard, Copenhagen, p 197-214 Prichard JW, Petroff OAC, Ogino T. Shulman RG 1987 Cerebral lactate elevation by electroshock: a 'Hmagnetic resonance study. Ann NY Acad Sci 508:54-63 Schwartz WJ, Smith CB, Davidsen L et a1 1979 Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science (Wash DC) 205~723-725 Smith TG Jr 1983 Sites of action potential generation in cultured neurons. Brain Res 288:381-383 Sokoloff L, Reivich M, Kennedy C et a1 1977 The [ 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 282397-916 Woolsey TA, Rovainen CM, Robinson 0 1990 Videomicroscopy of flow in single blood vessels in mouse barrel cortex in vivo. SOCNeurosci Abstr 16:25
Optimization of signal in positron emission tomography scans: present and future developments David W. Townsend Division of Nuclear Medicine, University Hospital of Geneva, 24 rue Micheti-du-Crest, 1211 Geneva 4, Switzerland
Abstract. The absolute sensitivity of a state-of-the-art, commercial neuroPET tomograph with interplane septa is about 0.5%. This poor utilization of the available photons could be improved by increasing the intrinsic efficiency of the detection process and, more significantly, by increasing the solid angle coverage of the tomograph. While multi-ring scanners currently have an axial length of about 10 cm, the useful solid angle is limited by the presence of interplane septa. These septa reduce the acceptance rate not only of scattered photons but also of true unscattered coincidences, although in studies performed at high photon counting rates the loss of potential signal may be less important than a reduction in scatter. Removal of the septa increases the absolute sensitivity of the scanner to about 3 % , a figure which also includes an unavoidable increase in scattered photons. However, in studies performed at low photon counting rates, any increase in scattered and random (uncorrelated) coincidences resulting from septa removal may be an acceptable price to pay for the accompanying increase in signal, provided that there is a real improvement in the signal-to-noise ratio. Recently, scanners with automatically retractable septa have become commercially available, thus enabling the configuration (i.e. septa extended or retracted) to be selected according to the study to be performed. 1991 Exploring brain functional anatomy with positron tomography. Wiley, Chichester (Ciba Foundation Symposium 163) p 57-75
A significant number of positron emission tomography (PET) studies of the brain are carried out at low coincident photon counting rates. The reasons include the low uptake of certain positron-emitting tracers, the requirement to follow tracer concentration as a function of time to low levels, the desire to do repeat studies in a single volunteer by giving multiple small doses of tracer, and the necessity to perform studies in children, where low doses are clearly indicated. Apart from studies in patients, we may, in the future, be required to reduce the tracer levels currently administered to normal volunteers under accepted research protocols. The key to performing these and other such studies more efficiently is an improvement in the sensitivity of the imaging system. 57
58
Townsend
Over the past ten years, a number of different PET camera designs have been investigated, most of which have used bismuth germanate (BGO) as the detector material. At the present time, therefore, the large majority of installed PET cameras consist of multiple rings of small BGO detectors surrounding the patient. Positioned between adjacent rings of detectors, thin lead or tungsten shields (septa) project a few centimetres into the field of view, beyond the front face of the detectors. A true coincidence is one in which the two coincident photons are unscattered and originate from a single positron annihilation. Ideally, PET images should include only true coincidences and the stack of annular septa serve (a) to limit the incident photon flux, thus reducing the probability of acquiring uncorrelated photon pairs (random coincidences) and (b) to shield the detectors from out-of-plane scattered photons. The septa, however, reduce not only the contribution from scattered and random coincidences but also that from true coincidences. PET cameras with septa acquire coincidences (true, random or scattered) between pairs of detectors if they are in the same or adjacent rings, thus limiting the effective coincidence acceptance angle in the axial direction to less than 1". In practice, this small angle is usually neglected and all coincidences are assigned to parallel two-dimensional transverse slices. Each slice can then be reconstructed independently using a standard, two-dimensional reconstruction algorithm (Herman 1980). The 2D slices can be stacked in order to recover the threedimensional distribution of tracer. The measured absolute sensitivity (that is, the ratio of the number of detected photon pairs to the total number emitted from the source in a given time) of such a camera is about 0.5% (Bailey et a1 1991a). One obvious way in which to improve this low sensitivity is to increase the maximum acceptance angle of the scanner. As a first step, this can be done by removing (retracting) the septa and allowing coincidences to be acquired between any two rings-that is, a three-dimensional or volume acquisition. Retraction of the septa increases the maximum acceptance angle to about 6", and raises the absolute sensitivity of the scanner to a little over 3%. However, while the increase in true coincidences reduces statistical noise, improving the signal-to-noise ratio in the image, there is an increase in scatter which reduces image contrast, thus reducing the signal-to-noise ratio. The net effect on the signal-to-noise ratio will have a positional dependence because the increase in true coincidences is spatially variant, being concentrated more towards the centre of the axial field of view. At the centre, the signal-to-noise ratio should be improved, whereas at the axial extremities it may even be worse than with the septa extended. A further requirement of a septa-retracted acquisition is the use of a three-dimensional (volume) reconstruction algorithm which processes the additional oblique-angle data, taking into account their non-uniform spatial distribution.
Signal optimization in PET scans
59
Recently, a neuroPET scanner with automatically retractable septa has become commercially available. This scanner, an ECAT 953B (Siemens/CTI Inc, Knoxville, TN, USA), consists of 16 rings of BGO detectors. The complexity and cost of coupling these detectors to individual photomultiplier tubes has been reduced by adopting the block-detector approach (Casey & Nutt 1986). In the latest design, an array of 8 x 8 detectors, 6 mm x 6 mm in size, are cut from a single BGO block, 3 cm thick and 5 cm x 5 cm in section. The block is coupled to four photomultiplier tubes (PMTs), and the relative distribution of light between the four PMTs is used to localize the most probable detector among the 64 possible candidates. For this brain scanner, two circular arrays, each of 48 blocks, are mounted contiguously to provide 16 rings of 384 detectors per ring, covering an axial extent of 10.8cm. In this chapter, the performance of the ECAT 953B scanner will be examined, and in particular its suitability for imaging the brain at low count rates, with emphasis on factors influencing the signal-to-noise ratio in the image. Apart from retracting the septa, there are, of course, other ways in which to increase camera sensitivity, such as by improving the intrinsic efficiency of the detector unit. This could be achieved either by improving the light collection from the currently used BGO block, or by using a different detector material with a better combination of stopping power, light output and decay time. However, even if the detection process were 100% efficient, the absolute sensitivity of the 953B scanner would still be less than 5% because of the small acceptance angle (<6")subtended by the 10 cm long, 75 cm diameter, cylindrical detector geometry. Further significant improvements in sensitivity must come from an increase in acceptance angle, although this will inevitably require an increase in the number of BGO detectors in the scanner. The implications of such developments for brain imaging will be briefly discussed at the end of this chapter. Retracting the septa A scanner with n rings of detectors subdivides the 3D imaging volume into 2n - 1 two-dimensional transverse planes. These planes are either direct planes where the detectors in coincidence are in the same ring, or cross planes where the detectors are in two adjacent rings, as illustrated in Fig. 1 for a scanner with four rings. If we neglect the small acceptance angle ($), coincidence lines between detectors in two adjacent rings are assigned to the transverse cross plane mid-way between, and parallel to, the two direct planes on either side. The average sensitivities of the direct (odd) and cross (even) planes therefore differ, as shown schematically in Fig. 2a for a scanner with eight rings. Each plane is reconstructed independently using a two-dimensional reconstruction algorithm. Calibration factors account for the sensitivity variations between planes.
60
Townsend
Direct plane
Cross plane FIG. 1. A cross-section through a neuroPET scanner with four rings of detectors. The rings are labelled 1 to 4, and detectors (al, bl), (a2, b2) are diametricallyopposing pairs of detectors in ring 1, ring 2, etc. Direct and cross planes are indicated, and tapered septa are shown between adjacent rings. II. is the maximum acceptance angle.
When the septa are retracted, coincidences are acquired between detectors in any two rings. The number of active coincidence lines of response increases from 0.95 million to 7.86 million. However, the additional oblique coincidence lines cannot simply be assigned to specific transverse planes without introducing significant spatial distortions into the images. As these oblique lines intersect more than one transverse plane, the set of 2n- 1 planes are no longer independent and the data must be reconstructed using a fully three-dimensional reconstruction algorithm. The average sensitivity of each plane with the septa retracted is shown schematically in Fig. 2a. The sensitivity variations due to the spatial variance of the camera response function cannot be corrected by simple calibration factors, but must be taken into account by the reconstruction algorithm. The sensitivity increase arising from septa retraction, which is a maximum in the centre of the field of view, is due both to the increase in the number of measured coincidence lines of response and to the elimination of the shielding effect of the septa which overlap (shadow) the crystal faces (Fig. 1); the increase in the outer planes is, of course, due mainly to the latter effect. The effect of scattered photons and random coincidences
In practice, the situation is more complicated than that shown in Fig. 2a. Septa retraction also leads to an increase in the detection of scattered photons and random, uncorrelated coincidences. The scatter fraction (the ratio of scattered to total coincidences) increases mainly because of an increase in out-of-plane scatters which are no longer absorbed by the septa. Random coincidences
61
Signal optimization in PET scans 50
0
septa extended
40 30
20 10 0
(a
1
1
2
3
4 5
6 7 8 9 loll 12131415 Plane number
20 septa extended
15
10
5
0
1
2
3
4 5
6
7
8
9 101112131415
Plane number
(bl FIG. 2. (a) The relative (noise-free) sensitivities of the direct and cross planes for a scanner with eight rings of detectors. The sensitivities are shown for septa extended and septa retracted. With the septa extended, the cross (even) planes have higher sensitivity than the direct (odd) planes. (b) The relative sensitivities of the direct and cross planes estimated from the noise equivalent count rate, including randoms and scatter, equivalent to a tracer concentration of 0.2 pCi/ml. The sensitivities are shown for septa extended and septa retracted.
62
Townsend
increase because of an overall increase in the incident photon flux. To take these effects into account, the concept of noise equivalent counts (NEC) has been introduced (Derenzo 1980, Strother et a1 1990). The noise equivalent count rate at a given true coincidence rate ( T ) ,scattered coincidence rate (S) and random coincidence rate ( R ) is the coincidence rate which, in the absence of scatter and randoms, would give the same signal-to-noise ratio. The NEC is given by Strother et a1 (1990) as: NEC =
T2
+
( T + s 2R )
where R is the random coincidence rate, taking into account only coincidence lines which cross the volume containing positron activity. The factor of two arises from the increase in statistical noise introduced by the random coincidence subtraction procedure. The noise-free situation shown in Fig. 2a can be modified by using equation (1) to estimate the noise equivalent efficiency for each transverse plane, with the septa extended and retracted. The result is presented schematically in Fig. 2b for scatter and random coincidence rates corresponding to a positronemitting tracer uptake of 0.2 yCi/ml uniformly within the brain. It is evident that the real improvement in the signal-to-noise ratio due to septa retraction could be significantly less than that expected from the noise-free situation, and that for the edge planes the improvement is actually less than unity; that is, for these planes, the signal-to-noise ratio is reduced by retracting the septa. The noise equivalent count concept as presented in equation ( I ) is useful for comparing different imaging situations in the presence of varying random coincidence and scatter rates. Bailey et a1 (1991b) have measured the overall NEC for the ECAT 953B scanner with septa extended and retracted for a number of different test objects containing positron activity, and for three clinical studies. These authors define an NEC gain factor as: NEC (septa retracted)/NEC(septa extended). This ratio gives an indication of the real improvement in signal-tonoise to be expected from septa retraction. The NEC does not take into account effects arising from changes in other physical parameters of the camera, such as spatial resolution. Furthermore, systematic effects introduced either by correction procedures such as scatter deconvolution, or by the reconstruction process (artifacts), may significantly affect the final signal-to-noise ratio in the image. However, for a 2D reconstructed image, in the absence of systematic effects the NEC is proportional to the square of the signal-to-noise ratio (Strother et a1 1990), at least for simple, high-contrast objects. The same relationship has also to be established for threedimensional reconstruction; we now examine the propagation of statistical noise by the reconstruction algorithm used in this work.
Signal optimization in PET scans
63
The 3D reconstruction algorithm Image reconstruction from data acquired with the septa retracted requires a fully three-dimensional reconstruction algorithm. A number of possible algorithms have been proposed in recent years (Colsher 1980, Ra et a1 1982, Defrise et a1 1987, Clack et a1 1989). The approach we have adopted in this work is a generalization to three dimensions of the standard 2D filtered backprojection algorithm (Pelc & Chesler 1979). Defrise et a1 (1990a) have shown that, with certain approximations, the coincidence data set acquired with septa retracted can be considered as a set of 2D projections of the three-dimensional tracer distribution. These 2D projections are first filtered with an appropriate function (Colsher 1980) and then the filtered projections are back-projected into the 3D image volume. This procedure is only valid if the system response function is spatially invariant. However, as we have seen (Fig. 2a), the sensitivity varies throughout the field of view. Lines of response in certain directions can be measured for a point at the centre of the field of view but not for a point at the extreme axial edge of the field, an inevitable consequence of the truncated cylindrical geometry of the scanner. To maintain the filtered back-projection approach, the response function is made spatially invariant by estimating the values of these unmeasured coincidence lines using a method first suggested by Pelc (1979) and more recently developed by Kinahan & Rogers (1989). After an initial, low statistics, 3D image has been obtained by stacking the usual 2D reconstructions of direct and cross planes, the values of the unmeasured lines of response are estimated by forward projection (integration) through this initial image. Completing the measured values with these estimates ensures that the response function is spatially invariant . The statistical properties of this algorithm have been studied by Defrise et a1 (1990b). They have shown that the variance on the reconstructed value f(x) at the centre (x = 0) of a uniform sphere (radius R) is: 2R/d var(f(0)1= - k (4) n where n is the number of coincidences per resolution element of size d, and the value of k ( $ ) depends on the maximum acceptance angle ($) of the scanner and on the reconstruction filter. For the filter used in our implementation, with $=6', k ( $ ) is approximately 0.47. This result is similar to that for the 2D reconstruction ($= 0) of a disk (Barrett & Swindell 1981), where k(0)= 0.82. Thus, at least for a uniform source of activity, statistical noise is propagated similarly by both the 2D and 3D filtered back-projection algorithms, and therefore the NEC concept applies equivalently to both 2D and 3D reconstructions. It can thus be used to compare septa-extended and septa-retracted acquisitions.
64
Townsend
This also means that, in principle, the noise in the 3D reconstruction should reflect the increase in statistics (true coincidences) due to septa retraction. We have estimated the statistical contribution to the reconstruction signalto-noise ratio as the ratio of the mean value ( M )to the standard deviation (a) for a region-of-interest located appropriately on the image. This ratio (SNR) can be calculated independently for each transverse plane. Note that, as with the NEC, this index does not take into account any non-statistical contributions to the image noise, such as reconstruction artifacts or systematic effects due to a scatter correction procedure. Results
We have performed a number of studies with the 953B scanner to evaluate its potential for imaging the brain (Townsend et a1 1991). Low count rate measurements made with a lower energy threshold at 380keV for a 20cm diameter cylinder (containing an activity concentration of around 0.1 pCi/ml) show that septa retraction increases the total system count rate by a factor of 7.4, which includes an increase in the scatter fraction by a factor of about three (to over 40%) (Michel et a1 1991). The real gain factor after scatter correction is only 4.7. These results depend, of course, on the particular choice of lower energy threshold. The current choice of 380 keV, which may not be optimal, is intended to maximize rejection of scattered photons without significant loss of true coincidences. Bailey et a1 (1991b) find that, for a 20cm diameter cylinder, the maximum NEC is achieved at 52000 coincidences per second (52 kcps; activity concentration 0.5 pCi/ml) with the septa retracted, compared to 74 kcps (2.5 pCi/ml) with the septa extended. Similar measurements for a 15 cm diameter cylinder show that the maximum NEC is about 150 kcps for both septa extended and septa retracted. However, with the septa retracted, this rate is achieved at only 10% of the positron-emitting activity required when the septa are extended. It is also interesting to note that with a given amount of radioactivity in the field of view, the random-to-true coincidence ratio increases (as expected) when the septa are retracted. However, for a given true coincidence rate the randoms/trues ratio is actually smaller with the septa retracted than with the septa extended. We have also acquired and reconstructed data for a uniform, 20 cm diameter, cylinder at two different radioactivity concentrations (0.08 pCi/ml and 0.31 pCi/ml). For each concentration, the cylinder was imaged for the same time with the septa extended and retracted. The data obtained with septa retracted were reconstructed using the algorithm outlined above. For each study, the SNR index was calculated for all 31 transverse planes. A SNR gain factor (the ratio of the signal-to-noise ratios) was then defined for each plane as: SNR (septa retracted)/SNR(septa extended). This factor is shown in Fig. 3 as a
Signal optimization in PET scans
W
65
High rate
flLow r a t e
3i
~
~
n n
m
b
~
~
4
~
m
a
o
~
~
m
t
~
~ - - - " - - - - ~ N N N N N N N N N N ~ ~
w
~
m
a
Plane number FIG. 3. The reconstruction signal-to-noise (SNR)gain factor (septa retractedlsepta extended) as a function of axial plane position for the ECAT 953B scanner. The factors are shown for a 20 cm diameter uniform cylinder imaged at activity concentrations of 0.08 pCi/ml (low count rate) and 0.31 pCi/ml (high count rate).
function of plane number for the two activity concentrations. The NEC gain factors were estimated to be 2.1 and 3.2 for the high and low count rate scans, respectively. Finally, Fig. 4 shows the thirty-one transverse planes from a study in which [ lSF]fluorodopa was injected in a normal volunteer. The study was done with (a) septa extended and (b) septa retracted. The scans were performed sequentially, approximately 90 minutes after injection, and each scan took five minutes. The average count rates were 1500 coincidences per second (septa extended) and 5300 coincidences per second (septa retracted).
Discussion These results suggest that real gains in sensitivity are to be achieved by retracting the septa at low counting rates. The NEC estimates show that, with the septa retracted, the useful increase in signal is limited by the contribution from increased scatter and random coincidences. A corresponding limitation is seen in the reconstructed signal-to-noise (Fig. 3), where, at high coincidence rates, the improvement may be as little as 30% in the centre of the field of view, whereas at low coincidence rates, with the same cylindrical object, the signal-to-noiseratio
o
-
~
66
Townsend
FIG. 4. Thirty-one 3.4mm thick, transverse sections through the brain of a normal volunteer following an injection of 6-L- [ **F]fluorodopa. The images were obtained about 90 minutes after injection from two, five-minute, scans performed sequentially with (a) septa extended (count rate, 1500 cps) and (b) septa retracted (count rate, 5300 cps).
may be increased by more than a factor of three for the same planes. It is impressive to note that, for the 15 cm diameter cylinder, the same (maximum) NEC, and hence signal-to-noise ratio, in the image is achieved at an activity concentration of only 0.6 pCi/ml with the septa retracted compared to 6 pCi/ml with the septa extended. The situation for brain imaging is more difficult to quantify. However, Bailey et al(l991b) have estimated the NEC in a study performed with a cerebral opiate
Signal optimization in PET scans
67
ligand ( [ "C] diprenorphine). They find that the overall NEC gain factor increases from four at the start of the study to about five at the end. This significant gain is reflected in the improvement observed in the reconstructed images of the low count rate fluorodopa study (Fig. 4). The standard deviation on a region of interest within the basal ganglia is reduced by a factor of two (for the same imaging time) when the septa are retracted. These improvements in the signal-to-noiseratio, particularly at low counting rates, have been achieved by increasing the acceptance angle of a commercially available PET scanner. It is interesting to speculate to what extent the signalto-noise ratio continues to improve as the acceptance angle is further increased, either by adding more rings of detectors, or by adopting a different design (Burnham et a1 1988, Rogers et a1 1988, Muehllehner et a1 1988). In the absence of actual measurements, such a question can be addressed by simulation. The effect of the increasing scatter fraction as the angular coverage of the scanner is extended beyond the 6" subtended by the 953B scanner has recently been studied (M. Defrise, personal communication 1990). The detector material is assumed to be 100% efficient at 5 1 1 keV. At an energy threshold of 300 keV, it is found that the scatter fraction does not increase continuously but tends instead to a constant value, essentially when all scatters with an energy greater than 300 keV are detected within the extended geometrical acceptance of the scanner. In the absence of random coincidences, the NEC sensitivity tends to increase monotonically with increasing angular coverage. At an angular coverage of 50°, the scatter fraction for a 20 cm diameter uniform sphere of activity is 45%, and the total and NEC sensitivities are 34% and 11070, respectively. The problem, then, is how to correct properly for such a large scatter fraction. A completely satisfactory measurement of scatter for PET has yet to be made, and any one of the proposed correction procedures is therefore likely to introduce a systematic error which has not been taken into account by the above NEC estimates. This is in contrast to the correction for random coincidences, where measurement of a time-delayed coincidence map results in a correction procedure which, while increasing statistical noise, does not introduce systematic errors. However, the 953B scanner has the capability to acquire data simultaneously from two energy windows (e.g. the photopeak and a lower energy scatter window), and work is currently under way to investigate how best to use this information ( S . Grootoonk & C . Michel, unpubfished work 1990). When the acceptance angle of the camera is increased, the aim must therefore be to obtain a reasonable balance between the statistical and systematic error contributions. Since the former decreases as the counts increase, whereas the latter is independent of the number of counts, there will be an optimal angular coverage for which the two contributions are balanced. For low count rate studies the statistical noise factor will dominate and hence a large acceptance angle will be beneficial. For studies performed at high rates with good statistics, it will be important to limit the systematic error introduced by scatter correction to
68
Townsend
a level compatible with the statistical contribution. Thus, the most appropriate scanner geometry will, in general, depend upon the study t o be performed. This suggests a future scanner design incorporating a larger acceptance angle than at present, but with retractable septa to limit the scatter fraction in low statistical noise situations. The use of shorter septa may be preferred, so that, with the septa extended, the scanner can still acquire oblique coincidence lines. A reduction in the coincidence timing might also be considered. At high random coincidence rates, a reduction in the statistical noise arising from the subtraction of the random coincidence background may be more significant than any accompanying loss of signal. Conclusion We have seen that the latest generation of neuroPET cameras with retractable septa offer significant advantages for low count rate studies. For higher count rate studies, the implications are that, with septa retracted, smaller quantities of radioactive tracer than those currently used can be administered without compromising image quality. Further improvements in signal-to-noise ratio in studies of the brain can be expected by increasing the angular acceptance of the camera beyond the present maximum of f6". Care must then be taken to limit any systematic error introduced by scatter correction. Retractable septa should also be provided to ensure satisfactory scanner performance with high levels of radioactive tracer in the field of view. A ckno wledgemen ts This work is supported by the Swiss Commission for the Encouragement of Scientific Research (CERS), grant number 1922.1. I am indebted to many of my colleagues, in particular to Antoine Geissbuhler, Michel Defrise, Dale Bailey and Terry Spinks, for their help and contributions to this work. The data for Figs. 3 and 4 were acquired with the ECAT 953B scanner at the MRC Cyclotron Unit, Hammersmith Hospital under the technical direction of Dr Terry Jones, to whom I express my gratitude.
References Bailey DL, Jones T, Spinks TJ 1991a A method for measuring the absolute sensitivity of positron emission tomographic scanners. Eur J Nucl Med 18:374-379 Bailey DL, Jones T, Spinks TJ, Gilardi MC, Townsend DW 1991b Noise equivalent count measurements in a neuro-PET scanner with retractable septa. IEEE (Inst Electr Electron Eng) Trans Med Imag, in press Barrett HH, Swindell W 1981 Radiological imaging, 1st edn. Academic Press, New York Burnham C, Kaufman D, Chesler D, Stearns C, Wolfson D, Brownell G 1988 Cylindrical PET detector design. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 35:675-679 Casey ME, Nutt R 1986 A multicrystal two-dimensional BGO detector system for positron emission tomography. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 33:460-463
Signal optimization in PET scans
69
Clack R, Townsend DW, Defrise M 1989 An algorithm for three-dimensional reconstruction incorporating cross-plane rays. IEEE (Inst Electr Electron Eng) Trans Med Imag 8:32-42 Colsher JG 1980 Fully three-dimensional positron emission tomography. Phys Med Biol 25: 103- I15 Defrise M, Kuijk S, Deconinck F 1987 A new three-dimensional reconstruction method for positron cameras using plane detectors. Phys Med Biol 33:43-51 Defrise M, Townsend DW, Geissbuhler A 1990a Implementation of three-dimensional image reconstruction for multi-ring positron tomographs. Phys Med Biol35: 1361- 1372 Defrise M, Townsend DW, Deconinck F 1990b Statistical noise in three-dimensional positron tomography. Phys Med Biol 35:131-138 Derenzo SE 1980 Method for optimizing side shielding in positron emission tomographs and for comparing detector materials. J Nucl Med 12:971-977 Herman GT 1980 Image reconstruction from projections, 1st edn. Academic Press, New York Kinahan PE, Rogers JG 1989 Analytic three-dimensional image reconstruction using all detected events. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 36:964-968 Michel C, Bol A, Spinks T et a1 1991 Assessment of response function in two PET scanners with and without interplane septa. IEEE (Inst Electr Electron Eng) Trans Med Imag, in press Muehllehner G, Karp JS, Mankoff DA, Beerbohm D, Ordonez CE 1988 Design and performance of a new positron emission tomograph. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 35:670-674 Pelc NJ 1979 A computerized filtered backprojection algorithm for three dimensional reconstruction. PhD thesis, Harvard School of Public Health, Boston, MA, USA, p 140 Pelc NJ, Chesler DA 1979 Utilization of cross-plane rays for three-dimensional reconstruction by filtered back-projection. J Comput Assisted Tomogr 3:385-395 Ra JB, Lim CB, Cho ZH, Hilal SK, Correll J 1982 A new true three-dimensional reconstruction algorithm for spherical positron emission tomograph. Phys Med Biol 27: 37-50 Rogers JG, Harrop R, Kinahan P et a1 1988 Conceptual design of a whole body PET machine. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 35:680-684 Strother SC, Casey M, Hoffman EJ 1990 Measuring PET scanner sensitivity: relating countrates to image signal-to-noise using noise equivalent counts. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 37:783-788 Townsend DW, Geissbuhler A, Defrise M et a1 1991 Fully three-dimensional reconstruction for a PET camera with retractable septa. IEEE (Inst Electr Electron Eng) Trans Med Imag, in press
DISCUSSION Evans: Dr Townsend, you are looking at the greatest number of counts that you can get out of one study, with septa extended or retracted, with different doses of radiation, which is basically the count rate capability of the PET system. You were showing with the NEC (noise equivalent count) curves that the maximum capability with septa out (retracted) was on the order of 150 OOO counts for the whole system, which is about what one can get now, with septa in (extended), albeit in fewer slices. You can therefore collect about the same total
70
Discussion
counts, dividing them up how you wish, but the limiting factor is 150000-200000 counts per second per study. So the question becomes: how useful is it that you can get the same number of counts with a fraction of the radiation dose? How practical is the benefit that you can do more repeats with the septa out, if you take into the account the facts that patients will move, and they may not maintain the same physiological status over repeated trials? Townsend: Our original interest in removing the septa was to improve the count rate in situations where one cannot increase the activity in the field of view by, for example, increasing the dose injected to the patient. We were thinking particularly of low-uptake ligand studies such as those with fluorodopa where one could even envisage retracting the septa between two frames of a dynamic study in order to compensate for isotope decay or wash-out. The application to activation studies is rather recent and we have yet to determine the optimum scanning conditions. The increased sensitivity will certainly offer the possibility to perform repeat activation studies in the same volunteer or patient-and even to study effects such as habituation. Problems arising from patient movement can, I’m sure, be solved. Evans: I am intrigued, because the attraction of taking the septa out had previously seemed to be that you could use it in cognitive subtraction paradigms, where the scatter problem is subtracted away; but it seems as though the greater benefit is the increase in NEC for [ I8F]fluorodopa studies, where you are typically doing quantitative studies and you are interested in a kinetic analysis and hence an improved signal-to-noise ratio. This somewhat turns things upside down. Townsend: Although it is true that with cognitive subtraction paradigms the scatter is essentially subtracted away, we have always taken the more general view that for 3D imaging to be successful, scatter must be properly corrected before reconstruction. We have been working on a scatter correction algorithm which involves convolving an exponential scatter function with each measured 2D projection in order to estimate the scatter distribution. This distribution is then subtracted from the measured projection before attenuation correction. The aim is not only to improve contrast but also to maintain quantitation. This same correction procedure would then be applied to, for example, the fluorodopa studies. An effective scatter correction is, I think, essential for the success of 3D imaging. Work is also continuing on estimating scatter from a dual energy window approach. Frackowiak: With cognitive studies, the main aim of trying to improve sensitivity is to carry out more measurements in a single subject. This is particularly important in trying to minimize a very potent source of variance in activation studies, which is the anatomical variance between subjects. Of equal importance is the ability to make statistically meaningful measurements in single patients suffering from a specific pathology or distribution of brain damage. If improved sensitivity allows measurement of blood flow at a fraction-say,
Signal optimization in PET scans
71
a fifth-of the current radiation dose, then five times as much information can be collected within radiation administration exposure guidelines. Evans: Theoretically, yes-if the patient can stand it. Frackowiak: That’s another problem, of whether the patient moves and whether you can put the patients into the tomograph, take them out and put them in again, achieving perfect spatial realignment of the resulting blood flow scans. Evans: That is a very real problem. Jones: There is also the possibility of bringing someone back on a subsequent day to complete the series of scans and then of realigning the two data sets. With the goal of achieving higher resolution than with previous systems, d o you think this a practical proposition? Evans: It certainly is, but it has been shown by Mark Mintun that you can take images and post-hoc re-register them, if you have sufficient axial sampling in 3D; so it’s conceivable to d o that. We are talking about a great potential with true 3D acquisition, but we need to have the 3D registration sorted out. You have to assume that the patient will not be perfectly aligned if you bring him back the next day and d o the same experiment. Fruckowiak: He has the same size and shape of head, of course! The registration is therefore easier with the same subject than with a group of subjects. Evans: It’s possible to d o this, but you have to d o it in a fully threedimensional re-registration environment. Jones: What do you think of the quality of the data that Dr Townsend showed when comparing the images recorded, for the same amount of delivered activity, between septa extended and septa retracted? Evans: It looked excellent, but I am suspicious of images; I want to see the numbers. Townsend: I should emphasize that each of the studies such as the fluorodopa study shown in Fig. 4b takes 3.3 hours to reconstruct on a SUN SparcStation 2 computer. For dynamic studies we have set up a multi-frame processing tool that automatically reconstructs a full dynamic study. No user intervention is required other than to supply the data file name and the reconstruction parameters at the start. The computer will then run for one or two days without intervention being required. This way we can d o about two, 15-frame dynamic studies per week without septa. We are currently analysing quantitatively our first 3D dynamic fluorodopa scan, so the numbers are coming. Evans: These computational issues will be solved; they don’t represent any fundamental obstruction. Townsend: I agree. That’s always been our view. Evans: What about the issue of habituation? To what extent can one take advantage of the option to repeat the scan again and again on the same subject?
72
Discussion
Mazziotta: You have to repeat the same paradigm. The beauty of this approach is that you can have 12 or more states, depending on the radiation dose, enabling you to do different tasks, or to bring subjects back on different days, as a pathological process changes, using the same behavioural paradigm instituted at different times in the recovery or progression of illness. Multiple low dose imaging gives you the flexibility to do those things, given the threedimensional re-registration. One of the most important criteria in the latter problem is having enough axial data to do the registration and alignment. Roland: Dr Townsend, you said that if you increase the count rate you will lose the gain, and get down to a factor of one, basically, if you take the septa out and do the 3D reconstruction. I need some absolute figures here. If you do ramp injections, you don’t run into the problems that you encounter if you use the bolus injection for measuring blood flow in a short time period, which is actually what you want to do, according to Dr Iida’s paper. What is the absolute count rate that you think you can handle before losing any gain? Townsend: As I showed, the NEC with the septa retracted for a 15cm diameter cylinder peaks at about 150 OOO counts per second. The same maximum value of 150OOO counts per second is measured with the septa extended, although ten times more activity is required to achieve this rate with the septa extended than with the septa retracted. The NEC is a global figure and, as shown in Figs. 2 and 3, the signal-to-noise gain actually has an axial dependence. Thus, even though the NEC may be at the maximum, the signal-to-noise gain for slices at the edge of the axial field of view may be worse than in 2D (the gain factor is less than one) with the septa extended. This is because you have little increase in signal from septa retraction in these slices. As I showed in Fig. 3 for a 20 cm diameter cylinder, the maximum signal-to-noise gain at the centre of the field of view can vary from only 30% at high rates (200000 counts per second) to more than a factor of 3 at lower rates (60000 counts per second). Roland: But in a normal study with bolus injection of about the same amount of radioactivity that you used, I imagine you would get a higher count rate? Jones: The maximum count rate obtained when infusing 30mCi over two minutes is around 200 OOO true coincidences per second. Roland: Another point that was not addressed was the electronic ‘deadtime’ in the system. This depends, of course, on the way your scanner is built, and it doesn’t apply to 3D reconstruction; but do you have any comment, Dr Townsend? Townsend: The deadtime problem is the same as for 2D acquisitions. In principle, a deadtime correction factor is estimated and used to correct each of the 256 acquired sinograms. In practice, at the present time, this estimate is not available and the data I presented were not corrected for deadtime losses. Obviously, for a given activity in the field of view, the deadtime increases when the septa are retracted, but this effect is included in the NEC estimate.
Signal optimization in PET scans
73
Evans: What sort of radioactivity dose do you envisage using, Dr Jones? Jones: We are using 30 mCi, which gives a net (NEC) gain fo three compared to when the septa are extended. In other words, the data obtained are equivalent to those obtained when 90 mCi is injected with the septa extended. Evans: We use 40 mCi in a conventional scanning system. You need to show that you can go down to, say, 20mCi before you will get an improvement in the number of studies you can do; 30 mCi is not much different from 40 mCi. You have to show that the dose is substantially smaller. Frackowiak: Dr Townsend, do you see any promising avenues in thinking about detectors, and detector materials, for improving PET systems further, or will the next advances come through cheaper, and better, electronics and decreasing the deadtime? Townsend: The ECAT 953B scanner has an absolute sensitivity with septa retracted of 3-3.3'70. We have calculated that increasing the detection efficiency to 100% would increase the scanner sensitivity to only 4.5%. The major problem is the solid angle coverage of the scanner, which is only 10 cm in length axially. Obviously, advances in detector material and light collection would also be significant, but the biggest advance will come from putting more detector material around the brain. Frackowiak: Is the advantage simply that you are increasing your gain on the outermost parts of your field of view, or is there also a gain in the centre? Townsend: It depends on the size of the axial field of view you require. Inceasing the axial length by 50% (from 10 cm to 15 cm) more than doubles the overall gain throughout the original 10cm field of view. However, you should expect the same centrally peaked sensitivity profile as I showed in Fig. 2, but now extended over 15cm instead of 1Ocm. Thus the (3D t o 2D) gain factor at the edge of the lOcm field of view should certainly be greater than one, although the factor may again be less than one at the edge of the 15 cm field of view. Raichle: I wonder whether one extension of this whole idea is not just to do three-dimensional reconstruction, but to go to spherical geometry, because then the efficiency of detection goes up dramatically. People are thinking about this; there are a number of limitations, not the least of which is the cost of such a machine. Scatter correction is a problem, but if you are talking about functional activation, you could potentially subtract the scatter away. Townsend: The data with septa retracted are acquired with scatter fractions of 30-40%, which have to be corrected. As I said before, we are working on a scatter correction algorithm based on subtracting the scatter distribution. The scatter distribution is estimated by convolving the measured 2D projections with an exponential scatter kernel. The dual energy window approach which attempts to measure scatter also appears to be promising. We have also looked at scatter in a spherical geometry. One trade-off must be to ensure that the statistical error is not disproportionately small compared with any systematic error introduced
74
Discussion
by the scatter correction procedure. A large acceptance angle system will essentially acquire all the out-of-plane scatter, which will result in scatter fractions of about 50%. Handling that will be quite a challenge. Raichle: Spherical geometry was considered early on, but was abandoned. But as one thinks about functional activation studies with image subtraction, where scatter could be dealt with rather directly, simply by subtraction, detection efficiency could go up by a factor of 10-20. The only problem is that you are talking of a system with thousands of detectors. The gain would be tremendous in terms of what this kind of machinery could do. Lassen: The deadtime problem become increasingly critical as you cover more and more of the brain. Everybody would like to have the sort of 3D scanner that we are hearing about by adding more rings. What are the chances of a substantial improvement in the deadtime problem that would allow us to go more logically, in terms of geometry, to the sphere? Jones: People are looking for a new crystal material. Derenzo et al (1990, 1991) have identified lead-based crystals which are faster and hence suggest less deadtime and better concidence-resolving times. These crystals will take some years to come to fruition as new detectors for use in tomographs. Raichle: Certainly it has begun to frustrate us that the standard PET machine covers only 10.5 cm and you would like 15 cm in the z axis, because what emerges from the activation studies are these tremendously distributed systems; what one hopes out of this imaging is to appreciate the geometry of such distributed systems, and it’s frustrating that you have got to leave out either the top or bottom of the brain because of inadequate sampling. One hopes that the right scanners will eventually take in the whole brain. Jones: There is a need to convince some government agency to make the large investment necessary to carry out the design and construction of a global PET system. The strategy would then be to allow researchers to come to this advanced facility to carry out experiments. Plum: An existing model of this principle has been the practice of governments to build high energy linear accelerators for shared use by multiple investigators. Raichle: Yes. It has concerned me that this work is ‘big science’; it takes not only very expensive equipment but the right kind of teams to do this work. The model of international resource facilities as used by astronomers and physicists would be an excellent model to adopt in the field of brain imaging research. For everybody, in each hospital or university, to try t o duplicate resources as they currently exist at the Hammersmith Hospital in London, or in our laboratory in St Louis, is nonsense, because the technology will stagnate. I think the right step is eventually to consolidate and have a limited number of centres, with the resources necessary, but with the obligation to support the research of investigators outside those centres with worthwhile projects. This approach has been followed successfully by the astronomers and by the physicists, and we should follow their lead.
Signal optimization in PET scans
75
Porter: It will be important to identify the major biomedical ‘unknown’ that requires this sort of commitment on an international basis. It is the appeal of, and the need to have an answer to, that overriding important question, for the President of the USA, or whoever else will fund the science, that will yield the necessary determination to make sure that such resources become available. Jones: Perhaps you yourself are in the best position to identify, during this meeting, what important, unknown questions there are which could only be answered by the ‘big science’ approach-for example, the development of a subtle neuropsychological test in a psychiatric patient. Raichfe: One might begin with the argument that to take the funds currently being spent on many small centres, and consolidate them into fewer centres, would accomplish a large part of what we are talking about. Frackowiak: Professor Porter’s point is that to speculate on the technology for its own sake is probably not productive, and not a good argument for added investment, Porter: Yes. The next-generation radiotelescope has to be justified on the grounds that you are looking for something that can’t be detected in any other way, but must be out there. What is the question, that would justify the ultimate international effort to produce the superlative PET scanner? That is what we have to establish. References Derenzo, SE, Moses WW et a1 1990 Prospects for new inorganic scintillators. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 37:203-208 Derenzo SE, Moses WW, DeVol TA, Cahoonn JL, Budinger TF 1991 Discovery of lead sulfate, a new scintillator for high-rate high resolution PET. J Nucl Med 32:995 (abstr no. 5)
The neurotransmitter basis of cognition: psychopharmacological activation studies using positron emission tomography K. J. Friston*t, P. M. Grasby*, C. D.Frith*, C. J. Bench*, R. J. Dolan*, P. J. Cowens, P. F. Liddle* and R. S. J. Frackowiak*
* MRC Cyclotron Unit, Harnmersmith Hospital, Ducane Road, London W12 OHS, ?University Department of Psychiatry, Westminster and Charing Cross Medical School, Fulham Palace Road, London W6 8RF and BMRC PsychopharmacologyResearch Unit, Littlemore Hospital, Oxford, UK Abstract. The neuromodulatory effect of manipulating monoaminergic receptor function was assessed by combining a psychological and a pharmacological activation during repeated positron emission tomographic (PET) scans. The effects of buspirone (a 5-HT,, receptor partial agonist) on changes in regional cerebral blood flow (rCBF) associated with free word recall were examined. A factorial design was used to demonstrate a significant interaction (changes in rCBF brought about by psychological activation which depend on drug administration) in the left parahippocampal region. This interaction was an attenuation of increases in local neuronal activity (rCBF) related to memory function. Buspirone-induced decreases in rCBF, independent of the memory effect, were seen in the left prefrontal and parietal cortices. We suggest that combined psychological and pharmacological activation is a way of measuring direct (main) drug effects and modulatory effects on neurotransmission associated with cognitive functions (interaction). 1991 Exploring brain functional anatomy with positron tomography. Wiley. Chichester (Ciba Foundation Symposium 163) p 76-92
Data from functional positron emission tomography (PET)neuroimaging are universally interpreted with reference to models. These models range from the physiological, as in the compartmental models of radioligand binding, to the psychological-for example, ‘cognitive subtraction’ (Petersen et a1 1988). We present a model for the combined manipulation of behaviour and neurotransmitter function which uses conjoint psychological and pharmacological challenge. The nature of functional brain systems and their associated neurotransmitter systems can be inferred from studying patients with specific behavioural deficits 76
Psychopharmacological PET studies
77
and identifying the sites of abnormal brain physiology. These inferences are based on the ‘lesion’ model of brain dysfunction and are limited, in that neither the behavioural nor the regional brain deficit is under experimental control. PET studies of regional cerebral blood flow (rCBF) activation permit experimental control of two aspects of brain function, namely the neurocognitive processes and neurotransmitter function. We suggest that combined psychological and pharmacological challenge in the same individuals provides more information than either challenge alone. To demonstrate this point we report a study which combines (or, in terms of experimental layout, crosses) a memory task with acute administration of the novel anxiolytic drug buspirone. Crossing psychological and pharmacological treatments enables the sites of interaction to be identified. An interaction in this instance is defined as a functional (psychological) increase/decrease in local neuronal activity which can be manipulated by acute drug administration. An interaction of psychological and pharmacological effects on rCBF is taken as evidence of an association between the functional system and the neurotransmitter system(s) affected by the drug. An effect of the drug may only be evident in the presence of increased/decreased neural firing and in this way may reflect a neuromodulatory role. Neuromodulatory neurotransmitters have a widespread distribution in the brain and modify neuronal excitability, not by a direct effect on membrane resistance but by altering responsiveness to other transmitters. Monoaminergic neurotransmitters in particular have been proposed to have this neuromodulatory role: ‘. . . the ability of these transmitter systems to regulate responsivity and discharge patterns of the targets in the neocortex may well rely upon interactions with intrinsic connections and . . . other afferents’ (Bloom 1988). Similarly, Mesulam (1990) emphasizes the distinction between ‘anatomically addressed channels for transferring information content and chemically addressed pathways for modulating behavioural tone’. We chose to investigate the neuromodulating effect of the serotonergic system on neuronal activity associated with performing a memory task. The pyrimidinyl piperazine, buspirone, binds with high affinity to central 5-HTIAreceptors in the rat brain and functionally has 5-HTlApartial agonist properties. Buspirone has anxiolytic and antidepressant effects and, interestingly, does not bind to the benzodiazepine/GABA receptor complex (Traber & Glazer 1987). In animals there is substantial evidence that ~ - H T ~partial A agonists, including buspirone, reduce glucose metabolism in the hippocampus (Wree et a1 1987, Kelly et a1 1988, Grasby et a1 1990)-an area with a high density of S-HT~A receptors in rats and man. Furthermore, ~ - H T ~ receptor A activation may have a neuromodulatory role in the hippocampus. The 5-HTlAagonist ipsapirone weakly inhibits spontaneous firing in hippocampal CA1 pyramidal cells, but the increased firing rates produced by the micro-iontophoretic application of glutamate are attenuated (Sprouse & Aghajanian 1988). The more marked effect of this drug is a reduction, not of spontaneous firing, but of the
78
Friston et al
increases brought about by an independent (glutamate) manipulation. In humans cognitive activation can be used to manipulate neural activity independently of drug administration. The cognitive activation we chose was a memory task. There is good evidence that the hippocampus has a key role in short-term memory in humans (e.g. Heit et a1 1988) and metabolic activation of the hippocampus by working memory has been demonstrated in non-human primates (Friedman & Goldman-Rakic 1988). The third link in the three-way relationship between buspirone, hippocampal firing and memory, namely that buspirone impairs memory function, has been less easy to establish. A study of the effects of repeated doses of buspirone (McKay et a1 1989a) reports a significant and sustained impairment of short-term memory but studies of the acute effects of buspirone do not (Luki et a1 1987, McKay et a1 1989b). It should be noted that memory testing in the ‘acute’ studies did not commence before 70 minutes after buspirone administration. In terms of centrally mediated neuroendocrine responses to buspirone, this is very much past the acute phase. It was our prediction that buspirone would show central, regionally selective effects on blood flow in man, particularly in the hippocampal formation. These effects would be inhibitory and would depend on increased firing brought about by a memory task. This finding would represent a significant interaction between the psychological and pharmacological treatments in, and only in, the hippocampus. This prediction was partially confirmed. Methods Subjects and study design
The subjects were six right-handed male volunteers (age 26-34) with no neurological or psychiatric history. Permission to administer radioactive substances was obtained from the local ethical committee and was approved by the Advisory Committee on the Administration of Radioactive Substances WK). Each subject was scanned six times, a 2 x 3 layout being used, involving three pairs of memory tasks, 30 mg of buspirone being given orally after the first pair. Each memory task pair comprised a baseline subspan memory task and a supraspan task. The subspan task involved nine presentations of a five-word list with immediate free recall. The supraspan task consisted of three presentations of a 15-word list, again with free recall. Presentation rate was one word per two seconds. The words chosen were high frequency, concrete words selected from the MRC Psycholinguistic Database. Performance on the task (supraspan) was recorded as the total number of correct recalls over the three presentations. To reduce differences in difficulty between the sub- and supraspan tasks we changed the 15-word list only between scans.
Psychopharmacological PET studies
79
The critical difference between the subspan and supraspan tasks was the degree to which words have to be remembered. Only in the supraspan task is there a requirement to recall words that are not immediately accessible from shortterm memory. Other components such as speaking, listening and attending were the same for both tasks. The inter-pair spacing was 20 minutes. There was an eight-minute interval between the subspan and supraspan task within each trial pair.
Neuroendocrine response Venous blood was taken and the neuroendocrine response to buspirone was assessed at -20, 0, 20 and 40 minutes. Buspirone was given at Omin. The prolactin response was used as a putative index of central 5-HTIAreceptor function (Cowen et a1 1990). Plasma concentrations of prolactin were determined by a previously described radioimmunoassay (Cowen et a1 1985). PET scanning We used a PET scanner (CTI model 931-08/12, Knoxville, TN, USA) whose physical characteristics have been described (Spinks et a1 1988). Scans were reconstructed using a Hanning filter with a cut-off frequency of 0.5, giving a transaxial resolution of 8.5 mm. Subjects inhaled CI5O2 at an activity of 6MBq/ml and a flow rate of 500 ml/min through a standard oxygen face mask for a period of two minutes. Dynamic PET scans were collected for a period of 3.5 min starting 0.5 min before P O 2 delivery, according to a protocol described elsewhere (Lammertsma et a1 1990). For the present study, integrated counts per pixel for the two-minute build-up phase of radioactivity in the brain during CI5O2inhalation were used (Fox & Mintun 1989).
Stereotactic normalization The 15 original scan slices (6.75 mm interplane distance) were interpolated, by bilinear interpolation, to 43 planes, in order to render the voxels (volume picture elements) approximately cubic. The intercommissural line was identified directly from the primary PET image (Friston et a1 1989) and the images were reorientated and resampled into a standard stereotactic space (Talairach & Tournoux 1988). In this space there are 26 planes with 2 x 2 x 4 mm voxels. Each image was smoothed using a Gaussian filter, 10 pixels wide. This increases the signal-to-noise ratio and accommodates normal variability in gyral anatomy. Statistical parametric mapping Global variance was removed on a pixel-by-pixel basis (Friston et a1 1990) using analysis of covariance, with global count per pixel as covariate. For every pixel
80
Friston et al
this analysis generates adjusted means for each of the six conditions and an adjusted error variance required for comparison of these means. 'Condition' means are compared with the t statistic (Wildt & Vahtola 1978) using a contrast or weighting of the means. The resulting t-values constitute a t-value statistical parametric map (SPMtt]). The 2 x 3 layout of the experiments allowed three effects to be assessed: the main effect of memory (supraspan versus subspan), the main effect of drug (pre-drug versus post-drug), and the interaction (pre-drug supra/subspan difference versus post-drug difference). The SPM(t)reflecting the main effect of memory was used to identify regions whose rCBF increased significantly ( P < 0.001). The significance of ths SPM or profile of significant change was assessed by comparing the observed and expected number of pixels using the X-squared test of proportions (Friston et a1 1990). This subset of pixels constitutes the memory system. The interaction between memory and drug and the main effect of drug were then assessed for this subsample of pixels, and thresholded at P=O.O5. For descriptive purposes the rCBF equivalents for all 36 scans were displayed graphically for two locations of special interest.
Results Neuroendocrine responses
There was a significant increase in plasma levels of prolactin (0 min vs 40 min: t = 4.01, P = 0.004, df;8) which was evident by 20 minutes. Complete data from the first subject were not available. The prolactin responses are shown graphically in Fig. 1.
7 3 5 Q. J -
6oo NEUROENDOCRINE RESPONSE P
30
.-U e 400c I
c
c 200-
-
9 2
/--4
25 -
20 -
P
0
n "
-50
0 time (minutes)
50
15'
-50
0 time (minutes)
I 50
FIG. 1. Neuroendocrine responses and performance. Left: plasma prolactin levels in mU/1 over time in minutes. Drug administration corresponds to 0 min. Right: Changes in memory performance (number of words recalled from three presentations of a 15-word
list).
main effects of memory
drug induced reductions on rCBF increases
on rCBF
FIG. 2 (Friston et al) Statistical parametric maps (SPMs) of the t statistic which reflects the significance of main effects of, or interaction between, memory and drug challenges to rCBF. The three projections correspond to views of the brain from behind, from the top and from the right. The brightest points along any of the three lines of view are displayed; all pixels displayed correspond to a significance of KO.001 for the main effects of memory and P<0.05 for the interaction and main effects of drug. The colour scale is arbitary; the brighter the image, the more significant the t value. The left parahippocampal region has been circled for reference. Top: the main effects of memory. This SPM{t} reflects the increases (P
Psychopharmacological PET studies
81
Memory performance Performance of the supraspan memory task was significantly impaired on the first post-drug trial compared to the pre-drug trial ( t = 2.91, P = 0.02, df;8). By 50 minutes this impairment had disappeared, on comparison with pre-drug performance ( t = 1.6, P=0.2, df;8). Figure 1 shows these changes in performance.
Regional cerebral activity The memory system identified by the (significant) main effects of the different memory tasks is shown in Fig. 2 (see colour plate). The number of significant pixels was far in excess of that expected (P
82
;I 58
Friston et al s
'
'
(I
0
0 0
52 -
'
0
561 54 -
'
0
-
-40
-u0
left parahippocampal region
48 46
1
- 8 . 4 . 4 m m F{omnibus}
=
4.075
64
1
62 60 58
B 0 0
56 54
A
8
8
*
--b
8
I
0 0
52 50
left DLPFC
48
-30,26,28mm F{omnibus} = 7.144
4 0 0
8
PsychopharmacologicalPET studies
83
The rCBF increases attributable to the immediate free recall of words implicated the left parahippocampal region, as expected. It was not surprising to see an equally profound increase in the DLPFC. Cognitive testing in nonhuman primates supports the notion that the DLPFC has a unique role in mnemonic processes implicit in delayed-response tasks. ‘By many accounts the most significant experimental discovery for understanding the functions of prefrontal cortex was the demonstration by Jacobsen that prefrontal cortex damage produced a profound and selective deficit on tests of spatial delayed response . . . Jacobsen himself stressed the mnemonic or temporal sequential processes required by the delayed response tasks’ (Goldman-Rakic 1987). A previous study of recall (Roland & Seitz 1989), which contrasted rest and recall of visual material, reported increases in rCBF in posterior parietal and bifrontal regions in a distribution not dissimilar from our present findings. Our interpretation of the effect of buspirone can only be very limited, because this was a preliminary study and was not placebo controlled. Although it is possible that non-linear time effects may have accounted for the decreased performance and hippocampal activation in the second but not the first and third trial pairs, we feel that these transient post-drug effects are probably mediated by a central action of buspirone. A number of explanations for the attenuated hippocampal activation can be provided and further studies will be needed to decide between them. Two explanations deserve discussion. It is possible that, as predicted, buspirone has a direct neuromodulatory role in the parahippocampal cortex that is mediated by its partial agonist effects at the 5-HTlA receptor. If true, this would directly implicate the 5-HT neurotransmitter system in the functional hippocampal memory system. It is equally possible that buspirone acts remotely in an area which has inputs to the parahippocampal region. This distant effect may be direct and not dependent on memory-related changes in firing (unless there is modulation of modulation). The decreases in rCBF seen in the DLPFC may be evidence of such an effect. In this regard, reduced binding of [ 3H]8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin,a 5-HTlAagonist) has been reported in autopsy samples of DLPFC from patients with Alzheimer’s disease (Palmer et a1 1987), a syndrome associated with memory impairment. Action at a distance is recognized in animal models of drug effects on cerebral metabolism. ‘, , . drug/receptor interactions may be localized to the primary site, FIG. 3. rCBF equivalent changes in the left parahippocampal regions ( - 8, - 44,4 mm) and left dorsolateral prefrontal cortex (DLPFC) ( - 30, 26, 28 mm). These regions demonstrate a significant interaction and main effect of drug respectively. The data are displayed in order of the six conditions: sub-supra-sub-supra-sub-supraspan.The drug was given after the first trial pair. rCBF equivalents are based on integrated tissue counts and adjusted to a global value of 50 (ml/dl per min). The solid line is the adjusted condition mean.
84
Friston et al
but may also result in marked changes in any number of regions with which the primary area has anatomical connections . . . for example intra-cerebral injection results in altered rates of glucose utilization one, two and three synapses away from the primary injection site’ (Kelly et a1 1988). It will be interesting to explore the possibility that the main effects of a drug, on rCBF, reflect a non-modulatory, direct effect on membrane potential (resistance) resulting in increased/decreased firing, while modulatory effects facilitate or attenuate converging input and can be localized by the interaction. Thus the reduced rCBF in DLPFC could represent a regional non-modulatory action of buspirone and the parahippocampal interaction, a separate local or primary modulatory action. Alternatively, the parahippocampal interaction could be a secondary consequence of reduced (modulatory) input from the DLPFC. These two models are depicted in Fig. 4. The direct effect of buspirone on DLPFC may not be attributable to 5-HT,* receptor-buspirone interaction. Buspirone has an active metabolite 1-(2-pyrimidinyl)piperazine(1-PP) which binds with nanomolar affinity to the
a
b
INTERACTION Parahippocampal
Parahippocampal
synapse
I
synapse
+% \ + modulatory
Rr primary
4 /effect of buspirone
non-rnoduldtory&primary ettect ot buqpirone
/
modulator]: input from
DLPFC
DLPFC synapse
DLPFC synapse
MAIN EFFECT FIG. 4. Schematic representation of two models for the main effects and interactive effects of buspirone on rCBF. (a) Main and interactive effects in the DLPFC and parahippocampal region respectively are independent and primary. (b) The interactive effect is secondary and remote from the main effect in the DLPFC and is mediated by reduced modulatory inputs to the parahippocampal region from the DLPFC.
Psychopharmacological PET studies
85
a2-adrenoreceptor, where it acts as an antagonist (Bianchi & Garattini 1988). There is evidence to suggest that a2-receptors in the prefrontal cortex have a critical role in delayed response tasks. Clonidine (an a2agonist) reverses agerelated deficits in delayed-response task performance in non-human primates (Arnsten & Goldman-Rakic 1985) and this effect can be antagonized in a dosedependent manner by the adrenergic antagonist yohimbine. Furthermore, pharmacological profiles in animals with lesions restricted to the DLPFC indicate that this area may be the site of action for some of clonidine’s beneficial effects. Buspirone also binds appreciably to dopamine receptors, so an effect mediated through dopamine neurotransmission cannot be excluded in the present study. Conclusions
Combined psychopharmacological activations in humans reveal the potential neuromodulatory effects of manipulating neurotransmitter function that cannot be demonstrated by psychological or pharmacological activations alone. This combined strategy is particularly relevant for investigating the monoaminergic systems that appear to have a neuromodulatory role. Interactions and direct regional effects result from acute drug administration. It is possible that main effects of drugs, on rCBF, represent a direct non-modulatory action and that interactions represent a neuromodulatory function. These effects may be primary, local changes in neuronal firing, or secondary, remote effects in connected areas. Acknowledgements K. J. F. was supported by the Wellcome Trust. We wish to thank our colleagues and collaborators at the MRC Cyclotron Unit for making the study possible and for helpful discussions.
References Arnsten AFT, Goldman-Rakic PS 1985 a,-Adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science (Wash DC) 230: 1273-1276 Bianchi G, Garattini S 1988 Blockade of a2-adrenoreceptorsby 1-(2-pyrimidinyl)piperazine (PmP) in vivo and its relation to the activity of buspirone. Eur J Pharmacol 147:343-350 Bloom FE 1988 What is the role of the general activating systems in cortical function? In: Rakic P , Singer W (eds) Neurobiology of the neocortex. Wiley, New York, p 407-421 Cowen PJ, Gadhui, H, Godsen B, Kolakowska T 1985 Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics. Psychopharmacology 86: 164- 169 Cowen PJ, Anderson IM, Grahame-Smith DG 1990 Neuroendocrine effects of azapirones. J Clin Psychopharmacol 10:21S-25S
86
Friston et al
Fox PT, Mintun MA 1989 Noninvasive functional brain mapping by change-distribution analysis of averaged PET images of H,I5O tissue activity. J Nucl Med 30:141-149 Friedman HR, Goldman-Rakic PS 1988 Activation of the hippocampus and dentate gyrus by working memory: a 2-deoxyglucose study of behaving rhesus monkeys. J Neurosci 8 :4693-4706 Friston KJ, Passingham RE, Nutt JG, Heather JD, Sawle GV, Frackowiak RSJ 1989 Localization in PET images: direct fitting of the intercommissural (AC-PC) line. J Cereb Blood Flow Metab 9590-695 Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA. Frackowiak RSJ 1990 The relationship between local and global changes in PET scans. J Cereb Blood Flow Metab 10:458-466 Goldman-Rakic PS 1987 Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In: Plum F (ed) Handbook of physiology, section 1: The nervous system, vol 5 : Higher functions of the brain. Oxford University Press, New York (American Physiological Society, Bethesda) p 373-417 Grasby PM, Sharp T, Grahame-Smith DG 1990 The effect of gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the rat. Br J Pharmacol99:27 (abstr) Heit G, Smith ME, Halgren E 1988 Neural encoding of individual words and faces by the hippocampus and amygdala. Nature (Lond) 333:773-775 Kelly PAT, Davis CJ, Goodwin GM 1988 Differential patterns of local glucose utilization in response to 5-hydroxytryptamine agonists. Neuroscience 3:907-915 Lammertsma AA, Cunningham VJ, Deiber M-P et a1 1990 Combination of dynamic and integral methods for generating reproducible functional CBF images. J Cereb Blood Flow Metab 10:675-686 Luki I , Rickels K , Giedecke MA, Geller A 1987 Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. Br J Clin Pharmacol23:207-211 McKay G, Alford C, Bhatti JZ, Curran S, Hindmarch I 1989a Repeated dose effects of buspirone and clobazam on cognitive and psychomotor performance. Med Sci Res 17:325-326 McKay G , Alford C, Bhatti JZ, Curran S , Hindmarch I 1989b Effects of acute doses of buspirone and clobazam on cognitive function and psychomotor performance. Med Sci Res 17:301-302 Mesulam MM 1990 Large scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol 28597-61 3 Palmer AM, Middlemiss DN, Bowen DM 1987 i3H]8-0H-DPAT binding in Alzheimer's disease: an index of pyramidal cell loss? In: Dourish CT, Ahlenius S, Hutson P H (eds) Brain 5-HT,, receptors. Behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, p 286-299 Petersen SE, Fox PT, Posner MI, Mintun M. Raichle ME 1988 Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature (Lond) 331585-589 Roland PE, Seitz RJ 1989 Mapping of learning and memory functions in the human brain. In: Ottoson D, Rostene W (eds) Visualization of brain functions. Stockton Press, London, p 141-151 Spinks TJ, Jones T, Gilardi MC, Heather J D 1988 Physical performance of the latest generation of commercial positron scanner. IEEE (Inst Electr Electron Eng) Trans Nucl Sci 35:721-725 Sprouse JS, Aghajanian GK 1988 Responses of hippocampal pyramidal cells to putative serotonin 5-HTlA and 5-HTlB agonists: a comparative study with dorsal neurons. Neuropharmacology 27:707-7 15 Talairach J, 'Tournoux P 1988 Co-planar stereotactic atlas of the human brain, 2nd edn. Thieme Verlag, Stuttgart
Psychopharmacological PET studies
87
Traber J, Glazer T 1987 S-HT,, receptor-related anxiolytics. Trends Pharmacol Sci
8:432-437 Wildt AR, Vahtola 0 1978 Analysis of covariance. (University Papers: Quantitative applications in the social sciences series, no. 12) Sage Publications, Beverly Hills, CA Wree A, Zilles K, Schleicher A, Horvath E, Traber J 1987 Effects of the S-HTIA receptor agonist ipsapirone on the local cerebral glucose utilization of the rat hippocampus. Brain Res 436:283-290
DISCUSSION
Porter: It would be helpful if you were to explain to non-users of the PET technique whether there could be a direct or local effect of the drugs you used on the vasculature itself. Friston: It is possible that local variations in the density of receptors expressed on vasculature could produce regionally specific changes in blood flow that d o not reflect regional neuronal activity. Using the effect of a drug on the increases in rCBF brought about psychological (behavioural) activation circumvents this problem, because this interaction must be dependent on neuronal activity. Cappa: Was there any activation effect of the memory span test on the baseline? Friston: There are only two conditions. The baseline was the ‘non-working’ task. Your question highlights the ‘relativity’ of cognition activation studies; there is no baseline in the sense you mean. We have indices of neuronal activity in two (cognitive) brain states and consequently we can only talk about the relative differences. There is no absolute ‘baseline’ brain state. Control tasks are devised to act as baselines for, and only for, the activation condition in question. Cappa: I am interested in the locus of activation in a memory span test, because there is some evidence, coming from studies of patients with a selective disruption of verbal short-term memory, that a lesion in the left inferior parietal lobule may be associated with a severely reduced verbal span (Warrington 1979). Did buspirone have any effect on the verbal memory span? Friston: The parietal cortices were activated bilaterally by the mnemonic component. Buspirone did not effect subspan recall performance, which was 100% in all subjects, by design. It had a deleterious effect on performance during the supraspan conditions, but only in the first post-drug trial. It would have been nice to complement the basis of this study, before starting, by completing the three-way link between the regional effects of buspirone on hippocampal formation metabolism in animals, the role of the hippocampal region in memory and the impairment of memory performance by buspirone. Unfortunately, there are no studies of the acute effects of buspirone on memory (where acute, in this context, means 20-40 minutes after administration, the time of peak neuroendocrine response). However, our limited data demonstrated this acute effect post hoc.
88
Discussion
Muzziotta: Can you tell us whether there are situations where you see changes in blood flow and you see purely grey matter or white matter differences? It looked as if you have a large volume of contiguous pixels that are showing flow change. Do you think that reflects neuronal activation? If so, why is there not some segregation between grey and white matter, or is there a vascular territory response (that is, the distribution of the middle cerebral or anterior choroidal arteries)? Friston: I think we are seeing not a vascular territory response, but an activation profile which reflects the functional anatomy of the brain systems activated. The signals are limited to grey matter and follow the contours of the cortical surface. These data are extremely significant and the large number of pixels displayed gives the impression of contiguous lumps, but I think this is an artifact of presentation. If a focus were seen in white matter, then we would be worried that something had gone wrong. So far we have not seen white matter activations. Ruichle: I have a question about the thresholding of your t-values, so that you can decide what is significant or not. I assume that if you established such a threshold, then made ‘rest-rest’ pairs and looked at your data, the data would fall below that cut-off point. Friston: The data presented correspond to a threshold of P
Psychopharmacological PET studies
89
Friston: Indeed. The profile of activations associated with memory function has been replicated twice-in a separate study combining a different drug and the identical memory tasks, and in a third study using a placebo. Raichle: Dr Friston, as a more general point, how does one distinguish between a hypothesis-generating experiment and a hypothesis-testing experiment? When one combines definition of areas within the same set of data on which one tests the statistical significance of these areas, is this not a hypothesis-generating experiment rather than a hypothesis-testing one? Friston: I think this study was hypothesis led (hypothesis testing), in the sense that buspirone has been shown to have a neuromodulatory action in the hippocampal formation in animals. There was therefore a specific prediction (that was confirmed), in and only in, this region. However, the prefrontal changes attributable to the drug (buspirone) were not predicted and these findings can only be hypothesis generating. If one thinks of a PET study as multiple, and parallel, studies of different brain areas, then it is possible to treat the results as both hypothesis testing and hypothesis generating, depending on the brain region under interrogation. Working with such large data sets means that only a limited subset of findings could have been predicted. The remainder (if any) can be used to guide the next experiment. Raichle: I was not of course implying that one type is more important then the other, because hypothesis-generating experiments are essential when one is mapping the cortex, where we are not sure where things are, but then one loses this distinction when one starts talking statistically about results, which might or might not be hypothesis-generating or testing. Zeki: Would it be true to say that there is no PET experiment which is not hypothesis testing, by definition, but some PET experiments generate hypotheses, although not all? Raichle: Yes. Zeki: There is a basic point here. An electrophysiological experiment in which one simply looks at the firing rate of cells carries an hypothesis with it, namely that a cell will respond by changing its firing rate. With PET, I get the impression that you are wedded to the notion that an increase in blood flow entails a change in cerebral activity. Raichle: I don’t disagree with that; we must assume that changes in blood flow reflect changes in neuronal activity at some level. Zeki: In anatomy, as an example, the cytoarchitectonic method is one based on the hypothesis that areas which differ in function will differ in their cytoarchitecture, and therefore if we don’t find any cytoarchitectural differences, we assume (wrongly) that these areas must have a uniform function. This is a mistake that has been made many times. This is unlike, say, the degeneration method, which is not hypothesis bound in the same way, to the extent that if you discover that a cortical area does not receive an input from the striate cortex,
90
Friston et al
it does not follow that it has no visual function. Therefore I am wondering whether PET is not also a very much hypothesis-bound method. Porter: We might be able to debate that philosophical point; I am not sure everyone would agree with that statement! Fox: In meetings like this, in discussions of PET activation techniques and particularly statistical parametric mapping and related methods, these have been labelled as ‘only’ hypothesis-generating techniques. We have been told not to think of them as hypothesis testing unless we do some other data manipulation. For example, in your case, Dr Friston, you would be advised to restrict your analysis, to sample one region about which you have a specific hypothesis, and to throw away all the other data. I find it refreshing to see that people are now coming to the view that perhaps the same statistical approach can be both hypothesis testing and hypothesis generating, depending on the experimental design and on what’s gone before. I found it disturbing t o be told that we should throw away large amounts of our data and only analyse them in very restrictive ways. Plum: Dr Friston, if you go back in your experiment after the drug has worn off, does the subject have memory of the experiment? Friston: Yes. Plum: So the assumption is that the frontal areas retain memory of the transaction but that the retrieval instrument is selectively impaired? Friston: The ability to hold information which is relevant and of a declarative nature, over extended periods of time would not, I suspect, be affected by buspirone. The specific mnemonic component which appeared to be impaired was the holding ‘online’ of immediately relevant information which could be lost after it was no longer useful. It is possible that the hippocampus is more critically involved in mediating this ‘online’ memory than in establishing declarative memories that can be retrieved at some point in the future-a function that may require the hippocampal formation and other (prefrontal) brain systems. Plum: I am wondering whether the experiment doesn’t include two components, one of which is to test whether the memory is engrained in frontal lobe circuitry, and the second of which is to determine whether the retrieval component (i.e., the hippocampal component, or some other structure governing recall) remains connected to the frontal engram. Such a hypothesis might be testable-for example, during retraining trials-by showing different intensities of metabolic activity, compared to control, in different regions involved in the learning-retrieval process. Friston: And it would be interesting t o explore that notion with other drugs that have a more selective effect on the different components of the acquisition and retrieval of declarative memory. Plum: Exactly. You might be able to show, for example, during the amnesia induced by certain benzodiazepines such as triazolam, that working memory
Psychopharmacological PET studies
91
would appear to be preserved but that there would be a loss of metabolic activity in retrieval areas. Similar differences might appear during the remarkable phenomenon of transient global amnesia, in which the entrainment and retrieval of memories appears to be temporarily lost, but the banked registry of past events remains pretty much intact. Friston: I think you highlight a very powerful way of using PET, namely to demonstrate a double dissociation. For example, when considering the various components of memory function, one approach would be to demonstrate a selective and regional effect of drug A on acquisition with no effect on retrieval and, similarly, to show that drug B affects retrieval but not acquisition. In this way one could ascribe regional and neurotransmitter specificity to separable cognitive components underlying memory function. These are certainly the sorts of long-term objectives one has in mind. Corbetta: May I ask you about your behavioural task, Dr Friston? I’m not convinced that the biggest difference between the two tests is working memory. In both the subspan and supraspan tasks, subjects were presumably maintaining information online. Since the short-term memory verbal span is 7 k 2 words, the buffer was almost entirely loaded in the subspan situation, too. I wonder whether more aspecific factors, such as arousal, or difficulty, may explain your differential activation. Friston: It was precisely these extra components that we wanted to engage. The supraspan task could not be performed using only a ‘buffer’. The further cognitive components required were the essence of the activation. The common components (e.g. word perception, lexical analysis, word production) are all controlled for, as was the rate of word presentation. You use the concept of ‘difficulty’ as a confounding variable which should be accounted for. I think this needs careful justification. Firstly, because ‘difficulty’ is confounded with the change in task, it is also deeply confounded with the cognitive dimension one is trying to measure. Attempts to ‘remove difficulty differences’ must, by definition, undermine the difference of interest. Secondly, difficulty is operationally defined in terms of performance; equating performance means presenting the same task twice (unless you take a measure of performance which is quite unrelated to the cognitive component in question). I personally do not think ‘difficulty’ is a useful concept in explaining the sorts of findings we deal with. Corbetta: I think that in the two tasks the working memory component is not very different. The normal span is about seven, so the memory buffer has been loaded in both situations. The difference in PET activation may not be easily accounted for by an explanation in terms of working memory. Friston: I am sure you are right to worry about the exact nature of the difference between the two memory conditions. The simplest answer is that we tried to choose tasks that were simple, had clear parallels in non-human primate
92
Discussion
work, and could be tightly controlled in terms of the parameters of the executive systems involved, such as speech and listening.
Reference Warrington EK 1979 Neuropsychological evidence for multiple memory systems. In: Brain and mind. Excerpta Medica, Amsterdam (Ciba Found Symp 69) p 153-166
Relating structure to function in vivo with tomographic imaging John C. Mazziotta*t$#, Daniel Valentinot, Scott Grafton*t$§, Fred Bookstein!, Charles Pelizzari", George Chen" and Arthur W. Toga5
*Division of Nuclear Medicine, iDepartment of Radiological Sciences, $Laboratory of Nuclear Medicine and 5 Department of Neurology, UCLA School of Medicine, Los Angeles. CA 90024, !Center for Human Growth and Development, University of Michigan, Ann Arbor, MI 48 109 and Department of Radiation Oncology, University of Chicago, Chicago, IL 60637, USA
Abstract. For the normal physiological responses of the brain or the pathophysiological changes that accompany disease states to be evaluated, it is necessary to compare data sets between different imaging modalities for individual subjects. Similarly, it is important to compare data between individuals both within and across imaging modalities for individual subjects. In a collaborative project with a number of university groups we have developed a system that allows for the within-subject alignment and registration of three-dimensional data sets obtained from different modalities for the same individual. This analysis takes into account the error induced by image acquisition, registration and alignment with regard to scaling, translation and rotation. A more difficult problem is the between-subject warping of individual brain anatomy to match that of another individual or of an idealized model. If the principles of morphometrics and homologous landmarks are applied, three-dimensional brain warping can provide this type of between-subject comparison. The result of accomplishing these two tasks is a system that allows data obtained in a given individual to be compared across structure and function, as obtained from magnetic resonance imaging (MRI) and from positron emission tomography (PET), respectively. It also allows comparison of the resultant information with averaged between-subject data from populations of normal individuals or patients with specific neurological disorders. This system provides the means by which to compare quantitative data between individuals in an objective and automated fashion. 1991 Exploring brain functional anatomy with positron tomography. Wiley, Chichester (Ciba Foundation Symposium 163) p 93-112
As early as 1984 it was realized that a systematic, objective and standardized approach to functional image analysis would be required in order to obtain the full potential of biochemical images obtained with positron emission tomography (PET) (Mazziotta 1984). Numerous approaches to the solution of these problems have been used (Bajcsy et a1 1983, Bohm et a1 1983, Evans et a1 1988, Fox et al 1985). Through a series of international symposia on the topic, a set of optimal criteria were developed for any system which seeks to provide the means by 93
Mazziotta et al
94
TABLE 1 Proposed criteria for the optimal solution to the problem of PET image acquisition and analysis 1.
Reproducible
2. Accurate
3.
Independent of tracer employed
4.
Independent of spatial resolution of the instrument When possible, independent of ancillary imaging techniques Minimizes subjectivity and investigator bias Fixed assumptions about normal anatomy not required Acceptable to subjects’ level of tolerance (e.g. head holders) Performs well in serial studies of the same patient and in individual studies within a patient population Capable of evolving toward greater accuracy as information and instruments improve Reasonable in cost Equally applicable in both clinical and research settings Time efficient for both data acquisition and analysis
5.
6. 7.
8. 9. 10.
11. 12.
13.
~~
From Mazziotta & Koslow 1987.
~
~~
~
which to regionalize and quantify PET data, both within subjects and between subjects (Mazziotta & Koslow 1987) (Table 1). It became clear that t o satisfy these criteria to the greatest degree, the merger of structural information obtained from magnetic resonance imaging (MRI) or computed tomography (CT) with functional images from PET or single photon emission computed tomography (SPECT) would be required. The complete problem of image analysis, both within and between subjects, can be separated into two parts (Fig. 1). In the first portion, which we termed ‘Merger l’, one seeks to align and register data about a given subject obtained from multiple imaging modalities. The second portion of the analysis is the between-subject comparison, termed ‘Merger 2’, in which the variations of neuroanatomy between subjects are accounted for by a three-dimensional warp of structural images to form a common average or t o fit an idealized model of the human brain. These mergers will be discussed independently. It should be noted that as a result of implementing these two approaches, one may build in an idealized modela system of three-dimensional volumes of interest that can be automatically sampled without bias or subjectivity-and produce regional quantification of individual subjects across modalities or time, or of a population of subjects, within or between modalities and time.
95
Relating structure to function in vivo MERGERP
MERGER1
BETWEEN SUBJECTS
WITHIN SUBJECT
BRAIN A
Slngle
3-D BRAIN
Subject
BRAIN C
t
I
A
FIG. 1. Two-step process for within-subject (Merger 1) and between-subject (Merger 2) comparisons. Details of this process are described in the text.
Merger 1
Past approaches to cross-modality image correlation typically utilized fiduciary markers in order to achieve alignment and registration. Pelizzari and Chen (Pelizzari et a1 1989) developed an approach whereby a rigid portion of the human body, for example the skull, can serve as its own fiduciary system, allowing for cross-correlation, alignment and registration of identical structures in the same subject between imaging modalities. This approach forms the basis for the within-subject image correlation termed Merger 1. The algorithm for the execution of the within-subject, Merger 1, process was originally developed by Pelizzari and Chen (Pelizzari et a1 1989) at the University of Chicago. Execution of this process results in the alignment and registration of data from different imaging modalities within the same subject. For the analysis of PET data, one typically uses MRI images for the structural component in order to maximize spatial resolution; however, correlations of any image sets that have a common surface can be processed with this approach. For example, MRI, CT, PET, SPECT or in situ cryomacrotome sections of the entire human head can be examined in this fashion (Santori et a1 1990). The basic premise of this approach is that a common three-dimensional surface obtained from two different image sets can be three-dimensionally aligned and registered. Once this fit is accomplished, alignment and registration will be achieved with an accuracy that is comparable to the spatial resolution of the imaging device with the lowest spatial resolution (Pelizzari et a1 1989). A typical PET-MRI Merger 1 correlation requires a transmission and an emission set of PET images as well as an MRI study that is highly sampled along the Z axis, using pulse sequences that maximize the grey-white and brain-cerebrospinal fluid (CSF) boundaries (e.g. TE = 30 ms, TI = 300 ms, TR = 1276 ms).
96
Mazziotta et al
Once these data sets have been obtained, they are corrected for distortions inherent in the image acquisition process. This step is achieved by the prior scanning of phantoms (geometric three-dimensional objects filled with material visible in each instrument) to characterize the distortions induced by each instrument. Once corrected for such distortions, a common boundary (e.g. skin, skull) is identified in the transmission PET and the MRI study. Semi-automatic software for this process exists. Contours obtained from the MRI study define a surface referred to as the ‘head’, while contours obtained from the PET transmission scan are defined as a three-dimensional ‘hat’ (Pelizzari et a1 1989). Typically the ‘hat’ is smoothed and subsampled to reduce the number and, hence, the total computational time required to fit it t o the ‘head’. The centres of gravity of the ‘head’ and the ‘hat’ are superimposed and then the ‘hat’ is fit to the ‘head’ using an iterative least-squares technique. The result of this fitting is a set of three-dimensional rotation, scaling and translation variables that describes the rigid body transformation required to re-format one data set to the other (Fig. 2) (see colour plate). Using these parameters, we re-format the PET emission data set to match the MRI data. The Merger 1 approach can be used to compare structure with structure (e.g. MRI to MRI) over time, function to function (e.g. PET to PET) over time, or structure to function (e.g. MRI to PET) at each examination interval or serially over time in a given patient. In addition, electrophysiological data from an EEG can be compared with such data sets by placing MRI-visualizable markers (i.e. fat-soluble vitamin capsules) glued to the sites of selected scalp electrodes (Jack et a1 1990). These sites will then be entered into the same registration matrix on the skin surface from the MRI data set. Re-formatted images can then be displayed side by side in two (Fig. 3) or three dimensions, or superimposed in two or three dimensions (Fig. 4) (see colour plate). Validation experiments for the Merger 1 procedure have been conducted by Pelizzari et a1 (1989). These experiments demonstrate that the accuracy and reproducibility of this technique results in alignment and registration that is spatially accurate to the level of the data obtained from the device with the lower spatial resolution. More recent studies, in which two copies of an identical image contour set were displaced by known amounts in terms of rotation, translation or scaling, resulted in realignment by the software with an accuracy of 5 3 ” for rotation, 1 pixel for translation and < I pixel for scaling. Phantom measurements (Pelizzari et a1 1989) demonstrated that the residual misfit between models of the external surface from MRI and PET transmission studies is on the order of 1.5-2.0 millimetres, averaged over the surface. Note that the transformations described here are affine, and this assumes that the surface is not elastically deformed between the acquisition of the two data sets. Relaxation of this assumption is implicit in Merger 2, discussed below. Merger 1 also assumes that the coordinate transformation which optimally matches the surface, as visualized in the two scans, may be used to transform
FIG. 2 (Mazziotta et al) Three-dimensional surface contour fitting with alignment and registration matrix. Solid lines demonstrate surface contours of the ‘head’ obtained from MRI while the dotted lines indicated the same boundary obtained from the PET transmission images. These two three-dimensional data sets were fit using the iterative approach described by Pelizzari et a1 (1989). The transformation matrix indicates the disparities between the original two data sets in terms of scaling, translation and rotation for each of the three axes. After the determination of this transformation matrix, PET data are re-formatted and sliced to match the MRI data set (see Fig. 3). (Reprinted from Mauiotta et a1 1991 with permission of Raven Press.)
(B)
FIG. 4 (Mazziotta et al) Three-dimensional volume rendering of structure and function. (A) Dorsolateral surface of the head and cerebral cortex. The MRI data are presented
in grey scale and the PET data in a colour scale, with red being the highest metabolic rate for glucose and blue being the lowest. Note the anatomical detail of the facial and cranial structures including the sylvian fissure, central sulcus, cerebellum and temporal pole. (B) Midsagittal three-dimensional rendering displayed using the same principles as in (A). Note the head of the caudate nucleus, medial surface of the thalamus, parieto-occipital fissure, calcarine fissure, fourth ventricle, brainstem and cerebellum. Such images allow for the multidimensional display of structural and functional information in a single composite image that is easily recognizable and interpretable by clinical or basic neuroscientists. (Reprinted from Mazziotta et a1 1991 with permission of Raven Press.)
Relating structure to function in vivo
97
FIG. 3. Re-formatted, aligned and registered MRI (left) and PET (right) data from the same subject. The PET data have been re-formatted to match the level, slice and scaling of the MRI image. Note the close concordance in the shape and position of the caudate nuclei, thalami and cortical folds. These data can be displayed side by side, as here, or superimposed in two or three dimensions (see Fig. 4).
internal coordinates-that is, the internal anatomy is rigidly fixed with respect to the surface. Both assumptions are well satisfied for brain imaging. Currently, the software required to accomplish Merger 1 runs on a SUN Sparc Workstation. Merger 2
Merger 2 is designed to deform the three-dimensional brain structure from one subject to match that of another, of a common average, or of an idealized model of the brain. This three-dimensional warping provides a single standardized coordinate system for all brain structures. This coordinate system can be thought of as an atlas, or standard brain. The coordinate system is then deformed or warped to fit the forms observed in each individual subject. As a result of this process, one can generate a three-dimensional brain atlas which itself is an
98
Mazziotta et al
average of a population of individuals rather than a haphazardly acquired single specimen. Warping functions called ‘homology maps’ (Bookstein 1991) go beyond the rigid motion transformations of Merger 1. Generally, they take the form of exact interpolants between scattered geometric features that are ‘known’ to correspond between forms. One very useful algebraic form for this interpolant is the thin-plate spline developed in the literature of surface interpolation and modified to apply the warping by Bookstein (1989). This technique can be extended to data for more complex situations, such as curves on surfaces, and this is a primary effort in the morphometric research designed to achieve the functions of Merger 2. Warping cannot preserve both densities and counts in the image sets. This leads to the problem of what to hold invariant under the transformation. This issue will require considerable experience with correlates of images after deformation. Three-dimensional volume renderings (Fig. 4) of the human cortex are being used to evaluate such results as well as to determine the appropriate homologous landmarks of the cerebral cortex. Currently, homologous landmarks have been obtained from a single set of two-dimensional, midsagittal MRI brain images. Through the use of Merger 2 procedures, an average image from 14 normal subjects has been produced (Fig. 5). This image demonstrates that distortions induced by warping are accurate for portions of the brain with abundant landmarks, such as the brainstem and diencephalon. Areas with fewer landmarks (such as the cerebral cortex) are less accurately warped and result in a blurring of the image in the composite average (Fig. 5 ) . A further reason for consistency in the brainstem and diencephalon may be the fact that these structures are phylogenetically older and perhaps less variable in terms of their structure in the human brain, whereas the cortical structures are the most recent to evolve and are known to be highly variable, not only between subjects but also between left and right hemispheres. Simultaneously with the acquisition of data from Merger 1 and its transformation with Merger 2, stereotactic (Talairach et a1 1967, Fox et a1 1985) and statistical (Clark et a1 1985) approaches can be applied to these data sets. This opportunity should provide a good test of the validity of a wide variety of regionalization methods-a goal that is intended as part of this project. Complete validation will also include the prediction and localization of functional stimuli, as has already been proposed and employed by Fox and colleagues (1985). Conclusions Functional and structural images are not equivalent. Despite the fact that functional images obtained with high resolution PET instruments of biological processes such as glucose metabolism appear to demonstrate structural
Relating structure to function in vivo
99
FIG. 5 . Composite midsagittal MRI image obtained from 14 normal subjects after unwarping of 13 landmarks obtained in the individual studies. Landmarks were indicated by the white circles. Note that the brainstem, cerebellar and diencephalic structures are sharply focused, indicating the accuracy of the warping and, perhaps, the minimal variability of these structures between subjects. Note further the blurring of cortical regions outside the zone where a high density of landmarks was provided. This may result from the lack of landmarks in the cortical areas as well as the greater variability of cortical structures between subjects. Landmarks for cortical regions have now been identified and this process is being extended to three dimensions. The image unwarping/averaging algorithm was provided by Fred Bookstein, at the University of Michigan, with the assistance of William Jaynes. (From Thin plate splines and analysis of biological shape; videotape 1990.)
neuroanatomy, they are actually functional images superimposed on structural neuroanatomy. PET investigators have always related functional images to discrete anatomical brain regions. As spatial resolution has continued to improve in PET, this has been done with increasing confidence. However, many tracers which bind to specific subsystems of the brain (such as 6-L- [ I*F]fluorodopa and [ "C] raclopride) produce images of specific neurochemical systems in the brain and indicate very little in the way of neuroanatomical features. Thus, the idea that increasing spatial resolution in PET will solve image analysis problems is erroneous. Complex analytical systems, such as the one described here, will
100
Mazziotta et al
undoubtedly be used t o regionalize a n d standardize functional image d a t a to a n optimal format. It is the aim of these efforts t o provide a system that is optimal in terms of the criteria described in Table 1. At the same time, this approach must be practical in terms of acquisition time and t h e comfort of the subject, as well as the requirements for data processing a n d data management. The Merger 1 system is now complete and fulfils those criteria. The Merger 2 approach is being developed and validated. Initial results obtained using two-dimensional midsagittal MRI images are promising. The extension of the homologous landmark set to the cerebral hemispheres in multiple dimensions is now under way, with the aim of determining the feasibility o f applying this approach to the entire intracranial contents. It is hoped that through these methods the analysis of biochemical, pharmacological and physiological information from functional images can be achieved with the greatest accuracy and reproducibility. T h e net result of these efforts should be an approach which maximizes the usefulness of functional image data.
Acknowledgements This work was supported, in part, by NIMH grant MH37916, NINDS grant NS 15654, NIH grant RR05956, NSF grant DIR-8908174 and DOE contract DEAC03SF7600012. The authors wish to acknowledge the efforts of H. K. Huang, DSc, Duffy Cutler and Ed Hoffman, PhD. They gratefully acknowledge the efforts of Lee Griswold in the preparation of the figures and Laurie Carr in the preparation of the manuscript.
References
Bajcsy R, Lieberson R, Reivich M, Berggren BM, Olsson L 1983A computerized system for the elastic matching of deformed radiographic images to idealized atlas images. J Comput Assisted Tomogr 7:618-625 Bohm C, Greitz T, Kingsley D, Berggren BM, Olsson L 1983 Adjustable computerized stereotaxic brain atlas for transmission and emission tomography. Am J Neuroradiol &I31-133 Bookstein FL 1989 Principal warps: thin-plate splines and the decomposition of deformations. IEEE (Inst Electr Electron Eng) Trans Pattern Anal & Machine Intelligence 11:567-585 Bookstein FL 1991 Morphometric tools for landmark data. Cambridge University Press, New York & Cambridge Clark C, Carson R, Kessler R et a1 1985 Alternate statistical models for the examination of clinical data positron emission tomography/fluorodeoxyglucosedata. J Cereb Blood Flow Metab 5:142-150 Evans AC, Beil C, Marrett S, Thompson CJ. Hakim A 1988 Anatomical-functional correlation using an adjustable MRI-based region of interest atlas with positron emission tomography. J Cereb Blood Flow Metab 8513-530 Fox PT, Perlmutter JS, Raichle ME 1985 A stereotactic method of anatomical localization for positron emission tomography. J Comput Assisted Tomogr 9: 141- 153 Jack CR, Marsh WR, Hirschorn KA 1990 EEG scalp electrode projection onto 3D surface rendered images of the brain. Radiology 176:413-418
Relating structure to function in vivo
101
Mazziotta JC 1984 Physiologic neuroanatomy: new brain imaging methods present a challege to an old discipline. J Cereb Blood Flow Metab 4:481-483 Mazziotta JC, Koslow SH 1987 Assessment of goals and obstacles in data acquisition and analysis from emission tomography: report of a series of international workshops. J Cereb Blood Flow Metab 7 (suppl): Sl-S31 Mazziotta JC, Pelizzari CC, Chen GT, Bookstein FL, Valentino D 1991 Regions of interest: the relationship between structure and function in the brain. J Cereb Blood Flow Metab 11 (suppl): A51 -A56 Pelizzari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT 1989 Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assisted Tomogr 13:20-26 Santori EM, Quintana J, Mazziotta JC, Valentino D, Payne BA, Toga AW 1990 Threedimensional digital atlas for Mucucu nemestrinu. SOCNeurosci Abstr 16:246 Talairach J, Szikla G, Tournoux P et a1 1967 Atlas d’anatomie sttrtotaxique du telenckphale. Paris, Masson
DISCUSSION Passingham: Are you undertaking a cytoarchitectural analysis of the human brain, Dr Mazziotta? There are significant disagreements between the maps produced by Brodmann (1925) and von Economo (1929). We lack an agreed cytoarchitectural analysis of the human brain. Mazziotta: I agree fully that the current sets of cytoarchitectural information are confusing. But I won’t commit myself to building a cytoarchitectural map because, as Professor Zeki said earlier, there are things that lie outside the domain of cytoarchitecture. What we are doing now is developing the tools whereby we can build the map of any given anatomical or functional variable. Cytoarchitecture is one of the most labour-intensive procedures if one attempts to examine a population of brains. But in given regions of brain, where there is activation, one could go to the ‘sliced’ post mortem specimens, and apply analysis to that area, and then merge that data set with a set of activation studies. So I would not want to contemplate the systematic re-establishment of the cytoarchitectural or other chemical-architectural systems. But it is important to have the tools to do that, for local experiments designed to answer local questions. Passingham: It is odd that we are talking about the functional anatomy of the human brain when we are so ignorant about the structural anatomy. Porter: We need to remember that Campbell (1905), before von Economo, undertook that very labour-intensive task and produced diagrams of the brain areas which he could define as being histologically different on a series of serial sections through the whole human cerebral cortex. These anatomical descriptions still, in my view, stand the test of subsequent investigations. Zeki: This is so only with the understanding that the cytoarchitectonic areas defined by Campbell and by everyone else since have turned out to be incorrect,
102
Discussion
to the extent that they don’t indicate functional subdivisions. I don’t think anyone would go by cytoarchitectonic maps exclusively now. In primate brains, it’s obvious that the interesting axis of organization is a tangential one, parallel to the cortical surface. So in our studies of the monkey brain we have devised three-dimensional programmes that allow us to open up a gyrus and look at a sulcus as if we were flying over it. This seems preferable to the two-dimensional maps which we also developed, which have the disadvantage that topography is lost. Are there techniques currently being used, not necessarily for MRI but just to obtain a three-dimensional map of the human cerebral cortex, in which you can keep the topographical relationships intact, but you can look into a sulcus from any angle? Mazziotta: That is an interesting question; three-dimensionality is important in understanding where you are in the brain. We have considered several approaches. In one, we dissolve the cortex away, down to the white matter, so that we have a place to put the PET cortical responses. A second approach is to take a midsagittal image of the brain and dissolve all subcortical white matter structures away until you reach the cortex from the inside out-looking at the inside of the walnut shell, as it were. You can look at cortical responses in deep sulci, by rotating that shape. Of course, the anatomical appearance of that inside-out structure is not very recognizable. Another approach is to do partial dissolving, to create an artificial ‘atrophy’; you shrink down, or dissolve, the outer pixels of the cortex, which allows you to see further into the sulci. Zeki: If you were to take a contour line through layer 4, which is present almost everywhere, could you not d o it like that? It would take twice as long as it does in the macaque monkey. Mazziotta: I don’t see why it couldn’t be done, if I understand what you are describing. Fox: What would you use to create that boundary? In magnetic resonance imaging, the CSF-grey boundary and the grey-white boundary stand out. Layer 4 might be a problem. Mazziotta: You wouldn’t have layer 4 to go by; you would have to use some arbitrary position through the width of the cortex, assuming that you were normal to the cortex in the direction of your dissolving. So it’s not a trivial issue. It would require that the magnetic resonance image had the signature of brain grey matter, so it might involve multiple scanning sequences to get enough data to be able to say that something is going to be an image of grey matter, or an image of cortex. GuIydx In the Karolinska Institute’s PET Center we use the computerized brain atlas (CBA) of Torgny Greitz and Christian Bohm for the analysis of MR and PET images (Bohm et a1 1983, 1985, 1986, 1991, Seitz et a1 1990, Greitz et a1 1991a,b). The CBA includes a standard ‘master’ brain, and images of individual brains can be adjusted in shape and size to this standard brain. For the standardization procedure we use as landmarks the contours of the cerebral
Relating structure to function in vivo
103
and cerebellar surfaces and those of the ventricular system. After standardizing dozens of MR images of individual brains, we have found that certain anatomical structures exhibit more stability with respect to their appearance and anatomical localization than others. Phylogenetically ‘ancient’ sulci (such as the central sulcus, the precentral and postcentral sulci, the calcarine sulcus, or the parietooccipital sulcus) exhibit less anatomical variation than sulci which may be phylogenetically younger and specific to the human brain (e.g. sulci in the prefrontal cortex or those in the lateral superior part of the occipital lobe). In a recent investigation we standardized 12 individual brains and measured the differences between the anatomical localizations of major structures in the occipital lobe of the individual brains and those of the CBA standard brain. Measurements were made at 1 cm intervals along the contours. The average difference in the case of the cerebral surface contours in the occipital lobe was 3.17k 1.40 (SD)mm, for the calcarine sulcus 1.96f2.16mm, and for the parieto-occipital sulcus 1.86 k 2.22mm. Nevertheless, it was almost impossible to identify additional sulci on the occipital surface being present in all individual brains and showing stereotactic stability throughout all the subjects. These data may support earlier observations by anatomists on the anatomical stability of gyral patterns in the human brain, namely that certain primordial structures are more stable than others (Connolly 1950,Talairach et a1 1967,Ono et a1 1990). Have you had a similar experience, Dr Mazziotta? Mazziotta: The best answer to that question comes from teachers of neuroanatomy: when one describes the brain, consistent items are fissures; they are identifiable. But they are not consistent in position, shape and direction. In our between-subject study we had to be able to rely on our ability to find a given midsagittal structure; it had nothing to do with consistency or identifiability outside that domain. We are now systematically looking for objects, shapes, or neuroanatomical landmarks, that a relatively naive individual could recognize reliably. It would be best if those landmarks had some other basis-neuroembryological, or as a growth centre- where we learn about the history of how the brain developed or evolved as key points, and homologous points between brains, in a given species. Fox: One could interpret your image of the crisp brainstem and the blurred cortex (Fig. 5 ) as simply indicating that in relation to the cerebral hemispheres, the brainstem is quite variable in position. If you fix the hemispheres relative to the anterior and posterior commissures, the averaged MRI images created by the groups in Stockholm, Montreal and elsewhere do show sulcal markings. So it is not so clear that the stereotactic approach is flawed. Professor Zeki brought up the idea of opening a sulcus, to see where the PET activation is. I suspect that the resolution of PET is not good enough for this to provide new information. Mazziotta: I agree that one can interpret the averaging in this way, with brainstem varying in its orientation in different people, with a resultant blurring
104
Discussion
of the cerebrum. That’s not to imply that stereotaxy doesn’t work. Clearly, you can operate it with a certain degree of accuracy and find expected structures. How good is it? These kinds of combined approaches may lead to answers to that question. In any of these systems, sites close to or between centres of the origin of the coordinate system will be best preserved, so that volume of tissue is going to be most accurately depicted. With regard to spatial resolution and the problem that Professor Zeki posed, there is certainly no point in localizing beyond the limits of the technique making the measurement. While it might not be possible to identify a focal activation at a given point in the depth of a sulcus, on one side or the other, one might be able to say that there is a difference in two different activations between the two sides. If you had a motor activation task, where the subject did something with a given finger, and you saw a site of activation in the cortex, you might not be able to say whether that was motor or sensory, or a combination of the two, using current PET resolution. If you could re-create that movement passively, so you had only a proprioceptive input (which is no small challenge), you might see that that site was now at a different point from the original one. You would then have the question of whether the first was a combination of motor and sensory, and the second task, pure sensory. Nevertheless, small differences might be of interest in the kind of issue that Professor Zeki raised. Zeki: Dr Fox is being much too pessimistic about this. The resolution of PET will improve quite a lot. Mazziotta: The other feature of this issue, and one reason we are so interested in primate studies, is the assumption that blood flow or metabolism and electrophysiology are matched. Our goal is to do combined experiments in the same animal, with electrophysiological recording in the behaving animal during PET scans. The kinds of instruments required, as well as the animal PET scanner, should help to resolve some of these questions, although they have their own complexities when you record from a small volume of tissue and scan from a larger volume. Evans: In your averaged images, were any cortical landmarks attempted? It is extremely difficult to track them down. Mazziotta: No. As I said, I didn’t feel confident in identifying cortical landmarks. The two that we attempted in cortical regions were the occipital pole and the frontal pole, so we only had that small inferior portion of the cerebrum identified. Evans: We attempted to identify some cortical landmarks (see below, p 106). This will be a serious problem with tomographic displays. Cortical surface display, and the facility for tagging specific cortical landmarks on such a display, would be very helpful. Passingham: We found the occipital and frontal poles difficult to identify reliably. I imagine that there is some ‘slop’ in your method?
Relating structure to function in vivo
105
Mazziotta: We used a sagittal image where the aqueduct was in focus and then chose the anteriormost and posteriormost points. They need not be the true occipital and frontal pole in that brain. Raichle: As this discussion is unfolding, I get a sense that MR is marching along getting better and better, and PET likewise, and we keep pasting the two together. But why couldn’t we use them more interactively, particularly using MR anatomy to constrain PET functional image data? Because magnetic resonance imaging will always lead PET in terms of spatial resolution, and if one is doing within-subject averaging, particularly when thinking about activation responses, where we subtract one image from another, perhaps we could then use the two methods interactively, to guide the PET reconstruction process by prior anatomical information from MRI. Mazziotta: There’s no doubt about that. This is part of the benefit of having a means of bringing structure and function together; then you can constrain the analysis of the PET. Zeki: What is meant by using ‘prior anatomical information’ in the reconstruction process, Dr Raichle? Raichle: It’s a rather simple concept. The resolution, for example, of PET is presumably not going to become as good as that of MRI, so you impose your PET image on an MR slice, and, if you look at it carefully, some of the data will spill out over the edge, because the resolutions of the two processes are different, You could ‘trim’ the edge of your PET image to fit the MRI, but this is hardly the best way to deal with the difference in spatial resolution of the two techniques, because you know that the PET data didn’t come from outside the brain, but from inside. So if one knows the properties by which the image has been reconstructed, one could use that to put the data ‘back into the brain’, guided by the anatomy as displayed by MRI. This sort of process creates noise, so it isn’t without cost, but it has been raised in the area of looking at brains with atrophy, which is where we first thought about this issue. To extend it further to the issue of cortical responses to functional activity, one might consider trying to constrain that activity to grey matter, assuming that it didn’t come from outside the brain and that the contribution from the underlying white matter is significantly less than that of the grey matter. I don’t know how far you can take this, but certainly activity outside the brain doesn’t belong there. We have a great deal of information in the MRI, and simply overlaying PET and snipping around the edges doesn’t take advantage of the kind of information available. Jones: An additional application of NMR, again from the constraining point of view, is to use it to guide the reconstruction process for areas that one wants information about. Reconstruction techniques exist which have signal-to-noise ratio advantages compared to current back-projection methods but which take days to process the data recorded from the whole brain. There are also computationally sophisticated methods to correct for scatter, using Monte Carlo
106
Discussion
simulation techniques. These could also be applied to NMR-selected regionsof-interest within the brain. Raichle: Dr Jones refers to the maximum likelihood algorithms, which at one point took 17 hours for the reconstruction of an image, but with computer technology today, this takes 15 minutes or so. These kinds of algorithms lend themselves to this kind of ‘prior anatomical information’, basically putting the activity back in the brain from whence it came. Zeki: Could 1 suggest a not improbable scenario? Suppose we study someone’s vision by PET and MRI. Then he or she dies and leaves the brain to us. We section that brain and look at its cytochrome oxidase content. We have a reasonable way of determining the extent of V1 and V2 from the cytochrome oxidase architecture. If you do have such a coincidence of circumstances, you will need a highly detailed reconstruction of the occipital lobe, but one that would be really worthwhile if you had obtained prior information with PET and MRI studies. Raichle: There is a great opportunity for interaction here, and there are people thinking about how to deal with these things mathematically. Lassen: Dr Mazziotta, I can’t understand why you try to superimpose the deoxyglucose map on the MRI map, because with a deoxyglucose map in the non-activated state you have no landmarks. If the eye or the fingers were moving, you would see the location of the corresponding active areas. Wouldn’t this be a more meaningful way of mapping identical structures, by saying that in this subject and that subject, or in this or that state, we have the finger moving and use its area as an internal standard? Muzziotta: This is simply an example. One thing we are beginning to see is whether there is a correspondence between functional and anatomical landmarks. Lussen: But we already know that no perfect agreement can be expected. It is known from stimulation of the exposed cortex that the hand area can be found not to lie at a completely constant place, relative to gross anatomical landmarks. Mazziotta: Is there consistency between functional sites in the brain, once the variance in the anatomy has been taken out of it? We don’t know that. Evans: In Montreal, we have been grappling with the problem of inter-subject variability. We have transformed MRI data from 16 normal subjects into stereotaxic space using both the conventional linear scaling approach and a nonlinear warping algorithm (Bookstein 1989). The algorithm has been implemented in three dimensions and, using an interactive 3D pointer, we identified 26 distributed landmarks throughout each brain and in a ‘master’ brain. I agree with you that it is very difficult to identify cortical landmarks but, since this is the area where we most need to reduce variability, we went t o some lengths to obtain such landmarks. The combined use of the 3D display interface and the Talairach atlas allowed us search for a specific landmark by its Talairach coordinates in each of three orthogonal image planes, rather than by vague terms such as ‘frontal pole’. These point ensembles from each data set were used to
Relating structure to function in vivo
107
define either a direct non-linear mapping or a best (least-square sense) linear mapping from each individual brain volume to the master space. We found (Evans et a1 1991) that the average image using the non-linear model was significantly sharper than that obtained by the conventional model, with a residual variability of 6-7 mm left over after the linear step. We hope that this will manifest itself in the averaged PET subtraction image as an increased signalto-noise ratio, but that remains to be seen. Frackowiak: It seems to me, from what I have heard here so far, and from our own experience, that in functional mapping experiments at present one is obliged to average across subjects, and in that case there is no need for anatomical information from any structural scanning. This is because the resoIution of the PET scanners at the moment is so good, in relative terms, and perfectly adequate, because we know that there is an inter-subject variability in gyral anatomy that is considerable, and that obliges us to smooth the flow maps for averaging in any case. Because of the variation in size and shape of individual brains we must re-orient and re-sample the blood flow data from subjects into a standard space. We use an excellent stereotactic atlas, which may bear no relationship to reality, but is organized around a standard set of coordinates that identify structures, in the standard space. We can therefore all work within this common reference and identify the average position of structures, give them coordinates, and communicate our data. Where MRI or CT scanning come into their own in relation to PET is in the single-subject study. The finer structural resolution may help us to overcome difficulties with the absolute quantitation and assignment of activation foci to individual gyri or their banks which are a result of the poorer intrinsic spatial resolution of the PET-derived blood flow maps. The other way in which structural scanning will be of major importance to PET studies is in the functional investigation of subjects in whom the brain anatomy is distorted in some way, developmentally or pathologically. But if we are talking about mapping the brain in groups of subjects, this degree of precision is in my opinion not especially useful, and I doubt whether it’s necessary to go to those lengths. Porter: You are saying something very similar to Dr Lassen, namely that if you are looking at functional mapping, it doesn’t have to be superimposed on structural diagrams or physical geography; it is sufficient to use the functional definition of an activated location. Frackowiak: The study of individuals as opposed to groups of subjects requires a reason. One reason may be that the individual has a disease, or that questions more profound than simply asking ‘where is there a change of blood flow across different brain states?’ are being asked. You may for example want to